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Abstract
Biofilms have been implicated in recurring nosocomial infections, often associated
with high mortality rates. Crucially, they have also been shown to be highly tol-
erant to commonly used antibiotics. In this work I investigated how the biofilm
lifestyle protected bacterial cells from antibiotics. I engineered an environmental
Escherichia coli isolate to express a clinically relevant blaCTX-M-14 gene which con-
fers resistance to β-lactam antibiotics, including third generation cephalosporins.
β-lactamases are considered to be potential social traits, i.e. public goods whose
advantages are shared between bacterial cells. I used the resulting experimental
system to test three central hypotheses: (a) social interactions between bacterial
strains are enhanced in biofilms compared to planktonic cultures, and coopera-
tion is facilitated when strain segregation is permitted, (b) the biofilm structure,
including the matrix and cell localisation, affects biofilm tolerance & (c) the phys-
iological state of bacteria in biofilms influences antibiotic tolerance.
I found that biofilms facilitate cheating but the dynamics of this behaviour did
not always agree with theoretical work on social evolution; in particular, cooper-
ative cells did not benefit from high frequencies as was expected. Additionally,
I used Optical Coherence tomography (OCT) and fluorescence microscopy to in-
vestigate the colony biofilm structure and strain localisation within the biofilms,
and observed distinctive responses to antibiotic treatment. This was the first
time colony biofilms were observed it their entity using microscopy. Finally, I
concluded that the metabolic rates of cells did affect antibiotic tolerance but a
straightforward correlation between metabolic rates and growth rates could not
be established. Taken together, my results suggest that both the sociality of
β-lactamase expression and the intrinsic tolerance associated with the biofilm
lifestyle may be significant factors in E. coli biofilm resistance to β-lactam an-
tibiotics. This has implications for the development of antimicrobial strategies
against Gram-negative bacteria.
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Chapter 1
Introduction
Increasing bacterial antibiotic resistance has become a great concern in the last
decade. A recent report from the United States [CDC, 2013] estimates that more
than two million Americans are infected by antibiotic resistant strains every year,
23,000 of whom die. Increased resistance has been reported in nosocomial and
community settings [Bean et al., 2008]. Some of the most important threats in-
clude the multi β-lactam resistant Enterobacteriaceae, such as Escherichia coli
and Klebsiella spp; the number of deaths attributed to this family of bacteria is
1700 per year [CDC, 2013]. According to a European wide survey on healthcare-
associated infections in hospitals, a third of in hospital environments were re-
ported to be resistant to third generation cephalosporins with Klebsiella pneu-
moniae and E. coli showing the highest resistance levels [ECDC, 2013]. Other
resistant Enterobacteriaceae reported in this study included Enterobacter spp and
Proteus spp but levels of resistance did not exceed 5% in those cases. An increase
in the resistance of Escherichia coli to β-lactam antibiotics [HPA, 2007] and to
third generation cephalosporins more specifically [WHO, 2014] have also been re-
ported. One of the main reasons for the increased antibiotic resistance is consid-
ered to be the overuse of antibiotics [ECDC, 2010]. According to the UK’s NHS
data, β-lactams are the most commonly prescribed antibiotics [NHS, 2010]. A
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case study of treating necrotizing fasciitis (flesh-eating disease) caused by Enter-
obacteriaceae, carrying the blaCTX-M-15 gene, highlights the difficulty and dangers
involved in the spread of antibiotic resistance seen worldwide [Soleimanian et al.,
2011].
Bacteria often develop or acquire tools that confer inherited antibiotic resis-
tance, i.e. resistance mechanisms that can be passed on to daughter cells. Sponta-
neous mutations subsequently selected for (vertical evolution), or horizontal gene
transfer (transformation, conjugation & transduction) are the main mechanisms
of such resistance [Tenover, 2006]. Genes acquired through horizontal transfer
may also mutate, thus enriching the arsenal of antibiotic resistance tools. The
spread of the genes coding for Extended Spectrum Beta Lactamases (ESBLs) is
a good example of this latter mechanism [Woodford & Ellington, 2007]. ESBLs
comprise of β-lactamases produced by any of the TEM [Perilli et al., 2002], SHV
[Kliebe et al., 1985] and CTX-M [Cottell et al., 2011] genes and they are capa-
ble of inactivating penicillins and third generation cephalosporins. Of the ESBL
genes, CTX-M is the one that has become of increasing concern over the last few
decades as its variants have been isolated more frequently from patients in hos-
pitals and in community settings, especially in Europe [Canto´n & Coque, 2006;
Livermore et al., 2007; Woodford et al., 2004]. It is believed that the CTX-M
genes were mobilised from the chromosome of Kluyvera spp on plasmids and then
spread to other species via horizontal gene transfer [Humeniuk et al., 2002]. At
the same time, mutations extended the spectrum of CTX-M genes further [Hall
& Knowles, 1976; Kliebe et al., 1985] as multiple variants of these genes have
been identified [Canto´n & Coque, 2006]. An additional resistance mechanism is
believed to be the appearance of phenotypic variants due to epigenetic inherited
changes of gene expression [Adam et al., 2008], including drug indifference and
persistence. “Drug indifference” refers to whole bacterial populations that are
tolerant to antibiotics, whereas “persisters” is a term attributed to the propor-
tion of cells that exhibit tolerance to antibiotics in a given population [Brauner
et al., 2016].
Another phenotypic mechanism of antibiotic resistance and the focus of this
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thesis, is biofilm formation. Biofilms are complex multicellular bacterial struc-
tures, embedded in a self-produced extracellular matrix [Costerton, 1999; Flem-
ming et al., 2007]. A biofilm infection manifests itself by reoccurrence after an-
tibiotic treatment [Davey & O’Toole, 2000] and the onset of the symptoms might
begin months or even years after infection [Fux et al., 2003]. Generally, biofilms
have been reported to be more resistant to antibiotics compared to their plank-
tonic counterparts (see section 1.2). In fact, biofilm antibiotic tolerance can be up
to 1000 fold higher than the planktonic cells they originate from [Ceri et al., 1999;
Nickel et al., 1985]. As biofilm infections need to be treated repeatedly and they
often require the removal of any infected foreign bodies (e.g valves, implants), they
contribute significantly to hospitalisation costs [Ro¨mling & Balsalobre, 2012].
Biofilms are commonly formed by pathogenic bacteria; indeed it is believed
that more than 60% of nosocomial infections in the developed world are due to
biofilm formation [Davey & O’Toole, 2000; Fux et al., 2003]. They have been
implicated in dental diseases and infected medical transplants [Wilson, 2001].
Biofilms are the leading cause of endocarditis, a disease that has a 70% mortality
rate [Davey & O’Toole, 2000]. Additionally, Pseudomonas aeruginosa biofilms
found in the lungs of patients suffering with cystic fibrosis have been associ-
ated with health deterioration and death [Emerson et al., 2002; Gibson et al.,
2003; Schaedel et al., 2002]. More specifically, Pseudomonas lung infection of
such patients results in the destruction of lung tissue, the subsequent inadequate
respiration and ultimately death [Frederiksen et al., 1999]. E. coli biofilms are
commonly implicated in urinary tract infections in women [Soto et al., 2006].
In the subsequent paragraphs I will summarise the unique characteristics as-
sociated with the biofilm lifestyle and how they may be implicated in antibiotic
resistance. A statement of the main aims of this work will complete this chapter.
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1.1 The biofilm lifestyle
The typical biofilm definition includes the bacterial structure with microcolonies
and water channels embedded in a cell-produced extracellular matrix and at-
tached to a surface [de Beer & Stoodley, 1995; Flemming et al., 2007; Maeyama
et al., 2004; Stewart et al., 2009]. However, attachment is not necessary for a
bacterial aggregate to be called a biofilm [Flemming & Wingender, 2010] and
not all biofilms are so complex; many are simple, flat and compact [Schuster &
Markx, 2013]. Finally, biofilms can be also formed by fungi and algae [Palmer et
al., 2006]. Neu & Lawrence [2010] defined biofilms on the basis of either struc-
ture or function. The structural definition includes the basic biofilm components
of microbial cells (bacteria, fungi, archaea, protozoa or algae), the extracellular
matrix (EPS) and an ”interface” where the biofilm forms. Attachment to a solid
surface is not considered necessary. The functional definition is intended to de-
scribe the effect of the microbial interactions in the biofilm on the overall function
of the structure. It is believed that the formation of biofilms is a process that
enables microbes to survive by sharing nutrients, resisting environmental dan-
gers and sharing of genes through horizontal transfer [Davey & O’Toole, 2000].
This section is dedicated to summarising the importance of the matrix and 3D
structure to the biofilm lifestyle.
1.1.1 The matrix
Most of the biofilm is made up of the matrix, which accounts for more than 90%
of its dry mass. It is constructed by the matrix-embedded bacteria and made
of extracellular polymeric substances (EPS), including polysaccharides, nucleic
acids, proteins and lipids [Branda et al., 2005; Flemming & Wingender, 2010].
However, water is the main component of the matrix and in fact, of the biofilm
as a whole [Vasudevan, 2014]. The formation and composition of the EPS de-
pends on the producing species and is affected by environmental factors such as
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temperature [Gancel & Novel, 1994; Gandhi et al., 1998], nutrient availability
[Gancel & Novel, 1994; Gandhi et al., 1998; Looijesteijn et al., 1999] and shear
forces [Stoodley et al., 1999].
The functions of the matrix are multiple and essential for the lifestyle and the
survival of the biofilm. The EPS is responsible for the adhesion onto surfaces, the
mechanical stability [Mayer et al., 1999], immobilisation and protection against
UV radiation (UV can be used to disinfect surfaces or water), pH shifts, osmotic
shock, desiccation, biocides, antibiotics and the host immune system. Addition-
ally, it serves as a nutrient source and maintains the availability of lysed cell
components such as DNA that can be used for horizontal gene transfer [Davey &
O’Toole, 2000; Flemming & Wingender, 2010].
Confocal Laser Scanning Microscopy (CLSM) has shown that the biofilm
structure consists of microbial pockets, heterogeneously distributed and sepa-
rated by water channels [Hope & Wilson, 2006; Korber et al., 1994; Lawrence et
al., 1991; Wimpenny & Colasanti, 1997]. The water channels serve as a means to
exchange nutrients and metabolites between the microbial cell clusters [de Beer
& Stoodley, 1995; Stoodley et al., 1994]. At the same time, they function as a
waste removal system [Davey & O’Toole, 2000]. The architecture and the me-
chanical stability of a biofilm are strongly affected by the composition of the
EPS, as for instance by the types of polysaccharides, the DNA and the presence
of non-enzymatic proteins, and by the chemical interactions between its anionic
and cationic components [Flemming & Wingender, 2010; Lo´pez et al., 2010].
1.1.2 The effect of biofilm architecture on embedded mi-
croorganisms
The EPS is the main factor affecting the compartmentalisation of the biofilms
[Sutherland, 2001a,b]. The extracellular environment of each microbial pocket is
the surrounding EPS and the water channels that constitute the means of commu-
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nication and nutrient transport between the cell clusters or pockets. Therefore,
each pocket constitutes its own microniche [Costerton et al., 1994].
1.1.2.1 Chemical and physiological gradients and different bacterial
phenotypes
The biofilm architecture results in the creation of a number of chemical gradi-
ents, e.g. oxygen, nutrient and pH gradients. These in turn result in different
physiological gradients with differences in respiration rates, nutrient availability
and protein synthesis, within the same biofilm [de Beer et al., 1994; Drenkard,
2003; Tolker-Nielsen & Molin, 2000; Wimpenny & Kinniment, 1995; Xu et al.,
2000]. The microorganisms located near the outer layers of the biofilm have bet-
ter access to oxygen and nutrients and they therefore exhibit faster growth rates
than their counterparts located in deeper layers of the biofilm [Drenkard, 2003].
Similarly, those microorganisms that grow near the bulk fluid interface are more
viable [Xu et al., 2000]. Thus, different bacterial phenotypes, e.g. slow and fast
growing, can be observed within a biofilm, even when the microorganisms are
separated by a distance of as little as 10 μm [Xu et al., 2000]. This is true for
multi-species as well as single-species biofilms [Stewart, 2002].
1.1.2.2 Sociality
Social behaviours in nature are defined as those that affect the reproductive
success of the actor and another individual [Davies et al., 2012]. When those
who benefit from the behaviour include close relatives, the actor gains an indirect
benefit which add to her own reproductive success Hamilton [1964a,b].
Social traits in bacteria include sharing of resources and cooperation against
threats [Foster, 2011]. The production of iron-scavenging molecules and their
exploitation by non-producers is a well studied such trait [Griffin et al., 2004].
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Some studies have reported that the production of β-lactamases is a social trait
[Dugatkin et al., 2005; Medaney et al., 2015; Perlin et al., 2009]. β-lactamases are
located mainly in the periplasm of Gram-negative bacteria or they are excreted
in Gram-positives [Livermore & Woodford, 2006; Minsky et al., 1986; Wilke et
al., 2005]. Irrespective of where they are localised, β-lactamases clear the antibi-
otic in their immediate environment, thus potentially allowing nearby susceptible
bacteria to survive. Therefore the enzyme is utilised as a “public good” available
to producers and non-producers alike.
The biofilm architecture with its bacterial microniches is more likely to sup-
port microbial interactions, cooperative or otherwise, between metabolically dif-
ferent species [Foster, 2010; Mitri et al., 2011]. The biofilm structure has been
shown to affect social dynamics due to limitations imposed on the public good
diffusivity Ku¨mmerli et al. [2009]; Zhou et al. [2014]. Stewart & Costerton [2001]
suggested approaching the issue of biofilms in general and of biofilm resistance
to antibiotics in particular, as a defence mechanism of a multicellular organism
rather than one of individual organisms and this is the approach taken in this
work.
1.2 Current theories on the reduced antibiotic
susceptibility of biofilms
It is a commonly shared view within the research community that biofilms show
increased resistance to antibiotics and biocides [Bordi & de Bentzmann, 2011;
Donlan & Costerton, 2002; Olson et al., 2002; Prashanth et al., 2007; Prosser
La Tourette et al., 1987; Smith, 2005; Tresse et al., 1995]. Higher antibiotic
resistance in biofilms by 10 - 1000 fold has been reported [Cerca et al., 2005;
Mah et al., 2003]. Even bacteria that are normally susceptible to antibiotics may
develop tolerance when in biofilms [Stewart & Costerton, 2001]. However, the
biofilm-forming bacteria do not always show increased antibiotic tolerance out-
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side the biofilm context [Lewis, 2007]. It is generally believed that this increased
tolerance is not a result of the inherited resistance mechanisms used by plank-
tonic bacteria [Stewart & Costerton, 2001]. The only exception to this might be
the up-regulation of eﬄux pump mechanisms in some bacterial biofilms formed
by some Pseudomonas and E.coli strains [Drenkard, 2003; Hancock & Klemm,
2007]. In other cases, researchers have suggested alternative mechanisms instead,
as discussed in the following subsections. Four theories regarding the mecha-
nism of tolerance in biofilms are discussed below: limited antibiotic penetration
through the matrix, antibiotic inactivation by β-lactamases, social interactions
and physiological state.
1.2.1 Limited antibiotic penetration
One of the most popular theories on why biofilms appear to be more tolerant to
antibiotics is that the biofilm structure and matrix inhibit the penetration of those
substances. This could be achieved by slower diffusion of the antibiotic within
the matrix, enzymatic inactivation of the applied antibiotic and/or removal of
the antibiotic through the water channels. Diffusion and matrix effects as well as
antibiotic inactivation by β-lactamases are discussed below.
1.2.1.1 Diffusion and matrix effects
An obvious explanation of the increased tolerance to antibiotics exhibited by
biofilms seems to be the presence of the matrix. The matrix may hinder the
diffusion of antimicrobial substances into the deeper layers of the biofilm either
by acting as a physical barrier or by binding the molecules. In fact, the thickness
of the matrix has been associated with limiting the penetration of leukocytes
in Staphylococcus aureus biofilms [Fux et al., 2003; Leid et al., 2002]. However,
theoretical studies on the diffusion and absorption (e.g. binding of antibiotics
to periplasmic glucans [Mah et al., 2003]) of several reactive and non-reactive
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substances through biofilms indicated that although absorption may hinder an-
tibiotic penetration, it does not sufficiently explain resistance [Stewart, 2002].
The action of the antibiotics rifampin, ampicillin and ciprofloxacin, as visualised
with the aid of electron microscopy in two studies [Zahller & Stewart, 2002; Zheng
& Stewart, 2002], also showed that in most cases antibiotics were able to reach
the cell clusters within the biofilms, but not to kill them. The case was different
for ampicillin in biofilms of β-lactamase producing strains. These experiments
are described in detail below.
1.2.1.2 Inactivation of β-lactam antibiotics by β-lactamases
Anderl et al. [2000] investigated the penetration of ampicillin in wild type Kleb-
siella pneumomiae biofilms. This team of researchers developed biofilms on poly-
carbonate filter membranes and then exposed them to 5000 μg/ml antibiotic con-
centration, 10 times the Minimum Inhibition Concentration (MIC) as measured
in planktonic cultures of the same species. β-lactamase producing K. pneumonia
prevented ampicillin from penetrating the biofilm while the antibiotic penetrated
the β-lactamase deficient biofilms. On the other hand, similar experiments with
ciprofloxacin showed that this type of antibiotic penetrated the biofilms in less
than 20 min. The authors attributed their results to inactivation of ampicillin by
β-lactamase enzymes in the surface layers of the biofilms at a rate higher than the
diffusion rate. The two Klebsiella strains were shown to have similar growth rates
and ciprofloxacin susceptibilities as well as biofilm structures, as seen under the
microscope, which means that those factors did not account for the differences
seen.
Zahller & Stewart [2002] investigated the penetration of ampicillin & ciprofloxacin
in Klebsiella pneumoniae colony biofilms grown on polycarbonate filter mem-
branes. The biofilms were grown using the method described by Anderl et al.
[2000]. The biofilms were then fixed, stained and cut before examination under
the transmission electron microscope (TEM). Each biofilm was sampled at three
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locations, namely, near the air interface, in the middle of the biofilm and near
the filter membrane. These workers found that ciprofloxacin did affect the cells
near the air interface, as these were shown elongated in the TEM images (cell
elongation is caused by the antibiotic interference with the chromosome segrega-
tion) and their density was reduced. No elongation was observed in the other two
locations. Biofilms treated with ampicillin were greatly affected by the antibi-
otic when the biofilm former was not a β-lactamase producer. Bloated and lysed
cells were evident at all three locations, although some areas in the middle of the
biofilm appeared unaffected.
The scenario was completely different when the biofilms formed by a beta-
lactamase producing strain were examined; TEM images did not show any evi-
dence of antibiotic action in this case anywhere in the biofilm. The authors hy-
pothesised that the antibiotic was hydrolysed by β-lactamases at the outer layer
of the biofilm at a rate faster than its diffusion rate thus preventing its penetra-
tion into the biofilm. Giwercman et al. [1991] showed that β-lactamases in Pseu-
domonas aeruginosa biofilms are inducible by β-lactam antibiotics (imipenem and
piperacillin) and that the production of the enzymes was higher with higher doses
of antibiotics. Similarly, the average β-lactamase activity developed in the pres-
ence of carbenicillin was 1.5x higher in Pseudomonas aeruginosa biofilms than in
planktonic cells [Davies & Geesey, 1995]. These results indicate that β-lactamases
when present do play an active role in increasing the biofilm resistance.
1.2.2 Tolerance due to physiological variation
It has been proposed that the presence of nutrient, pH and oxygen gradients in
the biofilm that result in different bacterial growth levels may be one of the fac-
tors contributing to the increased antibiotic tolerance of these structures [Stewart
& Franklin, 2008; Walters et al., 2003], as antibiotics such as β-lactams have been
found to be effective against rapidly growing bacteria only [Tuomanen et al.,
1986]. Ito et al. [2009] also found an association between growth rate and antibi-
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otic efficiency by showing that antibiotics (ampicillin, kanamycin and ofloxacin)
were less effective against planktonic E. coli cultures growing without glucose
compared to those growing on glucose. In order to test the effect of growth
rate in E. coli biofilms on antibiotic resistance, these researchers developed ma-
ture biofilms in flow cells and then removed the surface layers of the biofilms
by air flushing (to reduce any effects of limited penetration and heterogeneous
physiological stages). When kanamycin and ofloxacin were applied to those cells,
consisting of the inner layers of the biofilms, regrowth of the biofilm was inhibited.
Treatment with ampicillin though did not inhibit regrowth after the antibiotic
was removed from the growth medium; thick biofilms were formed again after
72 h. The resistance to ampicillin shown by Ito et al. [2009] and attributed to
persisters was explained as the result of the low metabolic activity of this type of
cells. In essence, since β-lactam antibiotics inhibit cell wall synthesis and there
is no such synthesis in persisters, the antibiotics are ineffective. This theory was
further supported by the results shown with the use of ofloxacin, which killed the
bacterial cells.
Zheng & Stewart [2002] also used the Anderl et al. [2000] system coupled with
TEM in order to investigate the penetration of rifampin in Staphylococcus aureus
biofilms. The workers concluded that although the biofilms were again protected,
this was not due to limited penetration of the antibiotic as the cell densities and
frequencies were reduced especially near the biofilm-air interface. Also, the cell
wall was found to be thicker after treatment with antibiotics in all locations and
thickening of the cell wall is considered to be a common reaction to antibiotic
treatment in Staphylococci. In this case the authors suggested that the biofilm
was protected due to the presence of slow-growing bacteria in the deeper layers
of the biofilm.
Contrary to the common belief that biofilms are more resistant to antibiotics
than planktonic bacteria, Spoering & Lewis [2001] reported that this is not actu-
ally the case when comparing planktonic stationary phase bacteria and biofilms.
In fact it was the stationary phase bacteria that appeared to be more resistant
than biofilms to a range of antibiotics (ofloxacin, tobramycin, carbenicillin and
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peracetic acid). The authors attributed the results seen to the presence of per-
sisters in stationary phase, biofilms and exponential phase bacteria in order of
decreasing abundance.
1.3 Aims and objectives
The overall aim of this project was to investigate the mechanisms of resistance
to β-lactam antibiotics in E. coli biofilms using a single experimental system in
an attempt to eliminate variations on the results due to system differences. An
environmental natural biofilm-forming isolate was used in order to exclude arte-
facts of biofilm formation by laboratory strains that may not apply to naturally
occurring ones.
β-lactamases were approached as a social trait when investigating the effect
of producers on the biofilm population under antibiotic stress. Novel methods
were developed to allow for the visualisation of the cells in the whole depth of
the colocy biofilms using confocal microscopy and Optical Coherence Tomography
(OCT). Furthermore, susceptible biofilm tolerance to antibiotics was investigated
using a new approach designed with consideration for the physiological state of
the cells in the biofilms.
After engineering the system in order to express a clinically relevant β-lactamase
gene (Chapter 2), the following factors were investigated for their contribution to
biofilm resistance:
• The production of β-lactamases and their use as a public good, i.e the extent
of protection offered to susceptible bacteria in biofilms (Chapter 3)
• The interactions between the antibiotic and the biofilm structure, i.e. the
matrix and the spatial mass distribution (Chapter 4)
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• The metabolic activity in biofilms and its relationship to antibiotic tolerance
(Chapter 5)
A general discussion on the results obtained and their relevance to current
research and real life applications is provided in Chapter 6.
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Strain selection and engineering
The aim of the experiments described in this section was to select a wild type
(WT) Escherichia coli strain that possesses the ability to form biofilms and sub-
sequently to genetically manipulate this strain, in order to create a pair of vi-
sually identifiable, isogenic bacteria that would be positive or negative for the
production of an Extended Spectrum Beta Lactamase (ESBL), coded for by the
blaCTX-M-14. The WT strains screened for biofilm formation properties were pre-
viously isolated from UK farms in Surrey and Berkshire in Spring-Summer 2012
[Medaney, 2014].
2.1 Introduction
2.1.1 Selection of a β-lactamase enzyme
β-lactamases are a diverse group of enzymes that are divided into four classes (A,
B, C & D) on the basis of their aminoacid motifs, or in three groups based on their
functionality (Group 1-cephalosporinases, Group 2 - serine β-lactamases & Group
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3 - metallo-β- lactamases) [Bush & Jacoby, 2010]. The Extended Spectrum Beta
Lactamases (ESBLs) form a heterogeneous group of enzymes that belong to class
A, Group 2 and can be divided into nine further clusters [Bonnet, 2004]. They
are most commonly defined as the β-lactamases that can hydrolyse penicillins,
the three first generations of cephalosporins and aztreonam [Paterson & Bonomo,
2005]. At least 26 bacterial species carry these genes but they are particularly
prevalent in E. coli [Zhao & Hu, 2013].
The ESBL gene used here was the blaCTX-M-14 gene, which belongs to the CTX-
M-9 group [Bonnet, 2004; Canto´n & Coque, 2006]. CTX-M-14 β-lactamases are,
along with CTX-M-15, the most widespread type of ESBLs in the world [Dhanji
et al., 2012]. Cottell et al. [2011] identified the blaCTX-M-14 gene on plasmid
pCT, which was isolated from an E. coli strain on a cattle farm in the UK. The
prevalence of CTX-M-9 group β-lactamases in the UK in 2004 was reported to be
4.1% in hospital isolates [Woodford et al., 2004]. CTX-M-14 carrying plasmids
were detected in 19% of human clinical isolates of E. coli in 2012 [Dhanji et al.,
2012]. This indicates an increase in prevalence of approximately 5-fold within 8
years (2004 to 2012).
2.1.2 Selection of a reporter gene
The use of fluorescence in biology and in biofilm research in particular has been
proven to be of great value (see for example Almeida et al. [2011]; O’Connell et
al. [2006]; Park et al. [2011]). Several important characteristics of the fluores-
cent proteins for experimental work, include brightness, photostability, toxicity
and environmental sensitivity [Shaner et al., 2005]. In general, brightness is an
inherent property of the given protein. Photostability is determined by the light
source and intensity but the mechanisms are not well understood at present. The
ideal maturation rate of the protein is faster rather than slower, in order for the
final signal to be high and stable [Zeiss, 2014]. Additionally, the chosen proteins
have to be optimised for expression in the chosen biological system.
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2.1.3 Challenges related to the use of recombinant pro-
teins during genetic engineering of cells
Working with recombinant proteins presents several challenges, the most impor-
tant ones being the potential loss of expression, the correct protein folding after
translation and the potential toxicity for the host cell. Several protein delivery
systems are currently in use, one of them being the incorporation of the gene of
interest onto a plasmid. This offers the advantage of a relatively easy genetic
manipulation, as well as a high gene dose, especially when the plasmid-carrier is
a high-copy plasmid [Palomares et al., 2004; Rosano & Ceccarelli, 2014]. How-
ever, maintaining the plasmid imposes a metabolic burden on the host bacterial
cells, which increases as the size of the plasmid, the size of the insert, the ex-
pression levels and the protein toxicity increase. This metabolic load results in
lower growth rates that carry the risk of the faster-growing, plasmid-free cells
overtaking the population [Baneyx, 1999; Palomares et al., 2004]. Environmental
factors such as nutrient availability and growth temperature can have an impact
on the plasmid copy number and as a result, on the plasmid stability [Palomares
et al., 2004].
When the gene of interest is incorporated directly into the host’s chromosome,
which is another commonly used delivery system, the stability issues described
above can be eliminated [Baneyx, 1999]. However, the process can be very time-
consuming and the production rate of the protein of interest low, as fewer copies
of the gene are usually present in this case.
With regard to how environmental factors more specifically affect protein
expression and plasmid stability, Broedel et al. [2001] investigated the effect of
growth media on the expression of a range of recombinant proteins in E. coli cells,
including Green Fluorescent Protein (GFP). The authors concluded that there is
no ideal medium for the expression of all proteins but instead that each protein
showed better yields in a different medium. However, LB was not the best medium
in any one case. For flow systems in particular, buffered media were believed to
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be more effective for high protein yields. In addition, nutrient limited growth
conditions can affect plasmid stability [Kumar et al., 1991]. Hebisch et al. [2013]
found that the E. coli strain chosen as an expression system, and more specifically
the growth rate and the duration of the lag phase, plays an important role in
the maturation of GFP and mCherry fluorescent proteins. These researchers
concluded that any correlation of fluorescent protein expression with the bacterial
growth rate and lag-time is not consistent across the spectrum of fluorescent
proteins and cannot be generalised. The role of growth rate in the gene expression
in bacteria was also investigated by Klumpp et al. [2009] who modeled the effect
of growth rate (in limited media) on the level of constitutively expressed proteins
and found that the protein concentration was decreased at faster growth, although
the number of protein copies per cell increased. The authors argued that this was
a result of the increased cell volume Klumpp et al. [2009].
Finally, another issue that needs to be considered is the cost to the bacterial
cell of unneeded proteins, such as fluorescent proteins. Shachrai et al. [2010] found
that during the early exponential phase the cost of unneeded proteins (GFP or
lac operon) was high, but that this cost decreased substantially during what the
authors named as, exponential phase 2, even as the protein production increased.
E. coli broth cultures in minimal and rich media were used for this study. Bacteria
experienced phase 2 between 12.5 and 17.5 h of growth in minimal media, while in
rich media (supplemented with amino acids) the reduced cost lasted for longer,
beyond the 17.5 h. These workers also found that the increased protein cost
during phase 1 was associated with a high ribosome production rate which at this
stage, was a growth-limiting factor. In phase 2 ribosome and protein production
balanced out and the protein production cost decreased.
In conclusion, a system expressing a recombinant protein, and more specifi-
cally a fluorescent protein, should have a number of characteristics as listed below,
in order to be reliable:
• The proteins chosen should be suitable for expression in the desired biolog-
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ical system
• The expression of the fluorescence should be stable for a given period of
time, defined by the desired length of the experiments
• The stability of the expression should be consistent throughout all sets of
experiments undertaken
2.2 Materials & Methods
2.2.1 Media and antibiotics
Lysogeny Broth (LB) (Lennox), Terrific broth and 2% (w/v) LB agar plates
were prepared according to the manufacturer’s instructions (Sigma L3022; Sigma
T0918; Oxoid LP0011). Working solutions of 20 μg/ml chloramphenicol (chl),
100 μg/ml ampicillin sodium salt (amp) and 8 μg/ml cefotaxime (cef) were used
for the preparation of antibiotic-containing media. Ofloxacine (ofl) for the Mini-
mum Inhibition Concentration (MIC) assay was from Sigma (O8757). Phosphate
Buffered Saline (PBS; Sigma-Aldrich PBS tablet, Cat no P4417-100AT) was used
for serial dilutions. 1 mM Isopropyl-beta-D-thiogalactopyranoside (IPTG)(Apollo,
BIMB1008) was used for the recovery of transformants and was added to all media
to induce the IPTG-inducible lac promoter of the fluorescent genes.
2.2.2 Screening for biofilm formers
Bacterial strains. Fourty-eight (48) Wild Type (WT) E. coli strains were re-
covered from glycerol stocks and screened for their ability to form biofilms, in
comparison to a positive control (E. coli, Nissle 1917) and a negative control (E.
coli DH10β). E.coli Nissle 1917 was isolated from Mutaflor capsules containing
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2.5x109 bacterial cells (capsules bought from Linda Versand Apotheke in Ger-
many). The capsule was cut with a flame sterilized scalpel and the contents
released in 10 ml PBS. The solution was vortexed, serially diluted in PBS and
plated. A colony was picked after a 24 h incubation at 37 ◦C and used to make
glycerol stocks for the positive control.
Screening protocol. Individual bacterial colonies from agar LB plates were
incubated in LB broth at 37 ◦C with agitation at 180 rpm. After 24 h, 5 or 1
μl of inoculum was transferred into a 24-well (first two assays) or 96-well plates
containing 1 ml or 180 μl of LB respectively. The plates were incubated for 24
h at 37 ◦C, with agitation (120 rpm). A slightly altered procedure was followed
after the second round of screening due to a relatively high variability observed
in (OD) readings between replicates of the same sample. Inoculated well-plates
were initially incubated overnight (16 h) at 37 ◦C with agitation and then left
in the incubator for another 24 h without agitation in order to allow for any
biofilms formed to stabilize. After removal of the LB medium with pipetting,
each well was washed gently with PBS in order to remove loosely attached cells
that were not part of the biofilm. The PBS was then removed and the cells that
were attached to the walls and the bottom of the wells were stained with 1 ml
or 180 μl (equal to the initial broth volume) of 0.5% (w/v) Crystal Violet (CV)
solution (in PBS) and left to incubate at room temperature for 20 min. The dye
was washed three times with PBS solution (volume equal to CV solution used) in
order to remove any excess dye that was not staining biofilm cells. The remaining
dye was subsequently solubilised with a 20% acetone/ 80% ethanol solution in
order to detach any biofilm from the walls of the well plate and measure the
Optical Density (OD) of the solution. The sample OD was measured at 600nm
wavelength, using a SpectraMax 190 absorbance microplate reader (Molecular
Devices). The samples were mixed by shaking for 5 sec before reading. The
experiments were performed in a stepwise manner: the best biofilm formers from
step 1 were compared to new strains in step 2 until the final step, where the
pre-selected best biofilm formers were also compared against the positive control.
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2.2.3 Plasmid construction and bacterial transformations
Bacterial strains and plasmids. DH10beta was used for cloning. The pCT
plasmid (described by Cottell et al. [2011]), carrying the blaCTX-M-14 gene was
provided by the Animal Health and Veterinary Laboratories Agency (AHVLA,
Weybridge, UK). Plasmid pTopo carrying the dif-CAT (chloramphenicol gene)
cassette was provided by Cobra Biomanufacturing [Bloor & Cranenburgh, 2006].
The fluorescent vectors pAmCyan and pE2-Crimson, optimised for bacterial ex-
pression and recommended for propagation in E. coli, were bought from Clontech
(Cat no 632440 and 632553 respectively). The properties of the fluorescent pro-
teins carried by these vectors can be found in Table 2.1. The commercial vector
plasmid maps can be seen in Fig. 2.1.
Table 2.1: Properties of the fluorescent proteins used in experiments
Vector pE2-Crimson pAmCyan
Origin of replication pUC pUC
Selective gene Ampicillin Ampicillin
Fluorescent protein Promoter lacZ lacZ
Fluorescent Protein E2-Crimson AmCyan 1
Protein Origin DsRed-Express2 Anemonia majano
Excitation max 611 nm 458 nm
Emission max 646 nm 489 nm
Extinction coefficient 126000 Mol-1 cm -1 39000 Mol-1 cm -1
Brightness (Relative to EGFP) 180
Obtaining the vector/insert constructs. The antibiotic resistance genes
(blaCTX-M-14 and CAT) and the vectors were amplified by PCR with SacI sites
at both ends. The Clontech fluorescent vectors were used as the backbone with
all their original elements intact, except for part of the ampicillin resistance gene
(Ampr) which was replaced by the CTX-M-14 or CAT gene. For further details on
PCR (primers, cycles, reaction components) see Appendix A. All PCR products
were confirmed with gel electrophoresis.
Digestions and ligations. All PCR products (inserts and vectors) were
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Figure 2.1: Backbone of the Clontech plasmids (taken from www.clontech.com)
cleaned up with the Promega Wizard SV Gel and PCR Clean-Up System (Cat
no A9281) before digesting with enzyme SacI-HF, chosen because this restriction
site not present in any of the vectors or inserts. Typical digestion volumes were
50 μl (to avoid star activity), containing 0.5 -1 μg DNA. The reactions were
incubated at 37 ◦C for 30 min to 1.5 h. The vector was dephosphorylated with
an alkaline phosphatase that was added into the vector digestion reaction after
the first 30 min and the whole reaction was incubated at 37 ◦C for another 15
min. The digestions were cleaned up, before proceeding to ligations, with the
same Promega clean-up system mentioned above. The typical ligation volume
was 20 μl and the vector:insert ratio was calculated by formula 2.1. Typical
vector:insert ratios were 1:2, 1:3, 1:5, or 1:6. The ligations were incubated at
room temperature for a time period of 2 h to 4 h and then inactivated as per the
enzyme manufacturer’s instructions. All enzymes used can be found in Table 2.2.
PCR primers and cycle conditions can be found in Appendix A.
ng of insert =
ng of vector ∗ insert size in kb
vector size in kb
∗ ( insert
vector
desired ratio) (2.1)
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Table 2.2: Enzymes used for the PCRs, digestions, dephosphorylations and ligations
Enzyme Provider Function
Q5 high fidelity polymerase (M0491S) NEB PCR (resistance genes and fluorescent vector)
OneTaq hot start high fidelity polymerase (M0493S) NEB Colony PCR
SacI-HF restriction enzyme (R3156S) NEB Sticky ends digestion
T4 DNA ligase (M0202S) NEB Sticky ends ligation
Antarctic phosphatase (M0289S) NEB Cyan and crimson dephosphorylation
TSAP (M9910) Promega Cyan and crimson dephosphorylation
Plasmid purifications and bacterial transformations. Plasmid pCT
was isolated using the Qiagen Highspeed midi plasmid kit (Qiagen, UK, Cat
no 12643). Plasmid pTopo and the subsequently engineered plasmids (cyan or
crimson with blaCTX-M-14 or CAT) were isolated with the Qiagen Highspeed mini
plasmid kit (Qiagen UK, Cat no 27104 ). The engineered plasmids were trans-
formed into DH10β-cells with electroporation using the high efficiency electro-
transformation protocol for Escherichia coli, suggested by Bio-Rad1. The trans-
formed wild strains were recovered on IPTG-containing LB plates with the ap-
propriate antibiotic selector. PCR was used used for the confirmation of the
transformants.
2.2.4 Sequencing constructed plasmids
The insertion was confirmed by sequencing. The constructed, cloned plasmids
were purified from E.coli DH10β with the Qiagen Highspeed mini plasmid kit
(Qiagen UK, Cat no 27104 ) and sent to Eurofins Genomics for sequencing. The
sequencing primers used can be found in Appendix A.
1available at http://www.bio-rad.com/webroot/web/pdf/lsr/literature/4006174B.pdf, ac-
cessed 14 Sep 2013
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2.2.5 Plasmid stability and fluorescent protein expression
Drastic strain selection. Five ml LB were inoculated with a colony of the
transformant of interest and incubated overnight (for approximately 17 h) at
37 ◦C in the presence of the relevant selective antibiotic. Five μl of this starting
culture were transferred into fresh LB (no antibiotic) for another overnight culture
for 3 passages (n=2). The cultures were sampled at the starting point (0 h) (after
the first growth cycle in antibiotic containing media) and at 24 h, 48 h & 72 h
thereafter. For the assessment of plasmid stability, part of the culture at each
sampling point was serially diluted and plated out (3 replicate plates per dilution
factor) on selective antibiotic containing media with the spread method. Those
strains that grew better on antibiotic containing plates were selected for further
stability assessments.
Improving fluorescence expression. Starting cultures grown in Terrific
broth for 17 h or 24 h were used to inoculate 5 ml LB broth tubes (time point
0). A passage assay was performed as before to assess the fluorescence expression
under these conditions. The cultures were sampled at 24 h and 48 h, serially
diluted and plated on LB and on antibiotic containing plates (chl or cef) using
the spread method. Alternatively, cultures were plated on LB and colonies picked
with sterile toothpicks and transferred to antibiotic containing plates.
For the estimation of the fluorescent protein expression the equation 2.2 was
used.
fluor. expression =
no of fluorescent colon. on LB+antib.
no of white colon. on LB+antib.+no of fluorescent colon. on LB+antib.
(2.2)
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2.2.6 Growth kinetics
Cultures of 11-CrimCTXM, 11-CyanCAT and WT CC11-1 grown for 24 h in 5 ml
Terrific broth, with cefotaxime or chloramphenicol as needed for selection, were
diluted in PBS to an OD600 = 0.05 and 20 μl were used for the inoculation of
a 96-well plate containing 180 μLB broth in each well (5 replicates per strain).
Non-inoculated LB containing wells were used as controls. The plate was then
placed in the SpectraMax at 37 ◦C and the growth was monitored for 24 h. An
OD600 measurement was taken every 5 min after a 3 sec agitation.
2.2.7 Fitness cost assay
Starting cultures were prepared as for the growth kinetics experiments and mixed
at different proportions. Mixtures included 11CrimCTXM - WT (RW), 11Cyan-
CAT -WT (YW) and 11CrimCTXM-11CyanCAT (RY) pairs (x3). A portion of
100 μl of each mixture were inoculated in 900 μl LB broth in 24-well plates and
incubated at 37 ◦C for 24 h with agitation (120 rpm). After the 24 h incubation
period the cultures were serially diluted and plated, using the droplet method, on
LB and antibiotic containing plates. Colonies were counted 24 h later. The pro-
portion of fluorescent colonies was estimated by [fluorescent colonies on LB(-ant)/
total colonies on LB(-ant)] and was confirmed by counts on antibiotic containing
plates: [total colonies on LB(+ant)/ total colonies on LB(-ant)] for higher accu-
racy. Relative fitness was calculated using Equation 2.3 [Ross-Gillespie et al.,
2007], where x2 equals the proportion of the given strain in the final point of
measurement and x1 the proportion in the initial point of measurement.
Relative F itness =
x2∗(1−x1)
x1∗(1−x2) (2.3)
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2.2.8 Minimum Inhibition Concentration (MIC) assays
For the MIC assays, starting cultures of strains CC11-1 (WT), 11-CyanCAT and
11-CrimCTXM were prepared by inoculating 5 ml Terrific Broth as before. The
cultures were grown at 37 ◦C for 24 h. After this incubation time OD600 was
measured with the Nanodrop and adjusted by dilution, if necessary, in order to
obtain cultures of similar OD. Five μl of the diluted starting culture was then
inoculated (x2) into 175 μl LB plus ampicillin, cefotaxime, chloramphenicol or
ofloxacin at 6 final concentrations (4861, 607, 76, 9.5, 1.2 or 0 μg/ml) in a 96-
well plate. The plate was placed in the Spectramax190 plate reader (Molecular
Devices) and the growth was monitored for 24 h. A measurement was taken every
5 min, after a 5 sec agitation of the plate. The MIC was estimated based on the
OD measurements and the visual growth in the wells at the end of the 24 h but
the growth curves used as a check control to ensure that growth did not occur
at any point at those concentration where no visual growth was seen at the final
point.
2.2.9 Biofilm formation
To test whether the best biofilm formers identified by the crystal violet assay
grew on polycarbonate membranes, overnight LB bacterial cultures were diluted
to OD600= 0.05. Filter membranes (Thermofisher, 11342885), placed on LB agar
plates with sterile forceps were inoculated, in the centre, with 5 μl of the diluted
culture. The colony biofilms were incubated at 37 ◦C for 48 h. The membranes
were transferred to new plates after 24 h to ensure nutrient availability [Merritt
et al., 2011].
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2.2.10 Statistical analysis
Statistical analyses were conducted in R [R Core Team, 2013]. Linear regression
analysis or one-way ANOVA were used for the biofilm screening results and linear
regression for the fitness cost results. Models were checked by inspecting residual
plots.
2.3 Results
2.3.1 Screening for biofilm formation
The strains that appeared to be the best biofilm formers during the first 5 rounds
of screening (on the basis of OD600 mean) were compared with each other and
against the positive and negative controls in a shortlisting final screening round.
Three 96-well plates containing three replicates of each strain were prepared for
the final shortlisting. The higher the OD reading the more cells present in the
well and the better the biofilm forming ability of the strain. As can be seen in
Figure 2.2, OC3-1, COW63, CC11-1, OC2-8 and OC2-1 showed higher or equal
ability to the positive control E. coli Nissle to form biofilms and were selected as
the best biofilm formers. The results of the first 5 assays, as well as a figure with
all the results combined can be seen in Appendix B.
A two-way ANOVA test with identity of the well-plate as a parameter was,
run on the final selective design and showed that plate contributed to variation in
biofilm formation [F(19,142)=23.04, p<0.05]. The strain identity was marginally
significant in explaining variation in biofilm formation [F(19,142)=1.64, p=0.06].
In order to investigate further the differences between the selected strain and the
positive and negative controls linear regression analysis was performed as well.
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The linear regression analysis confirmed that selection of strains based on
ODs (Fig. 2.2) was valid, as strains Cow63 (t=1.862, p=0.065), OC2-1 (t=2.240,
p=0.027), CC11-1 (t=1.658, p=0.09), OC2-8 (t=2.501, p=0.014) & OC3-1 (t=2.122,
p=0.036) were indeed the best biofilm formers compared to the standard labora-
tory strain E. coli DH10β (negative control). The overall regression model was
not sufficient to explain the differences in OD seen [F(17,144)=1.255, adjusted
R 2= 0.03, p=0.23], However, it should be noted that the strains used in this
last assay were pre-selected as potentially good biofilm formers and that large
differences between the strains were therefore not expected. When a linear re-
gression model was run on all the data from all the six assays, CC11-1 was found
to be a significantly better biofilm former than the negative control (t=2.054,
p=0.04) and not significantly worse than the positive control (t=-0.22, p=0.17).
This time the model did not improve much on the ability to explain the variation
within the data, compared to the aforementioned analysis run on the final assay,
but the variance explained was significant (F(48,689)=3.93, adjusted R
2=0.16, p
<0.001).
Subsequently, strain COW63 was found to be inherently resistant to ampi-
cillin (100 μg/ml) and cefotaxime (8 μg /ml) and it was therefore dropped. The
remaining strains OC2-8, OC2-1, OC3-1 and CC11-1, along with the controls
Nissle and DH10B were inoculated on polycarbonate membranes on LB agar
plates. By visual observation it was noted that all strains developed biofilms on
the membranes but differences in biofilm thickness were obvious. More specifi-
cally, most strains developed thick, concentrated biofilms with the exception of
DH10B and OC2-1 which developed thin, spread biofilms. For this reason strain
OC2-1 was also dropped. As a result, strains OC2-8, OC3-1 and CC11-1 were
used for transformations with the constructed plasmids.
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Figure 2.2: Mean OD+/-SE of the WT strain cultures after Crystal Violet (CV) staining,
during the final shortlisting assay. The dashed red line represents the mean OD value for the
negative control E. coli DH10β and the green dashed line represents the mean OD value for the
positive control E. coli Nissle.
2.3.2 Plasmid construction
All PCRs were successfully optimised to amplify the desired products (details
in Appendix A). The blaCTX-M-14 and CAT genes were obtained with SacI re-
strictions sites added to both sides for sticky end ligations. PCR products of
pAmCyan and pE2-Crimson vectors without part of the Ampr gene and with
SacI restriction sites added were also obtained (Fig. 2.4). In total, four plasmids
were created with the sequence of the original plasmid as shown in Figure 2.1 but
with an insertion replacing the removed part of the Ampr gene; the insertion was
either the blaCTX-M-14 gene or the CAT gene (Fig. 2.3).
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Figure 2.3: Expected sequence maps of constructed plasmids. Expected plasmid sequences
were generated with Serial cloner and map made in Snapgene Viewer 3.2 (snapgene.com).
Plasmid expected sizes, origin of replication, fluorescent proteins (E2-Crimxon, AmCyan) and
inserted genes (CAT, blaCTX-M-14) are visible.
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2.3.3 Bacterial transformations
The newly created plasmids were initially transformed into DH10β strains and
purified from this strain. The purified plasmids were subsequently used for the
transformation of the wild type strains. The results of the transformations are
shown in table 2.3. However, CC11-1 plus pCrimCTXM and the CC11-1 plus
pCyanCTXM transformants were not obtained immediately but rather after re-
peated efforts that were eventually successful.
Table 2.3: Results of wild strain transformations
Strain/Plasmid Cyan+CTX-M Cyan+CAT Crimson+CTX-M Crimson+CAT
OC3-1 positive positive positive positive
OC2-8 positive positive positive positive
CC11-1 negative positive negative positive
2.3.4 Plasmid stability and fluorescence expression
The stability of the plasmids pCyanCTXM and the pCyanCAT in the transformed
WT strains was assessed by a passage assay as described above, only on the basis
of the number of colonies formed on antibiotic containing plates. During this
assay it became evident that the fluorescence was not always expressed as white
colonies appeared on the antibiotic plates (Fig. 2.5A). Colony PCR targeting
the fluorescence gene showed that the gene was present in most cases (Fig.2.6).
Strain CC11-1 appeared to exhibit the highest expression of fluorescence up to
and including day 3. Growth was variable but again only three transformants
survived up to the final day of the assay,namely OC3-1 with pCrimCAT, CC11-1
with pCyanCAT and OC2-8 with pCrimCTXM (Fig 2.5B).
These results drove further attempts to obtain the CC11-1 mutants with
pCrimCTXM. Additionally, the issue of plasmid carrying cells that did not ex-
press the fluorescence needed to be resolved. Starting cultures of CC11-1 with
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Figure 2.4: Sequences maps of components used to constructed the 4 plasmids: (A)CrimSacI,
(B) CyanSaci, (C) CAT-SacI, (D) CTXM-SacI. Made in Snapgene 3.2.1(snapgene.com). (E)
PCR products used for plasmid construction. From the left: 5 copies of CyanSacI (2930 bp), 5
copies of CTXMSacI (1463bp) and 5 copies of CATSacI (1026bp). The ladder is a NEB 2-log
ladder (Cat no N3200S)
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pCyanCAT (11CyanCAT) or pCrimCTXM (11CrimCTXM) were grown in Ter-
rific broth plus the relevant antibiotic for either 17 or 24 h and the expression of
fluorescence was assessed by counting the proportion of fluorescent cells on an-
tibiotic plates. Figure 2.7 shows that growing a starting culture in Terrific broth
improved the expression of the protein. The duration of the starting culture also
had an influence with 24 h starting cultures resulting in less variability. Therefore
24 h starting cultures in Terrific broth were used for all the following experiments.
2.3.5 Plasmid fitness cost
The cost of carrying the constructed plasmids (pCrimCTX-M & pCyanCAT) was
measured for strains 11CyanCAT (Y) and 11CrimCTXM (R) by competing them
with each other or with the WT (W) at different starting proportions. pCyanCAT
was less costly for its host when co-cultured with the pCrimCTXM carrier strain
but the fitness of the plasmid carriers was lower than that of the WT in both
cases. Additionally, the fitness of both plasmid carriers was frequency dependent,
decreasing at higher relative abundance (Fig. 2.8). Linear regression analysis
showed that all factors considered (initial proportion of plasmid carrier, plasmid
type and competitor in the culture) contributed significantly to the overall vari-
ation in fitness seen (F(4,29)=14.67, adjusted R
2=0.62, p<0.0001). pCyanCAT
carrier was significantly fitter (t=4.517, p<0.0001) than pCrimCTXM carrier.
Any samples where the plasmid carrier did not grow either at the first or second
sampling points, were removed from the analysis because relative fitness could
not be calculated.
2.3.6 Growth Kinetics
As can be seen in Fig. 2.9 the WT had a growth advantage over the engineered
strains. In addition the strain carrying pCyanCAT grew better than the one
57
2. STRAIN SELECTION AND ENGINEERING
Figure 2.5: (A) Proportion of fluorescent cells on antibiotic containing plates over 3 days-
drastic stability assay. The circles highlight the strains that were associated with better flu-
orescence expression in days 2 and 3. Strain 11CyanCAT exhibited the best expression of
fluorescence until day 3. (B) Growth on antibiotic containing plates over 3 days, indicative
of plasmid retention. The circles highlights strains 3CrimCAT, 11CyanCAT and 8CrimCTXM
which grew up to day 3.
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Figure 2.6: Colony PCR products for the detection of the fluorescence gene in white colonies
recovered on antibiotic containing plates (chl) from strain11CyanCAT in this case. From the
left: 19 colonies, 18 of which were positive for the fluorescence gene, 2 positive controls (fluo-
rescent 11CyanCAT colonies) and a negative control (CC11-1 WT). The expected product size
was 1073bp. The ladder is a NEB 2-log ladder (Cat no N3200S).
Figure 2.7: Fluorescence expression in 11CyanCAT and 11CrimCTXM strains (n ≥ 2) in
varying starting culture conditions. Each of the gray boxes shows a sampling timepoint (0, 24,
48 h).
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Figure 2.8: Relative fitness of plasmids pCyanCAT (Y) & pCrimCTXM (R) in CC11-1 back-
ground when competing with the WT (W). pCyanCAT carrier was significantly fitter compared
to pCrimCTXM carrier when competing each other. Both plasmid carriers where less fit than
the WT. Additionally, fitness was frequency dependent with plasmid carriers being less fit when
abundant. The lines represent linear regression fit with SE.
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carrying the pCrimCTXM. A detailed analysis of the first 2 h of growth showed
that strain 11CrimCTXM remained in lag phase for longer (Fig. 2.10).
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Figure 2.9: Growth kinetic curves of the WT and the engineered CC11-1 strain with plasmids
pCrimCTXM, pCyanCAT in LB. The points represent the mean of 5 OD measurements with
+/-1 SE bars
MIC assays. Fig. 2.11 shows that both the WT strain and the engineered
susceptible strain shared the same patterns of resistance to β-lactams, i.e they
both died at about 9 μg/ml ampicillin and at less than 1 μg/ml cefotaxime.
Refining MIC assays showed that they could not survive concentrations of more
than 3 μg/ml. The strain carrying the β-lactamase gene was resistant to ampicillin
and cef in concentrations as high as 607 μg/ml (refining MIC assays showed that
it can survive concentrations up to approximately 3.7 mg/ml ampicillin). All
strains showed the same susceptibility to ofloxacin, as expected, as they all had
the same genetic background.
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Figure 2.10: Zoom in the lag phase of the growth kinetic curves of the WT and the engineered
CC11-1 strain with plasmids pCrimCTXM, pCyanCAT in LB
Figure 2.11: The results of the MIC assays for ofloxacin (ofl), chloramphenicol (chl), cefo-
taxime (cef) and ampicillin (amp) at different doses. All 3 strains survived a dose of 1.2 μg/ml of
all antibiotics tested but only the ones carrying the respective resistance genes survived higher
doses of chl, cef and amp. Resistant strains did not survive at concentrations of 4.8 mg/ml.
The log scale on the X axis facilitates the readability of the graph.
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2.4 Discussion
The aim of the set of experiments described here was to engineer a pair of isogenic
WT E. coli strains that would be natural biofilm formers, with one of them be-
ing resistant to β-lactam antibiotics. Such a pair was successfully obtained with
the aid of engineered fluorescent plasmids, one carrying an ESBL gene of clinical
interest (blaCTX-M-14) and the other resistance to chloramphenicol as a selection
marker. The fluorescence expression was optimised following literature leads (see
Section 2.1) pointing towards the manipulation of environmental factors for the
stabilisation of fluorescence expression. As LB did not perform well in expression
experiments [Broedel et al., 2001] and nutrient rich media were found to be better
for expression [Kumar et al., 1991], Terrific broth was tested here. Shachrai et
al. [2010] showed that longer incubation times may result in better fluorescence
expression, so an incubation time of 24 h was also tested. This combination of
environmental conditions for the starting cultures sufficed to improve the expres-
sion of the fluorescence and non-fluorescent colonies on antibiotic media were not
observed in any of the subsequent experiments described elsewhere in this report.
Plasmids pCrimCTXM and pCyanCAT, which were used for the final selected
pair in CC11-1 genetic background, were both costly to their hosts as competi-
tion with the WT showed. pCyanCAT carrier (11CyanCAT) performed better
when competing with the pCrimCTX-M carrier (11CrimCTXM), indicating that
the production of the ESBL carrying plasmid was more costly and this was also
confirmed by statistical analysis. Additionally, the cost of the plasmids was fre-
quency dependent with cost being reduced as the initial proportion of plasmid
carrier decreased in both cases. The fitness cost results correspond to the growth
kinetic results showing that 11CrimCTXM required a longer lag phase.
Better growth of bacterial cells carrying cooperative genes when they are
abundant have been observed [Raymond et al., 2012] which seems to be the case
also here with the ESBL-producing strain. However, the pattern was the same for
the chloramphenicol-resistant strain as well, although chloramphenicol resistance
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is not considered to be cooperative. The higher cost of pCrimCTXM compared
to pCyanCAT may be a consequence of the larger insertion in this plasmid (1463
bp) compared to the insertion in the CyanCAT plasmid (1026 bp).
Finally, MIC assays confirmed that the chosen WT biofilm former did not
possess an inherent resistance to any antibiotics used in any of the experiments
performed as part of this work. It also aided the decision on suitable antibiotic
doses in subsequent experiments as discussed in relevant chapters.
In conclusion, a reliable system of a WT biofilm forming isogenic strains was
developed and optimised. One of the strains expressed a potentially coopera-
tive trait (resistance to β-lactams) which was used for further investigations in
the sociality of these enzymes and their role in biofilm antibiotic resistance in
subsequent experiments, described in the following chapters.
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Chapter 3
The sociality of β-lactamases in
biofilms
3.1 Introduction
This chapter gives an overview of the social behaviour theory as applied to mi-
croorganisms followed by a description of the aims set for this part of the work.
The methodology, the experimental results and an overall discussion complete
the chapter.
3.1.1 The concepts of social behaviour and social evolu-
tion
“A behaviour is social if it has fitness consequences for both the individual that
performs that behaviour (the actor) and another individual (the recipient)” where
fitness is measured as the reproductive success of the individuals involved [Davies
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et al., 2012].
William Hamilton, the evolutionary biologist who shaped the field of be-
havioural ecology as we know it today, categorised social behaviours according to
whether they are beneficial or costly to the actor and the recipient as mutually
beneficial, altruistic, selfish or spiteful [Hamilton, 1964a,b]. Mutually beneficial
and altruistic behaviours are termed collectively as “cooperation”. The first refers
to the case when both the actor and recipient benefit from the behaviour in ques-
tion and the latter to the case when the recipient benefits to the cost of the actor.
Selfish behaviour benefits the actor to the detriment of the recipient and spiteful
is harmful to both individuals involved. Kin selection as defined by Hamilton
[1964a,b] in his early work, has been the main explanatory mechanism for co-
operation as an evolutionarily stable strategy compatible with Darwin’s natural
selection theory [Darwin, 1872]. According to the kin selection theory, the fitness
of an individual is the sum of direct fitness and indirect fitness, where direct
fitness refers to own offspring and indirect to offspring of relatives. The sum is
termed inclusive fitness. Therefore, genetic relatedness favours cooperation as
it increases indirect fitness. However, examples of altruism among genetically
non-related individuals have also been observed in nature [Davies et al., 2012].
As theory explains, a critical component of cooperation is the beneficial effect
of an act on another individual. In order for it to be examined through the
prism of evolution, though, it has to be selected for by natural selection because
of this beneficial effect [Foster, 2010; West, Griffin & Gardner, 2007b], at least
partially. For the purposes of the work discussed in this chapter, the explanations
for cooperative behaviour as reviewed and categorised by West, Griffin & Gardner
[2007a,b] will be assumed. This classification includes direct benefits, which are
meant to explain mutually beneficial behaviours and indirect benefits to explain
altruistic behaviours, although those two general categories are not mutually
exclusive (Figure 3.1).
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Figure 3.1: Classification of current explanations for cooperative behaviour. Image taken
from West, Griffin & Gardner [2007b]
3.1.2 Social behaviour in microbial life
Although social behaviour is usually considered to be a privilege of organisms
more sophisticated than the humble bacteria, those have not been overlooked by
scientists - Darwin’s contemporaries and beyond [Foster, 2010]. It is now widely
accepted that microbes lead social lives and share social traits [Foster, 2011;
Strassmann et al., 2011]. Social traits in microbes include the production of se-
creted products such as siderophores [Griffin et al., 2004], β-lactamases [Dugatkin
et al., 2005; Medaney et al., 2015; Perlin et al., 2009], toxins and their antidotes
[Gardner et al., 2004; Raymond et al., 2012], quorum sensing molecules [Diggle
et al., 2007; Fuqua et al., 1994; Miller & Bassler, 2001; Sandoz et al., 2007] and
biofilm development [Nadell et al., 2009; Oliveira et al., 2015]. These type of
products are termed ”public goods” [Davies et al., 2012; Raymond et al., 2012].
Bacteria compete for resources and they cooperate to increase chances of survival
and in doing so they employ several strategies (reviewed by Foster [2010]; Hibbing
et al. [2010]; West et al. [2006]).
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Kin selection is a favoured evolutionary theory that often applies to microbes
[Foster & Xavier, 2007; Griffin et al., 2004; MacLean, 2008; Strassmann et al.,
2011; West, Diggle, Buckling, Gardner & Griffin, 2007], especially in the case
of secreted products [Nadell et al., 2009]. In microorganisms, kin selection may
work via limited dispersal of cells which increases relatedness in a local level
and therefore the secreted public good benefits only the producers that are lo-
cated nearby [Griffin et al., 2004; Smith, 2001], or via kin discrimination whereby
cells direct the benefit of the public good towards their kins by preventing other
species/clones from exploiting it. For example, E. coli produces bacteriocins that
are toxic to cells that do not carry the antitoxin gene [Riley & Gordon, 1999].
The production of a public good can also have direct benefits to the producer in
which case in may be produced in a mutualistic relationship with other species or
when the expression of the gene is enforced in the population (policing) [West et
al., 2006]. An example of the later is the case of nitrogen fixing rhizobia bacteria
that are cut out of oxygen supply by the plant if they stop fix nitrogen [Kiers et
al., 2003].
Bacteria, therefore, are not solitary organisms but they have been found to
exhibit social behaviours, such as altruism. Nevertheless, the current assumption
in pathogen risk analysis is that each bacterial cell acts as an independent agent
of disease when this may not be the case [Cornforth et al., 2015]. Social traits in
bacteria may be a viable target for new drug development, by, for example, intro-
ducing a drug susceptible non-pathogenic cheater strain in a resistant pathogenic
population that employs a social strategy to survive antibiotics [Brown, West,
Diggle & Griffin, 2009]. However, such an approach may not be effective if resis-
tant bacteria have the capacity to re-emerge in a population dominated by cheats
[Harrison, 2013; Raymond et al., 2012] or if cheating is restricted to a tiny subset
of bacteria, such as persisters [Medaney, 2014]. It is therefore important to better
understand bacterial sociality in order to develop new antimicrobial strategies.
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3.1.3 The case of β-lactamases as a public good
β-lactamases are normally found in the periplasm of Gram-negative bacteria or
extracellularly in Gram-positives [Livermore & Woodford, 2006; Minsky et al.,
1986; Wilke et al., 2005]. β-lactamases are thought to be potential public goods
[West, Diggle, Buckling, Gardner & Griffin, 2007] and this can be true even when
the enzymes are not excreted from the cell, as even when cell-bound they can
detoxify their immediate environment from antibiotics allowing the growth of
otherwise susceptible bacteria.
Competition experiments between susceptible and antibiotic resistance strains
of the same or different species have shown that β-lactamase-producing Escherichia
coli can protect susceptible strains, without gene transfer, essentially arguing that
the production of the enzyme is a public good in bacterial communities [Dugatkin
et al., 2005; Perlin et al., 2009]. Medaney et al. [2015] showed that β-lactamases
can be exploited by slow-metabolising cells, appearing on agar plates only after
the antibiotic had been cleared by β-lactamase producing bacteria. Yurtsev et al.
[2013] mixed isogenic Escherichia coli strains, one of which expressed a plasmid-
carried β-lactamase enzyme gene and exposed them to several antibiotic doses up
to 200 μg/ml. They found that the proportion of β-lactamase producing bacteria
retained in the population equilibrated at approximately 25% at an ampicillin
dose of 100 μg/ml. This equilibrium proportion turned out to be dependant on
the ratio of antibiotic concentration/ initial total cell density. Additionally, it
has been suggested that at high antibiotic concentrations, when resistant bacte-
ria are killed, the lysis of the resistant cells may be enough /to protect susceptible
cells due to the release of β-lactamases [Sykes & Matthew, 1976]. Therefore, it
could be argued that in addition to living cells clearing the antibiotic in their
surrounding area, dead cells also offer cell-bound β-lactamases as public-goods.
Bagge et al. [2004] showed that the expression of β-lactamases in biofilms de-
pended on the type of β-lactam antibiotic applied and the dose. A low dose of
imipenem, a carbapenem, induced the expression of β-lactamases in the periph-
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ery of the biofilm, although cells were metabolically active in the centre as well.
A high dose induced the whole biofilm. The third generation cephalosporin cef-
tazidime induced enzyme expression the periphery only irrespective of the dose.
3.1.4 Biofilms and sociality
Well-mixed bacterial populations in broth have been shown to express coopera-
tive traits [Dugatkin et al., 2005; Griffin et al., 2004] but the spatial structure
observed in biofilms may alter the dynamics of cooperation, as producers may get
advantageous access to any self-produced public goods due to diffusion limitations
and local interactions [Drescher et al., 2014; Ku¨mmerli et al., 2009]. Zhou et al.
[2014] found that spatial structure limited availability of quorum sensing related
public goods to producers only. Ku¨mmerli et al. [2009] showed that increasing
viscosity in the media limited cell dispersal and public good diffusion in favour of
the producers’ fitness. Limited public good diffusion, limited cell dispersal, i.e.
high cell density, and microcolony expansion limited competition and favoured
cooperation in a model by Dobay et al. [2014].
Foster & Bell [2012] proposed that competition rather than cooperation is the
dominant force driving evolution in biofilms. Different strains usually evolve to
occupy separate niches in the biofilm, potentially as a result of division of labour
[Kim et al., 2016; Vlamakis et al., 2008] and they may compete for the best
spots [Kim et al., 2014]. However, cooperative behaviour may also be promoted
in biofilms [Foster, 2010; Kreft, 2004] and the presence of cheaters, cells non-
producing Quorum Sensing (QS) signal in this case, is likely to reduce biofilm
viability [Popat et al., 2012]. Spatial segregation of the different populations,
resulting from expansion, is more likely to promote cooperation [Seminara et al.,
2012; Van Dyken et al., 2013] when well-mixed populations result in competition
[Griffin et al., 2004; Nadell et al., 2016] as the cooperators are separated.
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3.2 Aims and Hypotheses
As discussed above, published work suggests that less cheating is facilitated in
biofilms. This is a result of strain segregation due to the seclusion of cooperators
into local patches where they tend to find themselves next to relatives. Addi-
tionally, the diffusion of public goods is expected to be restricted due to spatial
structure limitations. As theory suggests, any interactions are expected to be
dependent on the frequency of cooperators/ cheaters as well as on whether the
two groups are mixed or segregated. Additionally, higher antibiotic doses are ex-
pected to favour the cooperators. On this basis the following aims and hypothesis
were formulated.
Aim: To investigate whether β-lactamases are utilised as public goods in
biofilms and the conditions that facilitate the enzyme sociality. More specifically,
I hypothesised that:
Hypothesis 1: Growth in a biofilm mode does not favour cheating, when
strain mixing is not imposed upon the population, due to strain segregation.
Hypothesis 2: Population mixing results in higher susceptible fitness and
therefore broth cultures and mixed and re-stablished biofilms facilitate more
cheating.
Hypothesis 3: Higher cooperator frequencies in the founding popula-
tion and higher antibiotic doses select for cooperators both in broth and
in biofilms.
The frequencies of β-lactamase producing (resistant) bacteria, the fitness of
non-producers (susceptible) and the total population size in mixed Escherichia
coli biofilms under different antibiotic doses were used for inferences on β-lactamase
sociality when examining the aforementioned hypotheses.
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The resistant engineered E. coli strain created in Chapter 2, along with the
wild type bacteria (WT) were co-cultured and compared to control mono-cultures
as explained in section 3.3 below. The effects of starting proportions of resistant
cells and antibiotic dose were measured in broth and biofilms and compared in
terms of final resistant proportion, fitness and total bacterial abundance.
3.3 Materials & Methods
Bacterial strains. Escherichia coli CC11-1(WT, susceptible) and the con-
structed 11-CrimCTXM (resistant) strains were used for experiments in this
chapter.
Media and antibiotics. Terrific broth (Sigma T0918) and LB (Lennox) and
2% (w/v) LB agar plates were prepared according to the manufacturer’s instruc-
tions (Sigma L3022; Oxoid LP0011). 1 mM IPTG was added to the LB agar
plates and the LB broth. Starting cultures were prepared in 5 ml Terrific broth
containing 8 μg/ml cefotaxime for the resistant strain or no selection agents for
the susceptible strain. The ampicillin used was purchased from Sigma (A0166).
Sigma-Aldrich PBS tablet (P4417-100AT) was used for the biofilm disruption and
for serial dilutions. The inoculum was prepared by diluting the starting cultures
to a cell density of approximately 107 CFU/ml and mixing as appropriate when
required.
3.3.1 Sociality in ageing, undisrupted biofilms
Polycarbonate membranes on LB agar plates were inoculated with 5μl of either
resistant, susceptible or a mixture of the two bacteria. The biofilms were grown
on LB plates for 24 h and were then transferred to new LB or LB containing
ampicillin [1000 μg/ml] plates for 3 days. The membranes were transferred on
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new plates every day to prevent any changes due to nutrient limitations. Each day
3 biofilms per treatment (ampicillin dose) per biofilm type (resistant, susceptible,
mixtures) were disrupted by vortexing in 10 ml PBS and plated out with the
droplet method.
3.3.2 Sociality in mixed and re-established biofilms (biofilm
passage)
Polycarbonate filter membranes (Thermofisher 11342885) on LB agar plates were
inoculated with 5 μl inoculum of either susceptible, resistant or a mixture of the
two strains. The biofilms were left to grow for 24 h before they were transferred
to new plates with ampicillin of 0, 500, 1000, 2000 μg/ml for another 24 h. At
this stage the biofilms were disrupted by vortexing in 10 ml PBS. The disrupted
biofilms were used to inoculate new membranes and this process was repeated
for a total of 5 passages. The numbers of resistant and susceptible cells were also
counted at each stage. The mixed cultures were defined as above.
3.3.3 Broth passage
LB-containing (Sigma L3022) 24-well plates (900 μl) with ampicillin (Sigma A0166)
at a concentration of either 0, 100 or 1000 μg/ml were inoculated with 100 μl of
a susceptible, resistant or a mixed culture. A sample of each well was serially
diluted and plated out 24 h later and the bacterial colonies of each type (resistant
and susceptible) were counted. A portion of 100 μl of the 24 h cultures was used
as an inoculum for new cultures.
The mixed cultures were defined as High Resistant (HR) or Low Resistant
(LR) on the basis of the resistant proportion in the inoculum with a mean pro-
portion of 0.49+/- 0.02 SE in HR , and 0.02+/-0.01 SE in LR. The Resistant
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mean was 0.9+/- 0.09 SE due to plasmid loss in some of the starting cultures.
3.3.4 β-lactamase activity assay
The activity of β-lactamases produced in broth and in biofilms was assessed by a
nitrocefin assay:
Broth. Cultures were grown as before (3.3.3). After 24 h they were cen-
trifuged at 4600 rpm for 15 min. The supernatant was used for measuring
the activity of the extracellular β-lactamases and the pellet was stored at
−20 ◦C until processing. For measuring the intracellular activity the pel-
let was resuspended in 500 μl PBS and incubated at 37 ◦C with 1 mg/ml
lysozyme and 2 mM EDTA for 1 h. The lysate was used for measurements
without spinning in order to capture any β-lactamases attached to cell mem-
branes. For the measurements 2 μl of the sample was mixed with 198 μl and
20 μg nitrocefin in 96-well plates and placed in a spectrophotometer for up
to 18 h. For the Low Resistant and Susceptible cultures grown on LB 20 μl
sample was mixed with 180 μl PBS due to expected low enzyme activity.
Biofilms. Biofilms were grown as before (3.3.2) and after a 24 h exposure
to 1000 μg/ml ampicillin they were disrupted in 5 ml PBS and centrifuged
at 4600 rpm for 15 min. The supernatant was used to measure extracel-
lular activity and the pellet was stored at −20 ◦C until processing. For
measuring the intracellular activity the pellet was resuspended in 5 ml PBS
and incubated at 37 ◦C with 1 mg/ml lysozyme 2 mM EDTA for 1 h. For
the measurements 180 μl of the sample was mixed with 20 μg nitrocefin in
96-well plates and placed in a spectrophotometer for up to 18 h. The OD486
results were corrected for reaction volume before processing.
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3.3.5 Statistical analysis
Statistical analysis was performed with R Core Team [2013]. Package nlme [Pin-
heiro et al., 2016] was used for the linear mixed effects models. Fixed and ran-
dom effect residuals were checked for normality and homoscedasticity by plotting.
Residuals appeared to be sufficiently normal for the practical purposes of analysis.
A top-down model building strategy was used in all cases. The best model fit was
chosen on the basis of the Akaike Information Criterion (AIC) and the effect on
the model assumptions, i.e normality & homoscedasticity of residuals. After the
significance of fixed variables was checked, insignificant terms were removed by
model simplification. ANOVA comparisons of simplified models were performed
in addition to AIC tests. Further details about the the fitted models are provided
in the relevant sections.
3.4 Results
3.4.1 Population dynamics in ageing, undisrupted biofilms
Mixed strain biofilms and single strain biofilms were grown on LB for 24h before
being exposed to ampicillin for several days, undisrupted. Control biofilms were
allowed to grow on LB for the same amount of time. Biofilms were sampled
daily and the total cell density, as well as the proportion of resistant cells was
measured.
3.4.1.1 Viability of susceptible cells in ageing biofilms
The generations of bacteria after 24 h of exposure to 1000 μg/ml ampicillin was
calculated in mixed and mono-culture biofilms. As can be seen in Fig. 3.2
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susceptible cells in mixed cultures grew better at higher proportions of resistant
bacteria in the founding populations. This was the case both in the presence
in absence of the antibiotic. Notably, a low proportion of resistant cells in the
initial population did not allow for the susceptibles to grow in the presence of
ampicillin. Moreover, susceptible cell numbers reduced in exposed, mono-culture
biofilms, where β-lactamase producers were absent. Growth in this graph was
measured as number of susceptible generations, where generations = [log(no of
susceptible cells at the final point) - log( number of cells at the initial point)]/log2.
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Figure 3.2: The generations of susceptible bacteria in ageing biofilms after 1 day of exposure
to 1000 μg/ml ampicillin compared to the controls growing in the absence of the antibiotic.
After a 3-day exposure to ampicillin, the relative fitness of the susceptible cells
in HR biofilms remained similar to what it was in the absence of the antibiotic. In
exposed LR biofilms though, the susceptible fitness decreased. The decrease was
more profound in exposed biofilms compared to unexposed ones. Additionally,
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plasmid loss in R biofilms resulting in susceptibles gaining in fitness (Fig. 3.3).
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Figure 3.3: Relative susceptible fitness in ageing biofilms over time at 0 or 1000 μg/ml ampi-
cillin. Each colour represents a different resistant proportion in the inoculum The Y axis is in
a log scale where 0 equals 100.
3.4.1.2 Proportion of resistant cells in ageing biofilms
In line with the results so far, the proportion of resistant bacteria in undisrupted
biofilms after a 3-day exposure decreased when they were abundant (R), remained
relatively stable in HR biofilms and increased slightly in LR biofilms. In the
absence of the antibiotic resistant cells showed a similar pattern in most cases
but they tended to be eliminated when initially available in low numbers (LR)
(Fig. 3.4).
The initial resistant proportion was the most significant factor affecting the
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Figure 3.4: The proportion of resistant bacteria retained in ageing biofilms when growing in
the absence and in the presence of ampicillin at an ampicillin dose of either 0 or 1000 μg/ml.
78
3. THE SOCIALITY OF Β-LACTAMASES IN BIOFILMS
final proportions. Time affected the proportions on the basis of initial propor-
tions and so did antibiotic dose. The model explained approximately 50% of
the variance in final resistant proportions [F(3,162)=55.53, p<0.0001]. Table 3.1
shows the process of model reduction with AIC values.
3.4.1.3 Culture viability in ageing biofilms as measured by cell abun-
dance
In parallel, the total population size of exposed biofilms increased over time in
all cases but in the exposed mono-culture susceptible biofilms, as can be seen in
Fig. 3.5. The population size in unexposed biofilms also increased in all cases.
Table 3.1: Model fitting for the change in the frequency of resistant cells in the ageing biofilms
assay. Model 5 was the best fit model. DF: degrees of freedom
Mod Term removed AIC DF
1 Full model -84.34059 9
2 dose -86.16205 8
3 time -87.67751 7
4 Initial prop:time:dose -88.84336 6
5 Initial prop:dose -90.25276 5
3.4.2 Population dynamics in mixed and re-established
biofilms & broth cultures
In order to test the effect of mixing and structure disturbance on population
dynamics in biofilms, mixed strain biofilms and single strain biofilms were grown
on LB for 24 h before being exposed to ampicillin and disrupted again in a
continuing cycle. A broth passage assay was also performed in order to compare
the dynamics in the two modes of growth.
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Figure 3.5: Cell abundance in ageing biofilms when growing in the absence and in the presence
of ampicillin (1000 μg/ml).
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3.4.2.1 Viability of susceptible cells during the passage assays
As can be seen in Fig. 3.6 the growth of susceptible cells after one passage cycle
in biofilms was favoured more than in the undisrupted biofilms discussed above.
Once more, in HR biofilms susceptible cells grew better than in LR or pure
susceptible biofilms. Susceptible growth also depended on the ampicillin dose
with better growth in lower doses in LR and S biofilms. In HR biofilms where
producers were more in numbers, the dose did not seem to affect the susceptible
growth.
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Figure 3.6: The mean generations of susceptible bacteria in mixed and re-established biofilms
after 1 cycle. Ampicillin doses are presented in μg/ml. The error bar represents 1 SE.
In the case of broth cultures, the susceptible cells were more profoundly af-
fected by the antibiotic. Purely susceptible cultures did not grow in the presence
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of the antibiotic and at the highest dose the susceptible cells in LR biofilms were
reduced in numbers. In this case as well susceptible cells did better in HR biofilms
were resistant cells in the founding population were abundant (Fig. 3.7).
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Figure 3.7: The mean generations of susceptible bacteria in broth after 1 passage cycle.
Ampicillin doses are presented in μg/ml. The error bar represents 1 SE.
The relative fitness of the susceptible cells in mixed HR and LR biofilms or
broth cultures, after 5 passage cycles, can be seen in Fig. 3.8. Higher fitness
was achieved in exposed biofilms compared to exposed broth cultures and in HR
biofilms in all cases. An antibiotic dose of 1000 μg/ml had a bigger effect on
susceptible fitness in broth cultures compared to biofilms.
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Figure 3.8: Relative susceptible fitness in broth and in mixed and re-established biofilms
after 5 passage cycles at different antibiotic doses. Each colour represents a different resistant
proportion in the inoculum The Y axis is in a log scale where 0 equals 100.
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3.4.2.2 Proportion of resistant cells during the passage assays
The proportion of resistant cells surviving under these conditions tended to de-
crease overtime until reaching a similar proportion irrespective of the initial pro-
portion in the inoculum (Fig. 3.9) after 5 passages. This convergence point
depended on the ampicillin dose and the mode of growth (Fig. 3.11). The pro-
portion converged in biofilms at 0.08+/-0.005, 0.14+/-0.01 and 0.18+/- 0.05 at
500, 1000 and 2000 μg/ml ampicillin respectively. When no antibiotic was present
in the media the proportion of resistant bacteria was reduced to nearly zero in
all types (R, HR, LR, S) of biofilms (Fig. 3.9).
For modelling the change in the proportion of resistant bacteria in the biofilm
passage assays, the response variable was modelled against time, antibiotic dose,
initial resistant proportion and experimental block (results from 2 independent
assays were pulled together for this analysis). Lineage was used as a random
intercept with or without time as a random slope. Different variance-covariance
structures were tested for a more accurate representation of the correlation be-
tween the residuals. As can be seen in Table 3.2 the model with time as a random
slope and a compound symmetry variance-covariance structure was the best fit
according to the AIC (baseline model). This model was then simplified by re-
moving insignificant fixed effects one by one and checking the AIC against the
previous model and against the baseline model. ANOVA comparison did not show
significant differences between the simplified models and therefore the decision
for the best fit was based on the AIC as shown in the table.
Initial resistant proportion (β= 0.81, SE=0.07, p=0.0) and antibiotic dose (β=
0.0006, SE=0.00001, p=0.0001) had a significant effect on the resistant propor-
tion in biofilms. Time was also significant (β= 0.021, SE=0.01, p=0.07). Time
affected differently the proportion of resistant bacteria depending on the initial
proportions (β=- 0.18, SE=0.02, p=0.0). The interaction between initial propor-
tion, dose and time was also significant (β= 0.00001, SE=0.000005, p=0.007).
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Figure 3.9: The proportion of resistant bacteria retained in biofilms during a 5 day passage at
different antibiotic doses (0, 500, 1000, 2000 μg/ml). The biofilm types indicate the proportion of
resistant bacteria in the inoculum, with High.Resistant mean =0.49+/- 0.02 SE, Low.Resistant
mean=0.02+/-0.01 SE and Resistant mean=0.9+/- 0.09 SE.
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Table 3.2: Model fitting for the change in the frequency of resistant cells in the biofilm
passage assay. Model 6 was chosen as the most suitable model based on the AIC values and
it was simplified (models 9-12). Model 11 was the best fit model. I: intercept, S: slope, DF:
degrees of freedom
Mod Random effects Variance-covariance Term removed AIC DF
1 I: lineage default -337.5511 11
2 S:time, I:lineage default -367.2016 13
3 I: lineage compound symmetry -335.5511 12
4 I: lineage diagonal -335.5495 12
5 I: lineage first order autoregression -338.5754 12
6 S:time, I:lineage compound symmetry -388.5025 14
7 S:time, I:lineage diagonal -335.5495 12
8 S:time, I:lineage first order autoregression -370.7132 14
9 S:time, I:lineage compound symmetry blocks -389.9835 13
10 S:time, I:lineage compound symmetry initial prop:dose -390.8539 12
11 S:time, I:lineage compound symmetry time:dose -392.8079 11
12 S:time, I:lineage compound symmetry time -391.4999 10
In broth cultures the proportion of resistance cells decreased over time in R
biofilms irrespective of the dose. In HR and LR biofilms exposed to the highest
dose the proportion of resistant cells was increased and then retained over time.
A convergence was noticed in this case as well (Fig. 3.11). The proportion of
convergence in broth was 0.16+/-0.008 and 0.79+/-0.016 at 100 and 1000 μg/ml
respectively. In unexposed cultures resistant cells were eliminated over time (Fig.
3.10).
For modelling the change in the proportion of resistant bacteria in the broth
passage assays, the response variable was modelled against time, antibiotic dose,
initial resistant proportion and experimental block. Lineage was used as a random
intercept with or without time as a random slope. Different variance-covariance
structures were tested as for the biofilm data. As can be seen in Table 3.3 the
model with time as a random slope and no within group correlation (default)
variance-covariance structure was the best fit according to the AIC. This model
was then simplified by removing insignificant fixed effects one by one and check-
ing the AIC against the previous model and against the baseline model. Again
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Figure 3.10: The proportion of resistant bacteria retained in broth during a 5 day passage
at different antibiotic doses (0, 100, 1000 μg/ml). The biofilm types indicate the proportion of
resistant bacteria in the inoculum, with High.Resistant mean =0.49+/- 0.02 SE, Low.Resistant
mean=0.02+/-0.01 SE and Resistant mean=0.9+/- 0.09 SE.
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ANOVA comparison did not show significant differences between the simplified
models and therefore the decision was based on the AIC as shown in the table.
Initial resistant proportion (β= 0.68, SE=0.12, p=0.0) and antibiotic dose
(β=0.0007, SE=0.00007, p=0.0) had a significant effect on the resistant propor-
tion in biofilms. Time also had significant effect (β= -0.03, SE=0.02, p=0.06).
Time affected differently the proportion of resistant bacteria depending on the
initial proportions (β= -0.08, SE=0.03, p=0.003) and the interaction between
initial proportion, dose and time was also significant (β= 0.00008, SE=0.00003,
p=0.008).
Table 3.3: Model fitting for the change in the frequency of resistant cells in the broth passage
assay. Model 1 was chosen as the most suitable model based on the AIC values and it was
simplified (models 3-6). Model 5 was the best fit model. I: intercept, S: slope, DF: degrees of
freedom
Mod Random effects Variance-covariance Term removed AIC DF
1 S:time, I:lineage default -50.20969 13
2 I: lineage default -40.34369 11
3 S:time, I:lineage compound symmetry -48.20972 14
4 S:time, I:lineage diagonal -38.34369 12
5 S:time, I:lineage compound symmetry time:dose -52.18319 12
6 S:time, I:lineage compound symmetry blocks -51.26655 11
The effect of the antibiotic dose on the proportion of resistant bacteria at the
convergence point can be seen in Figure 3.11. For an ampicillin dose of 1000
μg/ml the proportion of resistant bacteria required to maintain a stable total
population as the convergence point in broth was 79% whereas in biofilm it was
14%.
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Figure 3.11: The change in the convergence point (passage point 5) proportion as affected by
the antibiotic dose (μg/ml).
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3.4.2.3 Culture viability during the passage assays as measured by
cell abundance
The resistant proportion at the convergence point reflected the amount of resis-
tant bacteria required to maintain the total cell density at a level similar to the
one in ampicillin free populations as can be seen in Figures 3.12 & 3.13. The
total cell density remained similar under all antibiotic doses tested when resis-
tant bacteria were present in the culture, irrespective of the starting proportion.
When the population consisted of susceptible bacteria only, a 10-fold decrease in
total cell density was observed in biofilms whereas population death occurred in
broth cultures (Figures 3.12 & 3.13). In the case of the ageing biofilms the total
cell abundance increased, when during the passage it remained stable (Fig. 3.5
& 3.12).
3.4.3 β-lactamase activity in broth and biofilms
The average β-lactamase activity per resistant cell in broth and biofilms was
assessed according to the level of nitrocefin hydrolysis achieved after 10 min
of reaction. As it can be seen in Fig 3.14A, more extracellular enzyme was
present in broth cultures. In biofilms more intracellular enzyme was recorded in
those biofilms exposed to ampicillin whereas when no antibiotic was present the
levels were more variable. The overall enzymatic activity was higher in biofilms.
The variation of enzyme activity was higher in biofilms but this can probably
attributed to the varying levels of resistant bacteria present compared to exposed
broth cultures that had reached similar proportions at the time of the assay (Fig.
3.14C).
When the different types of biofilms were looked at more closely (Fig. 3.14B) it
appeared that in biofilms the level of intracellular enzyme was always higher than
the extracellular but also, the less resistant bacteria present the more enzyme per
cell was produced. In broth cultures exposed to ampicillin nearly all the produced
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Figure 3.12: Cell abundance in disrupted and re-established biofilms over time at different
antibiotic doses (0, 500, 1000, 2000 μg/ml).
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Figure 3.13: Cell abundance in broth over time (0, 100, 1000 μg/ml).
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enzyme was extracellular. Enzyme production in unexposed broth cultures was
generally very low.
3.4.4 Discussion
A static biofilm system with no liquid interface, carrying a non-conjugative,
high copy plasmid was used in this work. The social trait, i.e the β-lactamase
blaCTX-M-14 gene which confers resistance to extended spectrum β-lactam antibi-
otics was carried on this plasmid. β-lactamase carrying plasmids have been found
to inhibit biofilm formation [Gallant et al., 2005], although in other occasions the
opposite effect was observed [Neupane et al., 2016; Teodo´sio et al., 2012]. As seen
in cell abundance and biofilm growth results here and in Chapter 4 no plasmid
and/or resistance gene inhibitory effect was observed on biofilm formation.
Biofilms offer an ideal environment for microbial interactions due to high
cell density and proximity [Stewart & Franklin, 2008]. Kin selection theory, as
applied to biofilms is mainly concerned with spatial localisation and public good
or cell diffusion as seen in section 3.1.4. In short, proximity to relatives and
limited public good diffusion or cell dispersal is expected to favour the cooperative
trait. Therefore, cell segregation leads to cooperation when cell mixing favours
competition.
The main social traits usually studied in a biofilm context are the production
of EPS [Kim et al., 2016; Seminara et al., 2012; Vlamakis et al., 2008], Quorum
Sensing (QS) [Popat et al., 2012; Zhou et al., 2014] and nutrient uptake and
growth dynamics [Kim et al., 2016; Liu et al., 2015; Ren et al., 2015]. Here, I set
out to understand social interactions in relation to the production of β-lactamases,
an enzyme that has been characterised as potentially social before (Section 3.1.3).
In order to test how biofilms responded to the antibiotic when resistant bacteria
were present and when they were not, different types of biofilms, defined by the
proportion of resistant bacteria in the founding population, were grown for 24 h
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Figure 3.14: β-lactamase activity plots, showing the level of extracellular and intracellular
activity per cell, per antibiotic dose (0, 1 mg/ml ampicillin) in broth and biofilms, 10 min after
the initiation of the reaction, corrected for reaction volume. (A) levels of intracellular and
extracellular activity in broth and biofilms by type.The red dashed lined indicates zero activity
(B) Proportion of resistant bacteria in broth and biofilms at the time of measurement.
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before exposed to different antibiotic doses. Two experimental set ups allowed
for the biofilm architecture to be considered as a contributing factor to resistance
and to bacterial interactions.
3.4.4.1 Growth in biofilms facilitates cheating only when the produc-
ers are abundant in the founding population
In the first set of experiments, biofilms were exposed to ampicillin for 3 days and
sampled daily. Figure 3.4 shows that under these conditions, when the biofilm
structure was maintained during the exposure, the proportion of resistant bacteria
was higher in the presence of ampicillin compared to the passage. Proportions
measured after a 3 day exposure were 22% in HR, 21% in LR and 49% in R
biofilms. Resistant cooperator cells were only maintained or increased when the
biofilms were under antibiotic stress, although the decrease in cooperator numbers
appeared to be slower than in the passage. In LB, 32% resistant cells remained in
R biofilms, 13% in HR and 2% in LR. Compared to survival of the cooperators in
broth, these results show that plasmid carrying cells were maintained in biofilms
for longer in agreement with results reported in the literature [Madsen et al.,
2013]. Susceptible cells in mixed biofilms were able to benefit during exposure
only when the producers were abundant in the founding population 3.2. After 3
days of exposure, the susceptible relative fitness was not affected by ampicillin in
R and HR biofilms (Fig. 3.3). However, it declined in LR, exposed biofilms.
Cell abundance was lower than in the controls in all cases, indicating that
the continuous exposure stressed the biofilms even in the presence of resistant
cells. Fully susceptible biofilms died after the 3 day exposure. They did survive
a two day exposure but the cell number reduced 100-fold after 48 h of exposure
compared to what it was after 24 h.
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3.4.4.2 Population mixing favours cheaters both in broth and in biofilms.
Cheating is higher in biofilms but reduces as antibiotic dose
increases
In the second set of experiments the biofilms were disrupted after exposure to
ampicillin and the disrupted population was used to establish new biofilms that
were treated in the same way for a total of 5 passages. During this experiment,
the structure was disrupted and the population dynamics of the newly established
biofilms at each step provided insight into the evolution of strain interactions into
the biofilms. As can be seen in Figure 3.9, the proportion of resistant bacteria
in biofilms, where they were initially abundant decreased over time under all
antibiotic doses tested. The proportions converged at approximately 8% at 500,
14% at 1000 μg/ml ampicillin, and at 18% at 2000 μg/ml. When antibiotics were
not present in the medium, resistant cells were effectively eliminated, indicating
that antibiotic pressure was required for plasmid maintenance in the population.
The total cell abundance was not affected by the antibiotic when resistant cells
were present (Fig. 3.12). WT, susceptible biofilms showed a 10-fold decrease in
cell abundance but were still able to survive the treatments.
Looking at the relative fitness of susceptible bacteria in broth and biofilms
(Fig. 3.9) shows that susceptible cells tended to have a higher fitness when
the resistant bacteria were abundant in both modes of growth which is in good
agreement with the literature [Raymond et al., 2012]. Biofilms allowed for better
growth of susceptible cells under antibiotic pressure compared to broth. Increas-
ing antibiotic dose reduced susceptible fitness (Fig. 3.8) but it remained positive
under all doses studied.
These results indicate that maximal cell viability, as measured by cell abun-
dance in the antibiotic treated biofilms compared to controls, did not require a
fully resistant population of bacteria in biofilms. A very small proportion of resis-
tant cells appeared to be enough to maintain viability at levels similar to growth
without antibiotic, something that fully susceptible biofilms did not achieve. In
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broth cultures, the proportion of resistant bacteria converged to approximately
80% in the presence of 1000 μg/ml ampicillin (Fig. 3.10). This was about 6 times
higher than in biofilms. Therefore, although the production of β-lactamases con-
fers protection to susceptible bacteria in broth and in biofilms, the effect was
higher in biofilms. Additionally, maximal population viability was not achieved
in broth cultures exposed to ampicillin even in the presence of resistant cells(Fig.
3.13). Under no antibiotic pressure, the plasmid carrying cells were eliminated
in broth as well. The proportion of cooperators maintained depended on the
antibiotic dose and the mode of growth as can be seen in Fig. 3.11.
3.4.4.3 Patterns of β-lactamase production differ in broth and biofilms
Finally, the average production of β-lactamases per cell was measured in broth
and biofilms. Given, that the fitness of cheating cells was higher in biofilms,
one would expect that the public good was more readily available. Therefore,
it was surprising to see that more intracellular β-lactamases were recorded in
biofilms compared to broth. However, the overall β-lactamase activity was higher
in biofilms (Fig. 3.14A) and this suggests that the localisation of the enzyme
in or outside the cells did not affect its potential as a public good. Although,
production of β-lactamases in response to antibiotics has been found to be higher
in biofilms compared to planktonic cells before [Giwercman et al., 1991] the phe-
nomenon has not been explained. In the present experiments, it could indicate
that the constant diffusion of the antibiotic in the biofilms from the agar does not
allow the cells to permanently detoxicate the environment and therefore they are
required to produce the enzyme in high quantities. However, enzyme production
was also high in unexposed biofilms.
Another potential explanation is that the high cell density in biofilms and close
proximity to neighbours may trigger more enzyme production. High cell density
has been shown to activate antibiotic production mechanisms before [Bainton et
al., 1992] and to protect bacteria against antibiotics [Butler et al., 2010; Udekwu
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et al., 2009]. Since the intracellular enzyme also has a social effect and the
assumption is that the cooperators are surrounded by relatives, they do not need
to excrete the public good and risk its diffusion in the biofilm.
In broth nearly all the enzyme produced was extracellular. In this case the
population is expected to be well-mixed and with no spatial structure, so the
cooperators are more likely to encounter cheaters and that would reduce their
fitness. However, the increased fitness of the cooperators under these conditions
is not in agreement with theory.
The proportion of resistant bacteria present in the cultures at the time of mea-
surement (Fig. 3.14C) affected the β-lactamase production per cell with more
enzyme produced by cells when they were rare, suggesting a potential mecha-
nism that allows the same viability of biofilms with different levels of resistant
cells present. This result indicates high cooperation levels once more, and ex-
pected proximity to neighbours. The antibiotic exposure increased β-lactamase
production per cell in broth but it did not affect the total enzyme production in
biofilms.
3.4.4.4 Conclusion
In conclusion, biofilms that grow undisrupted favour the growth of the coopera-
tors. In contrast to what theory predicts though,the cooperative strain increased
in numbers when rare and decreased when abundant. When mixing was imposed
on the population cheaters were favoured and the effect was again higher when
the cooperators were abundant. In this case cheating depended on the antibiotic
dose, with higher doses having a limiting effect. A higher proportion of resistant
cells in the founding population also favoured the cheaters. Growing in broth
made cheating more difficult under high antibiotic doses. Finally, the production
of β-lactamases appeared to be mostly intracellular in biofilms but extracellular
in broth.
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Chapter 4
The biofilm structure
4.1 Introduction
This chapter is about the visualisation of the biofilm structure and its response
to antibiotic treatment in conjunction with social interactions. An introduction
to the theory behind the development of the specific hypothesis is followed by the
description of the experimental work. The results of the experiments and future
directions are discussed towards the end of the chapter.
4.1.1 Antibiotic penetration into the biofilm
As discussed in section 1.2.1 it has been proposed that the biofilm matrix may
be responsible for the increased antibiotic tolerance of bacterial biofilms either
due to total prevention of penetration or due to reduced diffusion associated with
the biofilm matrix. Indeed, Pseudomonas biofilms have been shown to be highly
tolerant to aminoglycosides and β-lactams (tobramycin, piperacillin) on several
occasions [Anwar et al., 1989; Hoyle et al., 1992]. In most cases, however, al-
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though the presence of the matrix was suggested as a possible reason for this
increased tolerance, a link between the matrix and the reduced antibiotic pene-
tration could not be established. Such links were supported on some occasions,
e.g. tobramycin has been shown to bind to matrix components after those were
isolated from Pseudomonas biofilms. Nevertheless, this binding did not result
in a large enough reduction of the diffusion coefficient to protect the cells under
roughly physiological conditions [Nichols et al., 1988]. The extracellular DNA in
the matrix of Pseudomonas biofilms has been associated with increased tolerance
to cationic antimicrobial peptides via the induction of a resistance operon but had
no effect on β-lactam (ceftazidime) and fluoroquinolone resistance (ciprofloxacin)
[Mulcahy et al., 2008]. However, aminoglycosides, β-lactams and fluoroquinolones
have all been shown to penetrate Pseudomonas biofilms grown on transwell plates
without difficulty [Shigeta et al., 1997].
These observations have led to a second hypothesis, that any reduction in
antibiotic diffusion rates caused by the biofilm structure may result in cell pro-
tection just by allowing for extra adaptation time [Jefferson et al., 2005]. This
was supported by experimental data showing that fluorescent vancomycin added
to the liquid on top of biofilms reached the bottom layers of the biofilms with
a delay of approximately 60 min. This was determined by the detection of flu-
orescent cells where vancomycin had penetrated. In broth cultures, fluorescent
cells were detected within 5 min from the application of the antibiotic. A third
hypothesis discussed is that although antibiotics do surmount the matrix barrier
they may be removed by the water channels. If this is the case they may not be
able to reach their target in bacterial cells [Costerton et al., 1994; Walters et al.,
2003]. This hypothesis has been disproved for rifampin in Staphylococcus biofilms
[Zheng & Stewart, 2002].
Oubekka et al. [2012] answered several of the discussed questions, with the use
of confocal microscopy and a fluorescent antibiotic. They showed that vancomycin
penetrated Staphylococcus biofilms within less than 8 min and actually reached
the bacterial cells, as fluorescence was concentrated around the bacterial cell
walls. However, no reduction in cell viability was observed. Moreover, 50% of the
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antibiotic was found to be bioavailable (free to diffuse in the biofilm) indicating
that it was not its binding reaction with biofilm components that was responsible
for biofilm tolerance, although binding probably occurred.
Finally, the hypothesis that bacteria on the biofilm surface hydrolyse certain
antibiotics, thus protecting cells inside the biofilm has also been investigated.
Nichols et al. [1989] included β-lactamase action at the biofilm-antibiotic interface
into a model to measure protection due to antibiotic (tobramycin and cefsulodin)
hydrolysis and showed that although the matrix itself did not constitute a protec-
tion barrier, when hydrolysing enzymes were present the antibiotic concentration
reaching the centre of bacterial aggregates was reduced compared to the concen-
tration in the surrounding broth. Anderl et al. [2000] also showed that in the case
of the β-lactam ampicillin, the antibiotic was able to penetrate β-lactamase defi-
cient Klebsiella pneumoniae but not the β-lactamase producing strain, suggesting
that the penetration of active antibiotic molecules in the biofilm was limited.
4.1.2 Spatial structure
Biofilms are commonly defined as structured bacterial communities with micro-
colonies and water channels, attached to surfaces and embedded in a self-produced
extracellular matrix [de Beer & Stoodley, 1995; Flemming et al., 2007; Maeyama
et al., 2004; Stewart et al., 2009]. These biofilm components form the basis of
what is known as the biofilm architecture or 3D structure. However, attachment
is not necessary for a bacterial aggregate to be called a bioflm [Flemming &
Wingender, 2010] and not all biofilms are so complex; many are simple, flat and
compact [Schuster & Markx, 2013]. Finally, biofilms can be also formed by fungi
and algae [Palmer et al., 2006].
The biofilm structure can be affected by several factors including genetics,
cell interactions and the environment [Schuster & Markx, 2013]. Conversely,
the biofilm structure may influence all of the aforementioned factors forming a
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complex network of interactions. For example, the structure changes the oxygen
and nutrient availability within the biofilm [de Beer et al., 1994], resulting in
physiological heterogeneity [Stewart & Franklin, 2008] and metabolic stratifica-
tion [Teal et al., 2006; Tolker-Nielsen & Molin, 2000]. It is often the case that
biofilm heterogeneity is referred to as biofilm structure [Beyenal, Lewandowski
& Harkin, 2004]. For the purposes of this chapter, biofilm structure refers to
the biofilm architecture, i.e to the biomass distribution. Textural parameters de-
scribing heterogeneity, when used, are mentioned by name as defined in section
4.1.4.
Biofilm structure also affects cell-cell interactions; highly structured, repeat-
able patterns have been observed when biofilms were formed with more than one
strain, that were attributed to the division of labour within the community [Kim
et al., 2016]. Cells on the biofilm periphery were found to be responsible for the
oscillations in Bacillus biofilm growth, by limiting nutrient resources for cells in
the middle. At the same time the periphery offered protection to external at-
tacks by hydrogen peroxide [Liu et al., 2015]. High cell densities in the inoculum
were found to influence bacterial competition in experiments by van Gestel et al.
[2014]. At high initial cell densities the EPS-producers (cooperators) were at a
disadvantage compared to non-producers (cheaters) as the cheaters outcompeted
them.
The role of the biofilm structure in antibiotic tolerance is not well under-
stood, although several studies have implicated some of the biofilm components
as factors contributing to tolerance. For example it has been hypothesised that
antibiotics may be directed out of the biofilms by entering the water channels
[Costerton et al., 1994; Walters et al., 2003]. In addition to the mechanical prop-
erties of the biofilms that may be contributing to increased antibiotic tolerance,
the structured environment seems to influence this tolerance in more diverse ways,
for example by affecting the diffusion of molecules within the structure. In this
way, spatial structure is likely to interfere with quorum sensing by limiting access
to quorum signal molecules to producers only. In this way cheaters are prevented
from exploiting the public good [Zhou et al., 2014]. It then follows, that if dif-
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fusion of public good molecules is restricted due to spatial structure, antibiotic
hydrolysing enzymes with a public good status, such as β-lactamases, may also
be limited in certain niches within the biofilm. Spatial structure has also been
found to allow for the maintenance of cooperative plasmids, that may be carrying
antibiotic resistance genes, rather than those that do not carry the cooperative
trait, i.e. cheaters [Mc Ginty et al., 2010; Xavier & Foster, 2007].
Detailed studies delved further into biofilm structure. It appears that, in
biofilm grown in reactors, cell density is higher at the bottom layers and porosiy
higher at the top; Most of the living bacteria were also recorded at the top
layers [Zhang & Bishop, 1994]. The distribution of the bacterial biomass and its
association with the EPS was also studied by Staudt et al. [2004]. More bacteria
and EPS were found in the lower levels of the biofilms grown in rotating reactors,
compared to the top and the EPS was not always localised around the cells.
4.1.3 Microscopy in biofilm research
4.1.3.1 Confocal Laser Scanning Microscopy (CLSM)
CLSM has been an invaluable tool in microbiological studies [Neu & Lawrence,
2014]. The utilisation of fluorescent molecules as a staining aid or as expressed
by microbial genes after genetic manipulation, in combination with CLSM and
its variations [Neu et al., 2010] have found applications to the study of bacteria,
fungi and viruses alike [Neu & Lawrence, 2014]. Biofilm development, studied by
time-lapse or real-time imaging [Palmer et al., 2006], and architecture [Lawrence
et al., 1991; Weissbrodt et al., 2013], the composition of the biofilm matrix [Neu
& Lawrence, 1999], diffusion[de Beer & Stoodley, 1995], as well as, microbial
interactions have been extensively studied by the use of CLSM [Neu & Lawrence,
2015].
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4.1.3.2 Optical Coherence Tomography
Optical Coherence Tomography (OCT) has been extensively used as a non-
invasive medical diagnosis procedure in areas such as ophthalmology, histopathol-
ogy and in vascular imaging [Blatter et al., 2012; Fujimoto et al., 2000]. Addi-
tionally, it has recently been used in the study of biofilms [Wagner et al., 2010; Xi
et al., 2006]. OCT works by measuring the coherence of light pulses that reflect
onto a reference mirror placed at a known distance from the sample and pulses
that reflect onto the sample. Both signals return back to the same detector and
the difference in time in reaching the detector is used to “read” the structure
[Fercher et al., 2010].
4.1.4 Biofilm quantification using microscopy images
Biofilm quantification has been a major issue of discussion in the literature re-
sulting in the development of sophisticated software [Beyenal, Lewandowski &
Harkin, 2004; Heydorn et al., 2000; Xavier et al., 2003] that allow for the calcu-
lation of several quantitative parameters defining a biofilm. Biofilm quantifica-
tion parameters can be defined as textural or areal-volumetric, describing hetero-
geneity and morphology respectively [Beyenal, Donovan, Lewandowski & Harkin,
2004; Yang et al., 2000; Zielinski et al., 2012]. Areal parameters include average
run length, aspect ratio, diffusion distance, thickness and porosity. Textural pa-
rameters include entropy, energy (these two parameters are not identical to those
used in thermodynamics), homogeneity and roughness [Beyenal, Lewandowski &
Harkin, 2004; Zielinski et al., 2012]. All measurements are based on pixel and
voxel counting after thresholding, the latter being the most critical choice in im-
age quantification [Yang et al., 2001]. The textural and morphological parameters
that were utilised for the characterisation of the biofilms tested in this chapter
are summarised below:
Areal Porosity: the ratio of void pixels to the total number of pixels. It
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can be expressed as a percentage [Beyenal, Lewandowski & Harkin, 2004] and it
provides a measure of the void area within the biofilm image.
Roughness: a dimensionless coefficient calculated on the basis of biofilm
thickness measurements within the image. It provides a measure of biofilm het-
erogeneity [Heydorn et al., 2000].
4.2 Aims and hypotheses
The biofilm structure with its matrix, microcolonies and water channels is an
important aspect of the biofilm lifestyle. In this chapter I aim to investigate the
biofilm structure in the model system used for the experiments and understand
any potential effect of this structure on β-lactam tolerance and vice versa. The
antibiotic interactions with biofilm components and the interactions between re-
sistant and susceptible cell were investigated. A new bacterial system consisting
of the engineered environmental E. coli strain described in Chapter 2, with a nat-
ural ability to form thick biofilms was used. Within this context the hypotheses
below were investigated:
Hypothesis 1: The biofilm matrix prevents the antibiotic from penetrating
into the biofilm
Hypothesis 2: β-lactamase producing bacteria prevent the antibiotic from
reaching its target in the cells
Hypothesis 3: Structural changes in the biofilm as a response to the
antibiotic may contribute to its increased antibiotic tolerance
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4.3 Materials & Methods
4.3.1 Biofilm cultivation methods
Black polycarbonate filter membranes with pore size 0.2 μm (Sterlitech, PCTB
0225100), on LB agar plates containing 1 mM IPTG, were inoculated with 5 μl
starting culture of resistant (red), susceptible (green) or mixed biofilms diluted
to a cell density of approximately 107 CFU/ml and incubated at 37 ◦C for 24
h. Subsequently, 24 h biofilms were transferred to new LB plates or 1 mg/ml
ampicillin containing plates as required by the protocol. The biofilm types used
in these experiments were defined on the basis of the resistant proportion in the
inoculum as described in Table 4.1. The proportions of resistant cells at the final
point of imaging for 48 h biofilms on LB and 24 h biofilms exposed to ampicillin
for 24 h are shown in Fig 4.1.
Table 4.1: Definition of biofilm types according to the proportion of resistant cells in the
inoculum. SE refers to standard error.
Type Proportion SE
Resistant 0.92 0.3
High Resistant 0.61 0.7
Low Resistant 0.03 0.005
Susceptible 0.0 na
The microscopes and the related settings used in this study are shown in Table
4.3. The inverted microscope was only used for the lectin screening. The upright
microscope was used in all other experiments.
4.3.2 Visualisation of the lower layers of the biofilms
In order to visualise the deeper layers of the biofilms the membranes with colony
biofilms on top were transferred from agar plates on microscopy slides using
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Figure 4.1: Resistant (red) proportions in biofilms grown on LB for 48 h (control on the graph)
or on LB for 24 h and then on 1000 μg/ml ampicillin (ampicillin on the graph), as measured
by pixel counting using ConAn (see Section 4.3.7). Mean proportions per colony per type are
shown on this graph. The error bars represent +/- 1 SE. Any cells that may had lost the
fluorescence at the time of imaging could not be detected and considered for these calculations.
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forceps and were left to dry out for about 40 min at room temperature. After
this time the colonies detached from the membrane. With the use of toothpicks
they were turned upside down for imaging. The membranes were also imaged
after the colony was removed for detection of any remnants of the colony biofilm,
however none was found.
4.3.3 Antibiotic diffusion through the biofilm matrix
Five μl of Bodipy FL penicillin (Invitrogen, B-3233) at a concentration of 1 mg/ml
was added on top of biofilms (R, HR, LR, S) grown on LB agar plates for 24 h.
Sequential scanning was used when green cells and antibiotic coexisted in the
biofilm in order to avoid cross-talk. Single images of the diffusion stages and 3D
images of the colonies before (5 random spots per colony) and after full diffusion
(10 random spots per colony over 120 min after the application of the antibiotic)
were recorded. The total time until the whole volume of the antibiotic penetrated
in the biofilm was measured by detecting the light reflection coming from the
surface of the antibiotic solution droplet with confocal reflection microscopy (see
Fig. 4.9), as well as the green signal of the antibiotic. When the antibiotic was
first added it was difficult to detect the biofilm surface due to the volume of the
liquid and the surface disturbance and this is why the droplet surface was followed.
Cell and antibiotic mean signal before and after penetration were calculated on
the basis of signal volume (μm3).
4.3.4 The effect of ampicillin on spatial biofilm structure
Biofilms were grown as before on black polycarbonate membranes on LB plates
for 24 h. At this point they were transferred either on new LB plates or LB plates
containing 1 mg/ml ampicillin for another 24 h. Biofilm dimensions, volumet-
ric and textural properties, as well as strain localisation and interactions were
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Table 4.2: Stains for imaging white cells. All products mentioned in the table were purchased
from Molecular Probes, Invitrogen unless otherwise specified.
Stain Target Colour Emission Max (nm) Excitation Max (nm) Product Code
Syto 9 Nucleic acids Green 485 498 S-34854
Syto 9 Nucleic acids Green 485 498 S-34854
Syto 60 Nucleic acids Red 652 678 S11342
Sybr Green Nucleic acids Green 495 520 S-7567
FM4 - 64 Membrane Red 515 640 T3166
Sypro Red Proteins Red 550 630 S-6654
Propidium Iodine Dead cells Red 535 617 L-7012
CellTracker CMTPX Cells Red 577 602 C34552
Rhodamine 6G chloride Mitochondria Green 515 585 R-634
Acridine Orange Nucleic Acids Green, Red 502 526 A3568
Mitotracker Green FM Mitochondria Green 490 530 M7514
RedoxSensor Mitochondria - Lysosomes Red 540 600 R-14060
Yeast Vacuole Marker Yeast vacuoles Green, Blue 460 500 Y7531
FUN 1 Cell Stain Yeast Cytoplasm - Vacuoles green,red,yellow F7030
Calcofluor White Fungi Blue 370 420 F-6259, Sigma
JC1 Mitochondrial Membrane Potential Green 498 583 T3168
measured at two different ampicillin doses (0, 1000 μg/ml) both in monoculture
and mixed biofilms. Images of the top layers (∼ 30-90 μm) of the biofilms were
acquired and analysed.
4.3.5 Confirmation of void existence
A number of stains (Table 4.2) were employed in order to detect any cells that
may had lost the fluorescence carrying plasmids. This was in order to confirm
that what seen as voids in the CLSM datasets were not areas filled with colourless
cells that could not be detected by fluorescence microscopy. All stains were tested
with broth cultures of WT cells (in terrific broth) in addition to the 48 h R, S,
or mixed biofilms. For the staining, 10 μl of 1000x stock dilution were added
underneath the membrane and the stain was left to diffuse from the bottom of
the biofilms (membrane side) toward the top (biofilm-air interface). This method
of diffusion was chosen in order to minimise the disturbance of the structure that
a flow from the top could cause. Images were acquired 2 h after staining.
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Table 4.3: Specifications and settings of the microscopes used in this study
Leica SP5X upright Leica SP1 Inverted
Light source White light laser fixed laser lines of 488, 561 and 633 nm
Lens Air, 63x, NA 0.7 Water, 63x, NA 1.2
Image size 123x123 μm 158x158 μm
Resolution 1024x1024 512x512
pixel size 120.25x120.25 nm 310x310 nm
Step size 1 μm 0.5 μm
speed 400 Hz Medium
Pinhole Airy 1 Airy 1
E2-Crimson excitation 611 nm-80% na
E2-Crimson emission 625-725 nm na
AmCyan excitation 475 nm-100% na
AmCyan emission 490-550 nm na
Bodipy FL penicillin excitation 504 nm-80% na
Bodipy FL penicillin emission 515-580 nm na
4.3.6 Screening for glycoconjugate-binding probes (fluo-
rescent lectins)
Escherichia coli -CC11-1 WT biofilms were grown in 96 well-plates with hy-
drophilic or hydrophobic surfaces. Terrific broth (200 μl) was inoculated with
2 μl starting culture, grown for 22 h at 37 ◦C, with agitation at 180 rpm. The
inoculated plates were incubated at 37 ◦C for 24 h, with agitation at 120 rpm. Af-
ter the incubation time the medium was removed by pipetting and replaced with
100 μl of 100 times diluted lectin stock solution chosen from a list of 72 lectins as
listed in Appendix C. A different lectin was added to each well. The lectin was
left to incubate at room temperature for 1 h before it was removed by careful
pipetting or absorption. The samples were then rinsed twice with 200 μl water.
The inverted Leica SP1 microscope was used for this part of the experiment (see
Table 4.3).
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4.3.7 Biofilm quantification with OCT
Biofilms were grown on polycarbonate filter membranes as described in section
4.3.1 for 24 h and then transferred to new LB or ampicillin containing plates as
described in section 4.3.4. The biofilms were imaged with a ThorLabs Ganymede
BNG-912-J OCT imaging system, running ThorImage 4.2 software. A Refractive
Index (RI) of 1.38 was used as this has been reported to be the RI of E. coli
cells [Liu et al., 2013]. Biofilm thickness was measured at 5 locations within each
biofilm and averaged. The maximum biofilm diameter on the membrane side
was also recorded. Three replicates per condition (biofilm type, antibiotic dose,
biofilm age) were measured.
4.3.8 CLSM image processing and quantification
Software used for Image quantification. JImageAnalyser 1.4, an in-house
version of ImageJ at UFZ Magdeburg, was used for manual thresholding. The
same software was also used for the quantification of the antibiotic diffusion
images. ConAn 1.3 (BioCom GbR, Germany) was used for the quantification
of biofilm textural and volumetric parameters (porosity and roughness), after
thresholding and background correction were applied. Imaris 8.1.2 (Imaris, Bi-
plane AG, available at http://bitplane.com) was used for thresholding and for
producing rendered images for presentation purposes.
Automatic thresholding methods are generally considered more robust and re-
producible and are therefore desirable [Xavier et al., 2003; Yang et al., 2001]. The
automatic thresholding options offered by ConAn (Auto, Objective Threshold Se-
lection, Otsu, SMy) were tested in this case but they resulted in noisy images
and they were not preferred. Manual thresholding often gives results more rep-
resentative of the real observations, as seen under the microscope, which was
the case with the datasets obtained for these experiments. The thresholds used
were obtained by averaging the thresholds of all spots in the same colony. Each
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Table 4.4: Total Number of Images analysed, broken down per experiment. Biofilm types
include R, HR, LR and S. The number of colonies refers to the number of replicates per biofilm
type. The number of spots refer to the the spots imaged per individual biofilm. In the case of the
diffusion experiment 5 spots were imaged before and 10 after the application of the antibiotic.
The treatments refer to biofilms growth either on LB plates only or ampicillin containing plates
after 24 h on LB. In the case of the top structure visualisation 5 replicates were used for the
resistant and mixed types and 4 for the susceptible types.
Experiment Biofilm Types No of Colonies No of spots No of Treatments Total
Diffusion 4 5 15 1 300
Structure - top 3 5 5 2 150
Structure - top 1 4 5 2 40
Structure-bottom 4 3 3 2 72
White cells 4 3 3 2 72
channel was thresholded separately. Theses averages were used for quantifying all
the images coming from the respective colony. Whenever applicable (i.e. when
thresholds were similar) average thresholds per biofilm type/ antibiotic dose were
used.
Image quantity. A total of 632 confocal datasets were recorded and used
for further analysis and quantification as shown in Table 4.4.
4.4 Results
4.4.1 3D biofilm architecture
CLSM imaging of the top layers of the biofilms revealed that cell clusters of resis-
tant and susceptible bacteria were separated by voids (Figure 4.2). Resistant and
susceptible clusters were clearly visible, but intertwining, in the mixed biofilms.
It was also evident that at least in the case of the mixed biofilms the void coverage
increased over time. Finally, resistant cells in the LR biofilms that were exposed
to ampicillin (Fig. 4.2K) appeared to form more distinct clusters compared to
the same biofilm type on LB (Fig. 4.2C).
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Figure 4.2: The structure of the top layers of colony biofilms; The top row shows biofilms
grown on LB plates, for 24 h, without antibiotic. The second row shows biofilms grown on LB
plates, for 48 h, without antibiotic. The bottom row shows biofilms grown on LB for 24 h and
then exposed to 1 mg/ml ampicillin for another 24 h; Susceptible cells are illustrated as green
and resistant as red. Imaris Isosurfaces were used to enhance image presentation. Grid size
equals 10 μm.
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In order to observe the biofilm structure at the bottom layers where the laser
could not penetrate, dried out biofilms were used. Drying preserved the structure
of the biofilms with the microcolonies and location of the voids, remaining clearly
visible. When looking at the biofilms from the bottom we observed that in mixed
biofilms the very bottom layer of the biofilm was covered by resistant (red) cells
irrespective of the presence of antibiotic in the agar plates or the proportion of
resistant cells in the inoculum. Additionally, the bottom layers of all biofilm
types appeared to be less porous than the top layers shown in Figure 4.2. Dried
biofilms overall appeared to be denser than the top layers of the biofilms that
were imaged without any manipulation, however, this may be an artefact of the
water removal. Figure 4.3 shows top, bottom and side views of dried biofilms.
Verification of void existence. CLSM revealed a biofilm structure consist-
ing of cell clusters and voids. Given that the plasmid, carrying the fluorescent
protein gene, could be naturally lost in both biofilms and broth cultures, it was
essential to establish that those non-fluorescent cells were not taking up the space
that looked like voids in the datasets. Staining with rhodamine confirmed that,
indeed, the structure consisted of cells clusters and voids (Figure 4.4). The signal
from the stain came from within the cell clusters.
4.4.2 Quantification of the biofilm growth and structure
Biofilm growth. Total colony biofilm depth and diameter were measured with
OCT and the results are presented in Figures 4.5 and 4.6 respectively. Biofilms
grown on LB increased their thickness by about 70% [63-81%] over a period of 1
day (24 h to 48 h biofilms). Similarly, they also grew in diameter by about 40%
[22-56%]. Two-day old biofilms grown on LB or 24 h biofilms exposed to ampicillin
for 24 h, grew more when both strains were present. Exposure to ampicillin
did not affect the growth of resistant or the mixed biofilms, irrespective of the
proportion of resistant cells present. However, the exposed susceptible biofilms
did not grow either in thickness or diameter. Additionally, R and HR biofilms on
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Figure 4.3: Images of dried biofilms. Top three rows show biofilms grown on LB and bottom
three rows biofilms grown on ampicillin. Each column represents a different biofilm type (R,
HR, LR, S). Imaris Isosurfaces were used to enhance image presentation. The scale bar is equal
to 10 μm.
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Figure 4.4: Biofilms grown on LB for 48 h were stained with rhodamine to confirm the
existence of the voids. Signal from the cell (susceptible and resistant) channels, rhodamine
channel and an overlay of all 3 channels are shown in this image. The scale bars equals 10 μm.
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ampicillin seemed to grow marginally more than on LB, something that was not
true for the LR biofilms.
Average thickness in μm was as follows: R, 24 h on LB 133.7+/-4.0 SE; R 48
h on LB 241+/-9.7 SE; R, exposed 249.9+/-4.5 SE; HR, 24 h on LB 165+/-5.5
SE; HR, 48 h on LB 294+/-9 SE; HR, exposed 306 +/-7.6 SE; LR, 24 h on LB
175+/-4.3 SE; LR, 48 h on LB 322.5+/-7 SE; LR, exposed 292.3 +/-17.4 SE; S 24
h on LB 173.5+/-8.2 SE; S, 48 h on LB 282.1+/-28.8 SE; S, exposed 167.3+/-6.1
SE.
Average diameter in mm was as follows: R, 24 h on LB 3.4+/-0.19 SE; R 48
h on LB 4.1+/-0.2 SE; R, exposed 4.6+/-0.06 SE; HR, 24 h on LB 3.2+/-0.17
SE; HR, 48 h on LB 4.4+/-0.05 SE; HR, exposed 4.7 +/-0.07 SE; LR, 24 h on
LB 3.1+/-0.1 SE; LR, 48 h on LB 4.7+/-0.1 SE; LR, exposed 4.4 +/-0.2 SE; S
24 h on LB 3.5+/-0.1 SE; S, 48 h on LB4.7+/-0.1 SE; S, exposed 3.3+/-0.1 SE.
Figure 4.5: Biofilm thickness as measured in μm with OCT for 1 and 2-day old biofilms grown
on LB or 24 h biofilms exposed to 1000 mg/ml ampicillin as noted in the legend. The error
bars represent +/- 1 SE.
Textural and volumetric parameters. The biofilms grown for the exper-
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Figure 4.6: Biofilm diameter as measured in mm with OCT for 1-day or 2-day old biofilms
grown on LB or 1 mg/ml ampicillin as noted in the legend. The error bars represent +/- 1 SE.
iments described here, were too thick for the laser to penetrate in full depth.
Therefore, datasets of the intact, fully hydrated, top layers (20 - 90 μm) were
initially recorded. In order to be able to record datasets of the bottom layers,
the biofilms were dried out. Since the dried and stained biofilms were manipu-
lated with unknown effects on the biofilm areal and textural characteristics, this
analysis was based on the datasets of the top layers, that were imaged without
the application of any pre-processing treatment. Therefore the results cannot
necessarily be directly extrapolated to the whole depth of the biofilm structure.
As it can be seen in Figure 4.2 a characteristic of the these biofilm struc-
tures was the presence of voids, of different sizes and frequencies. Therefore, it
seemed appropriate to quantify biofilm porosity and compare how it changed be-
tween biofilms over time. Figure 4.7 shows the mean porosity per biofilm type.
Changes in resistant biofilm porosity did not seem to be dramatic over 24 h for
biofilms grown on LB. However, it seemed to reduce slightly in biofilms exposed
to ampicillin. The porosity of mixed biofilms, on the other hand, increased up
to a percentage of more than 90% in one day and exposure to ampicillin did not
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seem to affect this. In the case of the susceptible biofilms, porosity increased over
24 h when grown on LB but decreased when exposed. In fact, exposed, suscep-
tible biofilms exhibited the lowest porosity (0.65+/-0.03 SE) of all types on the
second day.
Average porosity was as follows:R, 24 h on LB 0.78+/-0.02 SE; R 48 h on
LB 0.8+/-0.02 SE; R, exposed 0.75+/-0.03 SE; HR, 24 h on LB 0.73+/-0.01 SE;
HR, 48 h on LB 0.98+/-0.002 SE; HR, exposed 0.97 +/-0.007 SE; LR, 24 h on
LB 0.54+/-0.04 SE; LR, 48 h on LB 0.96+/-0.008 SE; LR, exposed 0.96 +/-0.01
SE; S 24 h on LB 0.72+/-0.07 SE; S, 48 h on LB0.86+/-0.02 SE; S, exposed
0.65+/-0.03 SE.
Figure 4.7: Biofilm porosity in the top layers of colony biofilms grown on LB for 24h (grey
bars) or 48 h (brown bars) or grown on LB for 24 h and then exposed to ampicillin for another
24 h (green bars).The error bars represent +/- 1 SE.
All biofilm types, started off with a similar roughness after 24 h of growth (Fig.
4.8). Resistant biofilms retained a similar roughness under all conditions studied
(day 1, day 2, exposure to ampicillin). Mixed biofilms exhibited an increased
roughness from 24 h to 48 h, both in the presence and absence of the antibiotic.
Susceptible biofilms on the other hand showed increased roughness over 24 h only
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when they were not exposed to ampicillin.
Figure 4.8: Biofilm roughness in the top layers of colony biofilms grown on LB (black bars)
or ampicillin containing plates (grey bars). The error bars represent +/- 1 SE.
4.4.3 Antibiotic diffusion
Penicillin could fully penetrate the biofilm matrix when applied as a droplet of
aqueous solution on top of the colony at a concentration of 1.0 mg/ml. The
antibiotic overcame the matrix barrier and fully diffused into the biofilm. The
route of the antibiotic in a resistant and a susceptible biofilm can be seen in Figure
4.9. Figure 4.10 shows the difference in the mean fluorescence signal (pixel volume
μm3) coming from resistant and susceptible cells after the antibiotic had fully
diffused into the biofilm compared to the signal recorded before the application
of the antibiotic. The shape and size of the microcolonies was altered after the
antibiotic had penetrated and as it diffused towards lower levels. It can also be
seen that the antibiotic was detected in the voids and in the cell clusters. In the
susceptible biofilms (T1) it can be seen that bacteria detached from the colonies
and were suspended in the liquid before the antibiotic had reached the colony
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surface. To calculate the difference the following equation was used:
signal difference =
pixel volume before
total volume before
− pixel volume after
total volume after
(4.1)
where pixel volume (μm3) refers to the signal coming from either green or red
cells or the antibiotic and total volume refers to the sum of all pixel volume in a
given image (red, green and antibiotic).
As it can be seen in Figure 4.10 more antibiotic was detected in susceptible
biofilms compared to all other types. At the same time susceptible cells in suscep-
tible biofilms appear to be affected more than both resistant and susceptible cells
in all other types as less cell signal was detected after the antibiotic penetration.
These images represent the antibiotic effects in the top layers of the biofilm.
Additionally, the antibiotic penetration time was measured with full penetra-
tion defined by the point when the whole antibiotic solution was in the biofilm.
As can be seen in Figure 4.11 the more resistant cells in a biofilm, the more
time was required for full penetration. Mean diffusion times (in min) for each
biofilm type were as follows; R: 65.2+/-1.5, HR: 50.6+/-5.9, LR: 34.0+/-3.1, S:
38.2+/-2.2.
4.5 Discussion
4.5.1 Antibiotic diffusion
Diffusion of fluorescent penicillin in all four types of biofilms grown for the pur-
poses of these experiments (R, HR, LR, S) showed that the matrix did not prevent
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Figure 4.9: Penicillin diffusion in a susceptible (S) and resistant (R) biofilm until full pene-
tration. Green represents susceptible cells, red resistant cells and blue the antibiotic. Pink or
purple indicate that both antibiotic and cell signal was detected in those areas. The grey line is
the surface reflection of the antibiotic at time point T1 or the colony surface at all other time
points. Imaris isosurfaces were used for these images, with transparency 65-80%. The grid size
is 10 μm.
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Figure 4.10: Difference in cell and antibiotic signal in four biofilm types before and after
the application of 1 mg/ml ampicillin on top of the biofilm. Green is the signal coming from
susceptible cells and red from resistant. The error bars represent +/- 1 SE
Figure 4.11: Mean antibiotic diffusion time (minutes) in 24 h biofilms grown on LB. The error
bars represent +/- 1 SE.
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the antibiotic penetration (Figures 4.9, 4.10, 4.11). Antibiotic traits on the agar
plates, underneath the polycarbonate membrane confirmed that the penetration
was full, along the whole depth of the biofilms. However, the antibiotic did not
fully penetrate for several minutes (Fig. 4.11). This effect may be partially due
to the ability of the matrix to repel liquids as has been shown in the case of
Bacillus subtilis biofilms [Kova´cs et al., 2012]. When pure water droplets were
added on top of resistant or susceptible biofilms, the time needed for the water to
fully penetrate was similar for both biofilm types (40+/-1.7 and 44.3+/4.7 min
respectively).
In addition to this potential matrix effect though, the production of β-lactamases
also appeared to influence penetration time. In fact the time it took for the antibi-
otic solution to fully diffuse into the biofilms depended on the proportion of the
resistant cells present with more time required to diffuse in resistant biofilms and
less time in low resistant or susceptible biofilms. The fluorescent penicillin used
in this study carried a negative charge (one acidic group) which would increase
further by hydrolysis (two acidic groups). Since the matrix is mostly anionic
[Costerton et al., 1987; Mulcahy et al., 2008; Nichols et al., 1988], the more neg-
atively charged hydrolysed penicillin would be expected to show reduced ability
to penetrate the biofilm, which tallies with the results presented here, i.e more
time was required to fully penetrate R and HR biofilms, presumably due to the
production of more β-lactamases.
The antibiotic signal detected in the top layers of the biofilms over the course
of two hours after full penetration (Fig. 4.10) was the highest in the case of
susceptible biofilms and the lowest in resistant biofilms, i.e, when the antibiotic
needed less time to penetrate susceptible biofilms it also lingered in the top layers
for longer. This indicates that the diffusion of the hydrolysed negative charged
molecule once in the biofilm, accelerates compared to the intact molecule (in
susceptible biofilms), although the mechanism is not understood. Since the an-
tibiotic lingered around the cells for longer in susceptible biofilms, targeting more
of them in the process, this could account for the high reduction in the signal
coming from the susceptible cells in S biofilms. Fig. 4.10 also suggests that the
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signal coming from susceptible cells in mixed biofilms was not reduced as much
as in S biofilms. This latter observation could indicate a protection effect due to
the production of β-lactamases by the resistant cells. Reduced fluorescence signal
coming from the cells was probably due to cell lysis resulting from the action of
the antibiotic and subsequent protein degradation.
If the reduction of cell signal after antibiotic treatment is due to cell death
and lysis, this result indicates that in mixed biofilms susceptible cells did ben-
efit by the production of β-lactamases and this was despite the higher levels of
intracellular enzyme seen in Chapter 3. The biofilms used in this case were 24
h biofilms that generally showed less porosity (Fig. 4.7) and less heterogeneity
(Fig. 4.8). This observation supports the conclusion that the main factor affect-
ing diffusion in this case was the production of β-lactamases rather than other
structural characteristics.
In conclusion, the results presented here refute hypotheses 1 and 2; neither
the matrix nor β-lactamases prevented the antibiotic from penetrating into the
biofilm. Additionally, the antibiotic seemed to be able to reach its target in both
resistant and susceptible cells. Nevertheless, the production of β-lactamases did
confer protection to both resistant and susceptible cells, when present. Biofilm
growth and structure are discussed next.
4.5.2 Biofilm growth
All types of biofilms tested here increased substantially in thickness and diam-
eter over 48 h (Fig. 4.5 and 4.6). This correlates well with temporal thickness
measurements elsewhere in the literature where it has been observed that biofilm
thickness increases over time [Dervaux et al., 2014; Larimer et al., 2016]. This
finding also corresponds to visual observations of colony biofilms on agar plates.
Colony biofilms on agar were visually larger when growing on LB over time in all
cases (R, HR, LR and S biofilms).
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When mature biofilms (24 h old) were exposed to ampicillin for 24 h their
thickness and diameter increased in a similar manner to biofilms grown on LB
only whenever resistant bacteria were present. Ampicillin did not affect growth
in those cases. On the contrary, in the case of the susceptible biofilms ampicillin
impeded growth. The biofilms did not increase in size (thickness and diameter),
again consistent with visual observations on plates. As shown in Chapter 3, CFU
counts from susceptible biofilms exposed to ampicillin, were approximately 10
times lower than in all other cases. This indicates that susceptible bacteria in
exposed biofilms experience death, which in turn results in no further increase of
the biofilm size. Even though bacteria died under these conditions, and in fact
no CFUs were recovered from susceptible biofilms after 3 days of exposure (see
Chapter 5), the biofilm remained visible on the membranes. This result seems
to be in agreement with other reports indicating that the maintenance of biofilm
structure, after treatment with antibiotic, does not depend on cell viability. At
least not in terms of the viscoelastic properties that were measured by these
researchers [Zrelli et al., 2013].
Overall, growth measurements indicate that under normal conditions, all
biofilm types grow in thickness and diameter. After a 24 h of exposure to a high
dose of ampicillin, biofilm growth was not affected in the presence of resistant
cells. In purely susceptible biofilms though, no change in growth was observed,
probably due to cell death taking place. The results reported here validate OCT
as a method capable of measuring bacterial growth in the case of the colony
biofilms. To the best of our knowledge this is the first time this methodology has
been used with this type of biofilms.
4.5.3 Biofilm structure: texture and volume
Confocal imaging showed that colony biofilms were made of cell clusters sepa-
rated by voids. The existence of the voids was confirmed with cell staining which
revealed that the voids were not filled with non-fluorescent cells (Fig. 4.3). How-
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ever, other biofilm components such as extracellular polysaccharides, proteins or
DNA may still be present in those areas. Attempts to stain and visualise those
components with glycoconjugate binding lectins were not successful as no binding
occurred. A list of stains used for this can be found in Appendix C.
OCT showed that in most cases biofilm volume did not seem to be affected
by ampicillin, after a 24 h exposure. Changes to the internal structure were
investigated next. In order to test if this was the case, biofilm porosity (Fig.
4.7), was the first parameter to measure on the basis of visual observations in the
recorded datasets (Fig 4.2). The results indicate that monoculture biofilms were
generally less porous than mixed biofilms. Porosity increased over time for all
types grown on LB. With regard to exposed biofilms, porosity was not affected in
mixed biofilms; after a 24 h exposure it increased to a level similar to that on LB.
However, porosity was actually reduced in the case of single-strain biofilms, with
susceptible, exposed biofilms being the less porous type. Increased porosity could
indicate that the cell microcolonies reduce in size over time or that as the biofilm
grows, the newly created space is taken up by voids or other biofilm components
that were not visible by CLSM.
Based on biofilm roughness measurements, the heterogeneity of mixed biofilms
increased with time and the antibiotic did not affect this. This heterogeneity may
be a result of strain social interactions. Resistant biofilms however, tended to
retain a relatively low heterogeneity. In the case of the susceptible biofilms, the
antibiotic did affect the biofilm heterogeneity preventing it from increasing over
time, as it would happen if no antibiotic was present (Fig 4.8).
In conclusion, all biofilms studied here, where resistant cells were present, in-
creased in size over 2 days in a similar manner both in the presence and in the
absence of the antibiotic. However, the internal structure of the different biofilm
types did differ substantially. Mixed biofilms, where resistant and susceptible
bacteria grew together, had a higher porosity and heterogeneity and the antibi-
otic did not affect this trend. Additionally, the microcolony size tended to be
smaller on day 2 compared to what it was on day 1 and this may explain the
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Figure 4.12: Part of the periphery of a HR biofilm grown on LB for 48 h (Maximum intensity
Projection).
higher porosity measurements. Resistant biofilms showed a more stable porosity
and heterogeneity over time (day 1 and day 2) and across treatments (with or
without antibiotic). Finally, the susceptible biofilms appear to be more porous
and heterogeneous on day 2 compared to day 1 when grown on LB, but when
exposed to ampicillin, they did not grow in size, or heterogeneity. Additionally,
their porosity decreased. Using modelling, Picioreanu et al. [1999] suggested that
a porous structure is a result of stress on the biofilm and if this is the case then
decreasing porosity may be a biofilm response to stress.
4.5.4 Microbial interactions and cell localisation
In terms of susceptible and resistant cell localisation in the biofilm, CLSM images
of the bottom layers of the biofilms showed that in mixed biofilms the resistant
cells covered the bottom layer of the biofilm and that was the case whether
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ampicillin was added to the medium or not (Fig. 4.3). It was also noted that
resistant cells generally occupied areas with direct access to the voids, surrounding
the susceptible cells under all growth conditions. de Beer et al. [1994] showed that
oxygen was more available in the voids compared to the middle of cell clusters,
therefore it may be the case that the resistant bacteria in this case required more
resources (nutrients, oxygen) for growth. This may be related to the higher cost
of the plasmid they carried (see Chapter 2). Alternatively, the resistant bacteria
in mixed biofilms, may be outcompeted by the susceptible ones and pushed to the
edges. This theory could be supported by the fact that the periphery of the colony
biofilms was mainly occupied by resistant bacteria (Fig. 4.12). Resistant bacteria
pushed to the periphery are also visible on agar plates. It was also observed that in
the case of LR biofilms in the presence of ampicillin, the resistant cells, appeared
to form more distinct microcolonies, separated from the susceptible ones. This
arrangement may allow them to cooperate for a more efficient production of the
public good (β-lactamases) in order to protect themselves from the antibiotic.
In conclusion, imaging of the top layers of the biofilms showed that mixed
biofilms were more porous than single-strain ones and this was not affected by the
antibiotic. However, susceptible biofilms on ampicillin were less porous suggesting
that changes in porosity may be a strategy employed by bacteria in biofilms to
cope with the antibiotic. For example in a denser structure, the liquid phase
will be limited and thus diffusivity of molecules will be impeded [Hamdi, 1995;
Stewart, 2003]. Another interesting observation was that resistant cells in mixed
biofilms tended to form more distinct clusters in the presence of the antibiotic,
something that did not happen under normal growth conditions (Fig. 4.2). This
offers some partial answers to the third hypothesis investigated here, although
further work would be required for the full influence of structure on antibiotic
tolerance to be revealed.
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4.5.5 Summary and future directions
The effect of β-lactam antibiotics on biofilms in the presence or absence of re-
sistant bacteria was investigated here. Neither the matrix nor β-lactamases pre-
vented the antibiotic from entering into the biofilms. However, the presence of
β-lactamase producing cells did affect the time required for full antibiotic pene-
tration, as well as the amount of the antibiotic detected in the top layers of the
biofilm after full penetration. Although this result settles the question of whether
limited penetration of antimicrobial substances is responsible for the observed in-
creased antibiotic tolerance exhibited by biofilms, it still raises the question of
what is the mechanism by which β-lactamase producers achieve the discussed
effects.
Furthermore, it has been seen here that susceptible biofilms exhibit some in-
ternal structural changes, as a response to the antibiotic. Whether these changes
are universal or restricted to the experimental system used for this study remains
to be confirmed. It would also be of interest to investigate those structural char-
acteristics in response to other antimicrobials and with more controls such as
non-toxic fluorophores or even molecules beneficial for the bacteria. Understand-
ing the genetic mechanisms and identifying the elements of bacterial interactions
influencing those changes would also be of great interest.
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Chapter 5
Bacteria in Biofilms: The
Sleeping Beauties of the
microcosm?
5.1 Introduction
Discussions about the metabolic state of bacteria that “persist” after antibiotic
treatments, despite their genetic susceptibility, are ongoing. In this chapter, I
aim to shed light on the role of metabolism in biofilm antibiotic tolerance. A
review of the literature is followed by the description of the methodology used,
the results and a discussion.
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5.1.1 Metabolism and antibiotic tolerance
The term “persisters” was first coined by Joseph Bigger in 1944 to describe
Staphylococci cells that survived penicillin treatment in broth cultures [Bigger,
1944]. After testing the level of persisters under different conditions, Bigger de-
duced that persisters must be non-dividing, dormant, cells that penicillin could
not kill owing to its mode of action, i.e because of its ability to target divid-
ing cells only. He also distinguished this newly identified bacterial state from
inherently resistant cells, such as the β-lactamase producing bacteria that had
been discovered a few years earlier [Abraham & Chain, 1940]. After interest in
persisters revived, 30 years ago [Moyed & Bertrand, 1983], a lot of effort was di-
rected towards understanding the genetic makeup [Amato et al., 2013; Pu et al.,
2016; Rocco et al., 2013; Wang & Wood, 2011] and biological significance [Dhar
& McKinney, 2007; Kussell et al., 2005; Lewis, 2001] of these cells. It has become
clear that persistence is not a heritable trait [Balaban et al., 2004; Bhargava et al.,
2014; Jayaraman, 2008; Keren, Kaldalu, Spoering, Wang & Lewis, 2004] but is
believed to be controlled epigenetically instead [Smits et al., 2006; Zhang, 2014].
Although persisters are generally acknowledged to be a subpopulation of cells
that can survive antibiotic treatment, without possessing any inherent resistance
mechanisms [Kint et al., 2012; Singh et al., 2009], the actual nature of persisters
has troubled scientists in the last few decades. The notion that persisters are
actually dormant and Bigger’s definition of dormancy [Bigger, 1944], have both
been challenged. Kwan et al. [2013] and Shah et al. [2006] confirmed that trans-
lation levels in persister cells are low and different to expression patterns in both
exponential and stationary phase cells, in good agreement with the dormancy
hypothesis. Yet, Pu et al. [2016] showed that persister metabolism is rather
more complex than that, as they appear to be actively resistant to antibiotics
by overexpressing eﬄux pumps, which resulted in less accumulation of β-lactam
antibiotics in the cell. Meanwhile, the definition of dormancy was expanded to
include slow-metabolising cells when Balaban et al. [2004] identified two distinct
populations of persisters in E. coli : Type I and Type II persisters. Type I refers to
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a proportion of non-growing cells generated in the stationary phase without any
applied stress conditions (e.g. antibiotics) and it is proportional to the number
of stationary cells in the inoculum. If supplied with fresh nutrients, these Type
I persisters start to grow after an extended lag phase. These persisters do not
depend on the total population size. Type II persisters, on the other hand, are
slow-growing cells continuously produced in the culture in a stochastic manner.
Their numbers depend on the total population size and they are not related to
the stationary phase cells. In all cases persistence is considered to be a trait that
applies to a subpopulation of cells rather than to the population as a whole.
The terms “tolerance” or “drug indifference” have been used to describe whole
bacterial populations that are less sensitive to antibiotics [Handwerger & Tomasz,
1985; Jayaraman, 2008]. Two types of tolerance were proposed by Brauner et al.
[2016]: tolerance by slow growth and lag tolerance. The first was intended to de-
scribe tolerance seen in stationary phase or drug induced tolerance related to slow
metabolic rates. The latter was intended for the tolerance that lag phase bacte-
ria may experience while adapting to new environments. In this view persistence
becomes a special case of tolerance, with only a proportion of cells exhibiting the
reduced sensitivity trait.
The extent of persistence to various antibiotics, has been reported to vary
from 0.001% to 0.1% [Keren, Kaldalu, Spoering, Wang & Lewis, 2004; Kwan et
al., 2013; Lewis, 2008; Mulcahy et al., 2010; Orman & Brynildsen, 2013a; Spoering
& Lewis, 2001; Wood et al., 2013] of the population but generally no more than
2% [Shah et al., 2006], although, 100% tolerance to ampicillin in stationary cells
has also been reported [Keren, Kaldalu, Spoering, Wang & Lewis, 2004]. These
proportions have been found to be dependent on the growth phase of the culture,
with exponential growth showing the least tolerance to antibiotics (lowest pro-
portions of survivors recorded) and stationary cells the highest, even compared
to biofilm-released cells [Spoering & Lewis, 2001]. Tolerance to ampicillin or to-
bramycin has been found to be higher compared to ofloxacin [Keren, Kaldalu,
Spoering, Wang & Lewis, 2004; Spoering & Lewis, 2001] or sometimes the other
way round, with 0.07% persistence to ampicillin and 0.15% to ofloxacin in pre-
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determined low-metabolisers [Orman & Brynildsen, 2013a]. Antibiotics used in
those experiments did not normally exceed 100 μg/ml for ofloxacin [Kwan et
al., 2013; Mulcahy et al., 2010; Orman & Brynildsen, 2013a] or 600 μg/ml for
β-lactams / 200 μg/ml ampicillin. In all cases, tolerance was measured after an
antibiotic challenge which was performed in nutrient rich media and for 3-48 h.
Although the leading hypothesis has been that persisters are a subpopulation
of non-growing cells [Balaban et al., 2004; Keren, Kaldalu, Spoering, Wang &
Lewis, 2004; Lewis, 2001] that appear mainly at the stationary phase [Balaban
et al., 2004] or cells in deep dormancy [Balaban et al., 2004; Keren, Kaldalu,
Spoering, Wang & Lewis, 2004; Lewis, 2007] normally present in the population
[Shah et al., 2006], this has been challenged as new data become available. Or-
man & Brynildsen [2013a] argued that persisters are not necessarily dormant as
growing cells also produced persisters to antibiotics, and Wakamoto et al. [2013]
showed that persisters cells were actually metabolising cells. These studies led
to counterarguments about the validity of the methodologies used [Wood, 2016]
but further evidence by Pu et al. [2016] (discussed above) came to support the
hypothesis that persisters are a heterogeneous group of cells and the underlying
mechanism of their ability to tolerate antibiotics may not be metabolism-related.
Furthermore, the concept of persister heterogeneity was enriched by differences in
their gene expression patterns [Allison et al., 2011; Gefen & Balaban, 2009; Kint
et al., 2012; Orman & Brynildsen, 2013a], formation triggers [Amato et al., 2013;
Gefen & Balaban, 2009; Kussell et al., 2005; Ma et al., 2010; Orman & Brynild-
sen, 2013a; Tashiro et al., 2012] and tolerance patterns to different stressors, i.e
tolerating a certain stressor does not necessarily imply similar tolerance against
another [Allison et al., 2011; Gefen & Balaban, 2009; Kint et al., 2012; Orman
& Brynildsen, 2013a]. Nonetheless, multi-drug persisters have also been reported
[Willenborg et al., 2014; Wiuff et al., 2005]). Zhang [2014] suggested a yin-yang
model; persisters are constantly lurking within a growing population while, at the
same time a portion of the persisters population reverts back to active growth in
a linked, continuous manner. Jo˜ers et al. [2010] showed that persister frequency
follows an awakening kinetic curve that depends on the growth conditions.
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5.1.2 Persisters in biofilms
The inherent physiological heterogeneity observed in biofilms, due to nutrient [An-
derl et al., 2003; Anwar et al., 1992; Serra & Hengge, 2014; Stewart & Franklin,
2008], oxygen [Huang et al., 1995; Serra & Hengge, 2014; Stewart & Franklin,
2008; Walters et al., 2003], waste product and quorum sensing molecule [Serra &
Hengge, 2014] gradients, results in the production of several phenotypic variants
that exhibit different metabolic activities. Cells located near the nutrient/oxygen
interface metabolise at higher rates, whereas cells located further in the biofilm re-
semble stationary phase cells [Anwar et al., 1992; Serra & Hengge, 2014; Wentland
et al., 1996; Williamson et al., 2012]. Huang et al. [1995] measured the respiratory
activity in Klebsiella biofilms treated with a disinfectant and found that after the
treatment, respiration was higher in the deeper layers of the biofilm, near the
substrate, indicating that those layers may be characterised by lower metabolic
rates. Williamson et al. [2012] found that mRNA production in deeper layers was
low, indicating low metabolic activity. Ito et al. [2009] also showed that deeper
layers in mature biofilms resisted β-lactam treatment but did not resist amino-
glycoside and fluoroquinolone treatment pointing to metabolism as a candidate
explanation for the increased biofilm tolerance seen in the literature. They also
found that metabolic activity genes were down-regulated in mature biofilms.
It is no wonder that this wealth of metabolic rates seen in biofilms has been ex-
plored as a potential mechanism of resistance to antibiotics. It has been proposed
several times that the main mechanism of antibiotic tolerance seen in biofilms is
the presence of non-metabolising or slow-metabolising cells [Balaban et al., 2004;
Brooun et al., 2000; Lewis, 2001, 2007; Singh et al., 2009; Williamson et al.,
2012]. Persisters in a biofilm could survive antibiotic treatments due to their
slow metabolism and re-establish an infection after the antibiotic is withdrawn,
since the biofilm matrix would presumably prevent the host immune system from
reaching the cells [Lewis, 2007]. Tashiro et al. [2012] found a link between persis-
ter levels and cell density, which could support the hypothesis that more persisters
may be found in biofilms. Nevertheless, when biofilm cell tolerance was compared
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to stationary cell tolerance, it was found to be similar, if not lower in the for-
mer, when exposure to antibiotic was short (6 h) [Anderl et al., 2003; Spoering
& Lewis, 2001]. When exposure was 48 h long, biofilm cells survived better than
stationary [Singh et al., 2009]. However, it should be noted that in all these com-
parison studies, biofilm persisters were considered to be all the cells that survived
antibiotic treatment in an intact biofilm, i.e exposed biofilms were disrupted and
colonies counted. Surviving cells counted in this way could have been protected
by several tolerance mechanisms active in the intact biofilms. If persisters are hy-
pothesised to be slow or non-metabolising cells then their isolation method needs
to be improved to accurately measure their metabolic state (more on isolation
methods in section 5.1.5).
5.1.3 Persistence as a social trait
The evolutionary roots of persistence, as a result of slow metabolic rates, have
also been investigated. Persisters, as slow metabolising cells, experience the direct
benefit of surviving catastrophic evens at the cost of not growing; persisters need
up to 13 hours more to start growing, from broth cultures on LB plates, compared
to regularly diving cells [Balaban et al., 2004]. At the same time, they benefit
their counterparts by not competing for resources. This effect is expected to
be increased within clonal, i.e. genetically related populations [Gardner et al.,
2007]. Not only the formation of persisters can thus be considered as a social
trait, but in a study by Mo¨ker et al. [2010] their production was also increased
as a response to a quorum sensing-related molecules in Pseudomonas aeruginosa
cultures. Medaney et al. [2015] showed that cells appearing on agar plates later
than normal were able to exploit the protection from β-lactams, offered by β-
lactamase producing bacteria, better than growing susceptible cells. These cells
were presumed to be dormant, only appearing when β-lactamase producers had
detoxified the environment from the antibiotics. In summary, slow-metabolism in
bacteria is likely to be a social trait per se but it can also respond to and exploit
other social traits; a triangle of interactions that can be studied further as a
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potential tool in combating bacterial infections. Understanding the social aspect
of bacterial metabolism may allow for a more targeted approach. For example,
at the moment persister production is viewed as a partially random effect when
it could be a regulated response to other factors related to bacterial competition
and cooperation. With the use of a mathematical model subsequently confirmed
in vivo Ackermann et al. [2008] showed that a phenotypic variability within a
population of cooperators may be a survival strategy; since cooperation is costly
and may lead to self-destruction, if a proportion of the population does not express
the phenotype they may benefit from the self-sacrifice of the cells that expressed it
and died. If this is the case, the results of Medaney et al. [2015] could be further
supported as evidence for a persistence-sociality link. Ackermann et al. [2008]
found that such a mechanism would be more effective in structured environments.
5.1.4 Significance of persisters in health and disease
Persisters have been found in clinical isolates of Staphylococci [Bigger, 1944], E.
coli [Marcusson et al., 2005], Mycobacterium tuberculosis [Wallis et al., 1999] and
Pseudomonas aeruginosa [Mulcahy et al., 2010], which makes the issue a rele-
vant medical problem rather than merely a laboratory phenomenon. Cells that
can tolerate antibiotic treatment and revive after the end of the course can have
implications in treatment of infections, especially in cases when biofilms are also
involved. Persisters need to be considered when developing antibiotics and when
deciding the time course of treatments [Gefen & Balaban, 2009; Lewis, 2013;
Mulcahy et al., 2010]. They can also be targeted for new treatment strategies
[Gefen & Balaban, 2009; Rogers et al., 2012]. A protein that may be essential in
the maintenance of the slow-metabolic state, when relevant, may be a viable drug
target option [Lewis, 2010a]. Considering metabolic states other than exponen-
tially growing cells during drug development may also be a matter of regulatory
change [Lewis, 2007].
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5.1.5 Methods to measure persisters in biofilms
It can be argued that the “observer effect” in quantum physics whereby the result
of an observation can be influenced by the act of observing it [Scully et al., 1991]
can be equally true in the case of persisters. If the current consensus that persis-
ters are non or slow-metabolising cells is true, then by their very nature, persisters
are difficult to isolate; any sample manipulation may affect the physiological state
of the cells by either ”waking them up”, i.e inducing growth or inducing further
persister formation. Nevertheless, several methodologies have been developed to
study these cells. The most commonly used methodology for persister isolation
is exposing the culture of interest to the antibiotic of interest then enumerating
the surviving cells [Anderl et al., 2003; Jo˜ers et al., 2010; Keren, Shah, Spoering,
Kaldalu & Lewis, 2004; Moyed & Bertrand, 1983; Singh et al., 2009; Spoering
& Lewis, 2001; Stewart, 2002]. When the interest does not lie in persistence to
specific antibiotics a lytic antibiotic such as a β-lactam is used [Jo˜ers et al., 2010;
Keren, Shah, Spoering, Kaldalu & Lewis, 2004; Moyed & Bertrand, 1983; Stew-
art, 2002], presumably in an attempt to target growing cells. These approaches
are sensible when the population of interest is a planktonic culture. However,
the case of biofilms is a lot more complicated. As has been discussed elsewhere
in this report, several mechanisms of antibiotic resistance have been and are be-
ing investigated, many of which appear to be valid contributors to the increased
tolerance seen in biofilms. When a biofilm is disrupted after a treatment, be it
an antibiotic or any other stressor, what mechanism contributed to cell survival
cannot be readily deduced.
The dose killing curve method has been used in some cases as an extension
to the enumeration method discussed above [Brooun et al., 2000; Singh et al.,
2009; Spoering & Lewis, 2001]. The initial idea behind this method was that
increasing doses of antibiotic would kill increasing numbers of growing cells. But
if persisters are present in the population, the curve will plateau at some concen-
tration [Brooun et al., 2000; Lewis, 2008; Singh et al., 2009; Spoering & Lewis,
2001]. A time-dependent bimodal killing curve is also perceived as an indication
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of persisters [Balaban et al., 2004]. On this basis a Minimum Duration of Killing
(MDK) curve has been proposed as a method to detect persisters. The method
measures the time needed to kill the persister proportion of the population at an
antibiotic concentration higher than the MIC [Brauner et al., 2016].
A novel method to isolate persisters was developed by Shah et al. [2006] using
an unstable GFP protein with a promoter that is expressed only during active
cell growth. During normal growth, the fluorescence intensity is expected to
increase and stabilise. The researchers were able to sort E.coli cells according
to their metabolic activity, using a cell sorter. Roostalu et al. [2008] also used
weakening GFP signal, coming from a non-degradable protein, to measure cell
division. In a similar spirit, Orman & Brynildsen [2013a] used a fluorescent
protein (mCherry) to sort cells by metabolic activity. The different groups were
then exposed to antibiotics for 5 h and the survivors, which were considered to be
slow-metabolising persisters, were counted. In this way, it was possible to decide
which metabolic group produced more persisters. Levin-Reisman et al. [2010]
developed a technique to monitor delayed growth on agar plates by periodically
obtaining and analysing images. This was achieved by a computer controlled
system of an array of scanners and relays. To identify type I and type II persisters
Keren, Kaldalu, Spoering, Wang & Lewis [2004]; Willenborg et al. [2014] diluted
the investigated cultures in fresh medium and incubated them in a passage assay.
At certain time points the cultures were exposed to antibiotics and enumerated.
It was expected that in this way type I persisters would be gradually eliminated
due to dilution effects, whereas type II persisters would remain unaltered.
In order to measure metabolic activity per se Virta et al. [1998] used a lu-
ciferase assay (ATP reaction), Orman & Brynildsen [2013a] used a reductase
activity assay and Orman & Brynildsen [2013b] tetrazolium assays. Orman et
al. [2015] developed an aminoglycoside potentiation assay, which relies on carbon
metabolism and CFU counts in order to measure the metabolism of predeter-
mined persister populations. Once again, all these methods may provide fairly
accurate results on the metabolism of planktonic cells but in order to be used for
biofilms, the biofilms need to be disrupted first. Therefore, in such a context they
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should be used with caution. Wentland et al. [1996] used fluorescence staining or
RNA and DNA to define growth rates in biofilms, on the basis that RNA/DNA
ratios correlate with growth.
Based on the above it is evident that although a lot of progress has been made
in isolating and measuring persisters, this is often down in an indirect way due
to the technical difficulties associated with their isolation. Furthermore, a direct
measurement of persisters in biofilms is a technical challenge that is still to be
met. For the purposes of this work all planktonic or biofilm-released cells that
survived an antibiotic challenge were defined as tolerant without a prerequisite
for slow metabolic rates. Although, it was not possible to apply any methodology
to accurately measure cell growth in biofilms in situ, every effort was made to
maintain the metabolic state of bacteria close to what it was before they were
released from the biofilm. The protocols were also developed with the aim to
exclude biofilm structure-related resistance mechanisms that could have led to
survival.
5.2 Aims and hypotheses
The aim of the work described in this chapter was to measure tolerance in biofilms
and establish any potential relationship to metabolic activity. The hypotheses
tested in this chapter are listed below:
Hypothesis 1. As biofilms age, tolerance levels increase and this is due to
decreasing metabolic rates.
Hypothesis 2. Biofilm tolerance levels are higher compared to planktonic
cultures
Hypothesis 3. Biofilms exposed to antibiotics exhibit higher levels of tol-
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erance compared to non-stressed biofilms, as antibiotic-stress survivors would be
expected to be enriched for persisters.
5.3 Materials & Methods
5.3.1 Strain and media
Bacterial strains. Wild Type (WT) Escherichia coli CC11-1 was used for all
experiments in this chapter.
Media and antibiotics. Terrific broth (Sigma T0918), LB (Lennox) broth
and 2% (w/v) LB agar plates were prepared according to the manufacturer’s
instructions (Sigma L3022; Oxoid LP0011). Starting cultures were prepared by
inoculating 5 ml Terrific broth with a WT colony and incubating at 37 ◦C for 22 h,
with agitation at 180rpm. Sigma-Aldrich PBS tablets (Cat no P4417-100AT) was
used for the biofilm disruption and serial dilutions. The ampicillin and ofloxacin
used were purchased from Sigma (Cat No A0166 and O8757 respectively).
5.3.2 Tolerance in biofilm-released cells
Biofilms were grown on polycarbonate membranes as before for 24 h and they
were transferred to LB, or 1 mg/ml ampicillin plates for up to 3 days. Each day
samples were disrupted in 10 ml PBS, centrifuged, resuspended in 10 ml PBS
and split in equal portions. Either 1 mg/ml ampicillin or 1 mg/ml ofloxacin were
added to two of the portions. A sample in PBS without antibiotics was used as a
control to estimate natural changes in the population during the incubation time.
Samples were incubated at room temperature for 2 h. After this time the samples
were centrifuged again at 4600 rpm for 10 min, resuspended in equal amounts
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of PBS, serially diluted and plated out using the droplet method. As this was
an attempt to capture the metabolic state of the bacteria in the biofilms before
disruption, a 2 h exposure was chosen in order to eliminate any effects on the
metabolic state of the cells that longer incubation times could have. Additionally,
2 h were considered to be adequate time to inhibit growth of susceptible cells, as
growth monitored during the MIC assays described in Chapter 2 did not indicate
growth ability during the experiment.
5.3.3 Tolerance in stationary planktonic cells
In order to test persister levels in stationary phase broth cultures, 4.5 ml LB
inoculated with 500 μl diluted starting culture and incubated for 24 h at 37 ◦C.
After 24 h the cultures were used to inoculate new LB media in the same manner
and the rest was split in equal portions and centrifuged at 4600 rpm for 10 min.
The pellets were resuspended in PBS or PBS plus 1 mg/ml ampicillin or ofloxacin.
The samples were incubated at room temperature for 2 h. After this time they
were centrifuged again, resuspended in PBS and plated out. The process was
repeated over 2 days.
5.3.4 Measuring metabolism in biofilms
5.3.4.1 Awakening biofilm-released tolerant cells
Polycarbonate filter membranes were inoculated with 5 μl starting culture as
before and incubated at 37 ◦C for 24 h. The 24 h biofilms were transferred to
new LB plates for 1 to 3 days. Each day 3 biofilms were disrupted in 10 ml LB
(instead of PBS) and 20 μl were taken out, serially diluted in PBS and plated
for colony counting. This served as the baseline count of cells. The remaining
solution of disrupted biofilms was split in equal portions and ampicillin (1 mg/ml)
142
5. BACTERIA IN BIOFILMS: THE SLEEPING BEAUTIES OF
THE MICROCOSM?
was added to one of them. The samples were incubated at 37 ◦C for 2 h, with
agitation at 180 rpm. After this second incubation, the samples were centrifuged
at 4600 rpm for 10 minutes, resuspended in PBS, serially diluted and plated out
on LB plates. When the experiment was repeated an ofloxacin treatment of 1
mg/ml was also added.
5.3.4.2 Measuring ATP production in biofilm-released cells
ATP measurements. Biofilms were inoculated as before and were grown on
LB plates. At 5, 10, 17, 24, 48 and 72 h of growth they were disrupted in 10 ml
PBS. 100 μl of the disrupted samples plus 100 μl BacTiter Glo (Promega, Cat
No G8230) reagent were mixed in 96-well plates. 100 μl PBS mixed with 100
μl reagent was used as a control. Endpoint luminescence measurements of the
reagent reaction with the ATP produced by the bacteria were taken at high PMT
(photomultiplier) voltage for higher sensitivity in detecting low concentrations of
ATP and medium precision with a spectrofluorometer(SpectraMax Gemini XS,
Molecular Devices, Workingham, UK).
Measuring ATP in exposed biofilm-released cells. 5, 10, 17, 24, 48
and 72 h old biofilms were exposed to 1 mg/ml ampicillin for 24 h and ATP
production was measured in the same way as above.
ATP curve. ATP, 100 mM solution, purchased from ThermoScientific (Cat
No R0441) was used to produce an ATP curve. The protocol suggested by
Promega in the BacTiterGlo manual was used. Briefly, 1 M ATP was prepared
in PBS (100 μl of 1 μM ATP solution contains 1010 moles ATP) and diluted in
10-fold serial dilutions in PBS (1 M to 10 pM; 100 μl volume contained 1010 to
1015 moles of ATP). 100 μl of the ATP dilutions were added to a 96 well plate
and mixed with 100 μl of BacTiter-Glo reagent. The 96-well plate was placed
in the luminescence reader, mixed for 5 seconds and left to incubate for 1 min.
Luminescence was recorded. PBS plus reagent was used as a control.
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5.3.5 Statistical analysis
Statistical analyses were conducted in R [R Core Team, 2013]. Linear regression
analysis was used to model the log tolerance ratio in ageing biofilms, station-
ary broth cells or pre-exposed biofilms against age, antibiotic type and exposure
time or passage time, as appropriate. Log Tolerance Ratio was defined as the
natural logarithm of the ratio: [number of antibiotic survivors]/[number of cells
before antibiotic challenge]. 10 5 cells were added to the CFU counts before cal-
culating the log in order to be able to include zero CFU counts in the analysis.
Residual plots were used for checking model assumption of residual normality
and homoscedasticity.
5.4 Results
5.4.1 Building an ATP curve
As can be seen in Figure 5.1, the luminescence signal corresponded very well to
increases in ATP concentration. The regression line generated here was used to
calculate ATP concentrations in biofilm and broth samples, where luminescence
was measured.
5.4.2 Tolerance to antibiotic fluctuates and increases as
biofilm ages
Figure 5.2A shows how biofilm-released cells responded to antibiotic treatment as
the biofilms aged. Tolerance was measured on the basis of colony forming units
and represents the proportion of cells that survived the 2 h antibiotic challenge
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Figure 5.1: The ATP curve used to estimate ATP production in biofilm and broth sam-
ples, based on luminescence measurements. The regression equation represented by the line in
the graph was [ATP]= 5.105220e-15[Luminescence signal] - 5.100973e-13 with R 2 = 0.9995,
p<0.0001
compared to the number of cells that were present before the challenge. An oscil-
lation in the first 48 h and subsequent stabilisation of tolerance is visible for both
classes of antibiotics used in these experiments. At all ages cells were significantly
less tolerant to ofloxacin compared to ampicillin (t=-8.394, p<0.0001). In a linear
regression model here both time and antibiotic type contributed significantly to
explaining variation [F( 2,45)=41.18, p<0.0001, R
2 adjusted=0.63]. These toler-
ance patterns corresponded to an increasing number of CFUs that appeared to
stabilise after 24 h (Figure 5.2C), and a metabolic rate that increased sharply
from 5 to 10 h and then decreased until it reached stability (Fig. 5.2B). Within
the first 24 h of growth, growth rates did not correspond to ATP production very
accurately, as CFUs kept increasing even when ATP production was reduced.
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Figure 5.2: (A) Survival rates at 1 mg/ml ampicillin or ofloxacin. Survival increased as the
biofilms aged. The same trend was observed for both classes of antibiotics. The dashed red line
indicates 100% survival.Each colour represents a different resistant proportion in the inoculum
The Y axis is in a log scale where 0 equals 100. (B) Colony Forming Units (CFUs) increased
as biofilm aged and reached a plateau after 24 h. (C) ATP production per cell was generally
higher in younger biofilms and stabilised in mature biofilms, older than 24 h.
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5.4.3 Stationary cultures are more tolerant to antibiotics
compared to biofilm-released cells
Tolerance in 24 h stationary broth cultures (Fig. 5.3) was higher than in 24 h
biofilms (Fig. 5.2A); 68% for ampicillin and 37% for ofloxacin, on average, at 24
h and increased even further after one passage (48 h) to 100% for both ampicillin
and ofloxacin. The respective values for 24 h biofilms were approximately 10% for
ampicillin and 1% for ofloxacin. For 48 h biofilms it was 90% for ampicillin and
1% for ofloxacin. Tolerance to ampicillin and ofloxacin in stationary broth cells
were not significantly different at both time points (t=-0.879, p=0.39). The model
[F( 2,29)=19.96, p<0.0001, R
2-adjusted= 0.55] explained 55% of the variation
seen with time being a significant factor (t=6.256, p<0.0001).
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Figure 5.3: Stationary cell tolerance to ampicillin and ofloxacin. Tolerance was measured in
a 24 h culture and in a subsequent passage culture (48 h). Each colour represents a different
resistant proportion in the inoculum The Y axis is in a log scale where 0 equals 100.
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5.4.4 Ampicillin exposed biofilm-released cells show higher
tolerance to antibiotics although long-term exposed
biofilms gradually die
I predicted that if tolerance was important for survival in biofilms, biofilm-released
cells that had survived exposure to antibiotics would be enriched for tolerant cells
(Hypothesis 3). This hypothesis was supported in that, in a different set of ex-
periments, where tolerance of pre-exposed biofilm-released cells to ampicillin and
ofloxacin was measured, it was found to increase over time for ampicillin but re-
mained relatively stable for ofloxacin (Fig. 5.4C). The number of cells in exposed
biofilms decreased over time until they were killed after a 72 h exposure (Figure
5.4D). Cells from pre-exposed biofilms were more tolerant to ampicillin than from
unexposed biofilms although, this was not significant (t=-1.504, p=0.14) in a lin-
ear regression model (F( 3,56)=30.13, R
2-adjusted=0.67, p<0.0001). The effect
of time was not significant either (t=1.308, p=0.19) but ofloxacin tolerance was
significantly lower than ampicillin (t=-9.310, p<0.0001) in the same model.
ATP production was measured in biofilms of different ages that were exposed
to ampicillin for 24 h. Fig.5.4A shows that the exposed biofilms appeared to
metabolise more rapidly as they aged (older than 24 h), in contrast to slowing
metabolism of the unexposed biofilm. It should be noted that 5 h old biofilms
exposed to ampicillin did not survive the treatment. At the same time the number
of cells surviving exposure increased over time and stabilised after 24 h (Fig.5.4B).
In biofilms that were not exposed to ampicillin the ATP production per cell
decreased in older biofilms and CFU/ml increased, as seen in Fig. 5.2. The
unexposed biofilm data are the same in the two figures but each figure is meant
to discuss a different hypothesis. Unexposed older biofilms survived ampicillin
treatment better than younger ones, as the number of cells dying decreased.
However, unexpectedly their metabolic rates did not seem to slow down as a
result of the ampicillin induced stress in pre-exposed biofilms. On the contrary,
they appeared to be higher than in unexposed biofilms from 24 h old biofilms
upwards.
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Figure 5.4: (A) Mean+/- SE ATP production in biofilms exposed to ampicillin for 24 h
compared to unexposed controls (B) CFU/ml +/- SE in exposed biofilms compared to un-
exposed controls (C) Tolerance to ampicillin and ofloxacin in biofilm-released cells when the
intact biofilms had been exposed to ampicillin for up to 72 h.Each colour represents a different
resistant proportion in the inoculum. Where the Y axis is in a log scale where 0 equals 100.
(D) CFU/ml in biofilms exposed to ampicillin for up tp 72 h.
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5.4.5 Biofilm-released cells in nutient rich media show a
lower tolerance to antibiotics
In order to verify that metabolic rates were indeed involved in the results de-
scribed thus far, biofilms were disrupted in LB and incubated in nutrient rich
media, instead of being disrupted in PBS at room temperature. Figure 5.5B
shows that under these conditions the cells grew in numbers compared to the
disruption point but growth rates decreased as biofilms aged. At the same time
the proportion of cells that tolerated the antibiotic treatment this time decreased
substantially (Fig.5.5A).
5.5 Discussion
Tolerance and persistence are terms used interchangeably in the literature al-
though they do not always describe the same condition. In this report survivors
of a 2 h antibiotic challenge were described as tolerant and it was left as an open
question whether they are also persisters, i.e. whether they represented only a
small proportion of the population, in an attempt to abide to recent definitions
found in published work (section 5.1.1) and avoid further confusion. However,
the word persisters was used when referring to work of others. Slow metabolic
rates were not included in the definition but instead it was the aim of this work
to determine if tolerant cells were in fact slow metabolisers.
In the experiments described in this chapter unusually high doses of antibiotics
were used (nearly 1000 times higher than the MIC) to test tolerance. Since the
main aim of this work was to investigate tolerance in biofilms rather than in broth,
the antibiotic concentration was chosen with the biofilm physiology in mind, i.e.
lower doses were not challenging enough for biofilms as they had been previously
found to survive doses as high as 6 mg/ml for 24 h (data not shown). Additionally,
biofilms were disrupted in PBS, as well as in growth-promoting media and the
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Figure 5.5: (A) Antibiotic tolerance decreased substantially compared to what was seen in
Fig. 5.2A.Each colour represents a different resistant proportion in the inoculum Where the Y
axis is in a log scale where 0 equals 100. (B) Proportion of cells compared to numbers at the
disruption point; cell growth under these conditions is evident
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antibiotic challenge was kept relatively short. These precautionary measures were
taken in order to ensure that the metabolism of the biofilm-released cells remained
similar to what it was in the biofilms, as far as this could be achieved with the
disruptive methods used. Disruption in growth-promoting media was used as
a control. It was therefore assumed that the biofilm-released cells retained a
metabolism similar to what it was before the biofilm disruption. Also, although
the method could not capture biofilm metabolism in situ, disruption eliminated
other reasons that bacteria can survive for when in biofilms, leaving metabolism
as the main candidate. Brooun et al. [2000] tested resistance of biofilm-bound
cells in growth medium and biofilm-released cells in PBS and found the tolerance
to be similar. This result validates the assumption that disruption in PBS retains
the metabolic state of the cells. However, the results reported in this paper were
not in survival ratios and could not be used as a comparison.
Interestingly, even at such a high dose, the levels of tolerance were extremely
high in biofilms, fluctuating with biofilm age (Fig. 5.2A). In fact tolerance cor-
responded to a proportion of ampicillin-tolerant cells equal to 15% for 5 h old
biofilms up to 100% in 48 h and 72 h old biofilms. Ofloxacin tolerance started
at 7% in 8 h old biofilms (5 h old biofilms did not survive ofloxacin treatment)
and did not exceed this level in older biofilms. These figures are higher than
those reported by other researchers, probably reflecting the differences in the
methodology used.
To make my methodology more comparable to what was seen in the litera-
ture and to check on the metabolic state of the biofilm-released cells, biofilms
were also disrupted and incubated in nutient rich media. Under these circum-
stances any low-metabolising cells were expected to initiate growth and results
were strikingly different. The biofilm-released cells showed low survival during
the antibiotic challenge in high nutrient media (Fig. 5.5), with ampicillin toler-
ance levels in this figure corresponding to 0.2% for 24 h biofilms and up to 0.5%
for 48 h and 72 h biofilms (ofloxacin tolerance was 0.04% for 24 h biofilms up to
0.6% in 72 h biofilms). Tolerance measured in this way was more in line with
levels reported elsewhere in the literature for biofilms not older than 24 h. When
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nutient rich media were used, cells started growing (Fig.5.5B). The substantial
differences in tolerance between bacteria in PBS and in high nutrient broth indi-
cate that physiology responds very quickly to nutrients and that this substantially
affects tolerance. It is plausible that the different assays reflect different modes
of antibiotic tolerance that exist in biofilms. The PBS-challenged cells had high
levels of tolerance but the results from the LB-challenged assays indicate that
only a small proportion of these were fully dormant persisters.
Stationary broth cultures were more tolerant than biofilm-released cells as has
been reported before [Anderl et al., 2003; Brooun et al., 2000; Spoering & Lewis,
2001]. Stationary cells after 1 passage, where cells from the 24 h time point were
diluted in fresh broth media and incubated for another 24 h (48 h time point),
not only survived both ampicillin and ofloxacin treatments, at concentrations that
planktonic bacteria cannot normally survive, but they appeared to have grown
as well (Fig. 5.3) (it should be noted, that substantial cell death occurred in the
PBS controls after the 2 h incubation at 48 h). Even at 24 h 68% of stationary
cells survived the ampicillin treatment and 37% the ofloxacin treatment. Cells in
the control were not affected by the incubation at this time point. Again, this
level of tolerance was beyond anything that was found in the literature using the
nutrient rich media method of disruption. Stationary cells though, were a lot more
tolerant than biofilm-released cells using this method too. In order to test for
genetic resistance due to random mutations, some of the colonies recovered from
the antibiotic challenge were re-streaked onto antibiotic containing agar plates
and they did not grow. The same control was also used for biofilm-released cells.
Increased tolerance in pre-exposed biofilms was consistent with the expecta-
tion that under antibiotic stress, metabolism slows down and therefore, higher
tolerance to antibiotics should be expected [Do¨rr et al., 2010]. Firstly, biofilms
survived the ampicillin in the growth medium for 2 days before they were finally
eliminated (Fig. 5.4D). This was a far higher survival rate compared to planktonic
cells that could not even survive a dose of 9 μg/ml in the MIC assay. Brauner
et al. [2016] suggested that if longer exposures to the same antibiotic dose are
effective in killing a population, this should be considered as an indication for
153
5. BACTERIA IN BIOFILMS: THE SLEEPING BEAUTIES OF
THE MICROCOSM?
the presence of slow-metabolising persisters. If this is true and given that a 72 h
exposure was required to kill biofilms, this could be consistent with the hypoth-
esis that biofilm-bound cells are slow-metabolisers. Intact biofilms exposed to 1
mg/ml ofloxacin survived for 24h only (data not shown). Figure 5.4C illustrates
that 48 h pre-exposed biofilm-released cells show increased ampicillin tolerance
(100%) compared to 48 h biofilms that had not been pre-exposed to ampicillin
(30%). Ofloxacin tolerance in 48 h exposed biofilm-released cells was about 3%,
similar to 24 h and 48 h unexposed biofilms. In 24 h exposed biofilms, ofloxacin
tolerance was about 10%.
Thus far, results suggested that biofilm-bound cells exhibit reduced metabolic
rates as biofilm released cells were extremely tolerant to antibiotics. Similarly,
stationary state cells were also very tolerant to both antibiotics tested. Disruption
in LB and incubation in nutrient rich media precipitated growth and resulted in
a very substantial decrease in tolerance, corroborating the hypothesis that cells
in biofilms are “sleeping beauties”. Furthermore, pre-exposed biofilms exhibited
an increased tolerance, consistent with hypothesis 3.
Although the results discussed above appear to be in good agreement with
what others have concluded, slow metabolism was only assumed as the reason
behind the patterns seen. In order to get a measure of metabolic activity, ATP
production was measured in biofilm-released cells. Metabolic activity in biofilms
younger than 24 h old showed an increase and then a subsequent decrease in
metabolic rates (Fig. 5.2C) which stabilised for biofilms up to 96 h old. The
oscillation in metabolic rates seen in younger biofilms may be a result of the
biofilm growth patterns seen by Liu et al. [2015]. These researchers observed
a periodic reduction in biofilm expansion after it had reached a certain size,
owing to nitrogen limitations which stopped the peripheral cells from growing
in an oscillating manner. Peripheral cells were found to experience glutamine
limitations. Since, both glutamate and ammonium are needed for the production
of glutamine and glutamate was provided in the medium, it was ammonium that
was in shortage for the cells in the periphery. This was found to be associated with
the reliance of peripheral cells to ammonium produced by the internal cells in the
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biofilm. Ammonium production internally was in turn limited when glutamate
was consumed by the peripheral cells and did not reach the internal layers. This
co-dependence of peripheral and internal cells in the biofilm appeared to be a
mechanism of social conflict resolution.
Older biofilms showed a stable, decreased average metabolic rate compared to
young biofilms. Tolerance levels (Fig. 5.2A) in older biofilms were consistent with
the slow-metabolism hypothesis but this was not the case for younger biofilms
where increases in tolerance corresponded to higher metabolic rates and higher
growth rates as measured by CFUs (Fig. 5.2B). This result was unexpected and
it would require further investigation. The discrepancy may have been due to
the use of mean ATP production per cell as an indication of metabolic rates.
Using this measure assumes that all cells metabolise equally. Research suggests
that this may not be strictly true [Ito et al., 2009; Stewart & Franklin, 2008;
Wentland et al., 1996]. Also, metabolic rates as measured by ATP may not be a
good indicator of growth rates, at least not in young biofilms, as can be seen by
comparing Figures 5.2A & B; CFUs kept increasing even when ATP decreased in
biofilms younger than 24 h.
When ATP was measured in pre-exposed biofilms the results were surprising
as generally higher metabolic rates were observed in 24 h old biofilms and older,
compared to unexposed biofilms (Fig. 5.4A). Therefore, the underlying hypothe-
sis that cells in stressed biofilms would not be metabolising, as much, could not be
validated by this experiment. Ampicillin tolerance in pre-exposed 24 h biofilms
was slightly lower than in unexposed biofilms but increased in 48 h old biofilms.
Metabolism in 48 h biofilms in this case could not be mapped to 5.4A though as
the treatment was different.
Two types of antibiotics were used in this study: the β-lactam ampicillin
and the fluoroquinolone ofloxacin. β-lactams are believed to be more effective
against actively diving cells [Tuomanen et al., 1986] as they target the cell wall
synthesis process [Tomasz, 1979] whereas ofloxacin interferes with DNA synthesis
[Sato et al., 1986] and can kill non-growing, as well as growing cells [Tanaka et
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al., 1992]. It is also particularly active against E. coli [Sato et al., 1986]. It
was expected that ofloxacin would be more effective in killing cells that could
be tolerant to ampicillin due to their slow metabolic state. Indeed ofloxacin was
more effective in killing cells but the killing pattern followed that of ampicillin
and that of metabolic rates in an almost identical manner in biofilms grown on
LB (Fig. 5.2A &C). Stationary cells showed a very high level of tolerance to this
antibiotic as well; a lot higher than biofilms. In the case of biofilms pre-exposed
to ampicillin, ofloxacin tolerance did not change much over time (Fig. 5.4), when
tolerance to ampicillin increased.
In conclusion, the majority of results presented here support the idea of slow-
metabolising cells in biofilms behaving like sleeping beauties. However, the high
metabolic rates seen in biofilm-released cells coming from biofilms that were pre-
viously exposed to ampicillin are not consistent with the hypothesis that intact
biofilms exposed to antibiotics survive the treatment due to reduced metabolism.
Additionally, metabolic rates in young biofilms did not validate the metabolism
hypothesis either. These observations in conjunction with reports indicating that
persisters may actually be actively metabolising cells, highlight the need for meth-
ods more accurate measuring metabolic rates in bacteria without affecting those
rates in the process. Additionally, a definition of active metabolism and an es-
tablish link of such metabolism to growth rates are required in order to be able
to use tolerance to β-lactams as an indicator of slow growth.
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Chapter 6
General Discussion
Microbes play an important role in our lives and this should not come as a surprise
since they have cospeciated with humanoids since 15 million years ago [Moeller
et al., 2016]. Their influence in the function of our human bodies has become
evident in the last few years. For example gut bacteria have been associated
with mood alterations in mice [Bravo et al., 2011], potentially by modulating the
production of neurotransmitters [Strandwitz et al., 2016]. Bacterial community
make up has been associated with the training of our immune system [Mazmanian
et al., 2005].
Bacteria are also social beings, living in communities [Costerton et al., 1994],
communicating [Losick & Kaiser, 1997; Miller & Bassler, 2001], cooperating and
competing with each other [Foster, 2010; Griffin et al., 2004]. These bacterial in-
teractions are likely to play a role in human health and disease. Bacterial interac-
tions have not been incorporated in our current risk assessments of pathogenicity,
although they may be significant [Cornforth et al., 2015]. Social traits can be used
for new drug development, with the “Trojan Horse” strategy being a discussed
option [Brown, West, Diggle & Griffin, 2009]. Nonetheless, such a strategy would
rely on the resistant cooperators not bouncing back in the cheater dominated
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population via evolutionary selection [Harrison, 2013; Raymond et al., 2012].
In this work, bacterial interactions were studied in the context of biofilm tol-
erance to antibiotics. Biofilms are very common in nature [Costerton, 1999] and
they are believed to be ideal for the expression of bacterial sociality [Foster, 2010].
Furthermore, they are highly tolerant to antibiotics, at a time when increased an-
tibiotic resistance has reached alarming levels [ECDC, 2013; EFSA, 2016]. The
experimental system chosen comprised of an environmental E. coli strain with a
natural ability to form thick biofilms, engineered to express the clinically relevant
blaCTX-M-14 gene (Chapter 2). This gene confers resistance to β-lactam antibiotics
by coding for the production of an antibiotic hydrolysing enzyme which is con-
sidered to be a public good, i.e a social trait [Dugatkin et al., 2005; Yurtsev et
al., 2013]. The sociality of β-lactamases in biofilms along with the interaction of
the antibiotic with the biofilm structure and the bacterial metabolic state were
the main themes investigated.
6.1 The sociality of β-lactamases
In Chapter 3 the sociality of β-lactamases was examined in biofilm and planktonic
cultures using competition experiments between β-lactamase-producing (cooper-
ators) bacteria and non-producers (cheaters). The central hypothesis was that
social cheating, i.e exploitation of β-lactamases by non-producers is enabled in
biofilms more so than in planktonic cultures due to high cell density and prox-
imity to relatives, as predicted by evolutionary theory. Additionally, in the case
of biofilms theory predicts that population mixing favours social cheating but
population segregation favours cooperation (Section 3.1.4).
The experimental results indicated that in biofilms the cheaters maintained
a higher fitness in undisrupted biofilms when they were present at low or inter-
mediate frequencies in the starting culture which is what theory predicts [Ross-
158
6. GENERAL DISCUSSION
Gillespie et al., 2007] and what other researchers reported for other social traits.
Additionally, the intact biofilm structure allowed for more cheating than dis-
rupted and re-established structures but only when initial frequencies of cheaters
were low or intermediate. When cheaters were present in high frequencies in the
starting culture, the fitness loss in undisrupted biofilms was higher than in dis-
rupted and re-established ones. Cheating was disfavoured in broth cultures, in
the presence of ampicillin. The proportion of cooperators required for maximal
biofilm viability, i.e. for total cell abundance to reach levels equal to unexposed
biofilms, was no more than 14%, when in planktonic cultures this was 6 times
higher and with no maximal viability achieved. These results support the hypoth-
esis that biofilms form a fertile ground for cooperation and social conflict between
bacterial strains but cooperation is negative frequency dependent for the cooper-
ators which does not agree with theoretical models and other experimental work
in biofilms, looking at other social traits.
Another interesting observation was that β-lactamase production in biofilms
was mostly intracellular when in broth it was extracellular instead. This may
indicate that strains were segregated in the biofilm, as theory predicts for coop-
erative behaviours, and diffusion of the public good was not required in biofilms
but it was in broth were strains were mixed. Also, the amount of enzyme pro-
duced in biofilms was not affected by the antibiotic, when in broth production
was minimal when no antibiotic was present in the media. Additionally, when the
cooperators were rare they produced more enzyme per cell on average in biofilms.
When considering targeting bacterial sociality for treatment of infection, two
questions need to be asked: (a) is it going to be effective? and (b) is it going to be
evolutionarily stable? In order for a social intervention to be successful the inter-
actions between the strains or species used and their effect on virulence need to
be well-understood. For example, it has been suggested that clonal infections are
more potent because the pathogens are more closely related and they cooperate
instead of competing, as would happen in a mixed-clone infection [Brown, Fredrik
& Taddei, 2009; Diggle, 2010; Harrison et al., 2006]. Kinship may only be an ef-
fective way to reduce virulence at an intermediate frequency though [Gardner et
159
6. GENERAL DISCUSSION
al., 2004]. With regards to the second question posed, in order to effectively treat
a pathogen that expresses a cooperative trait, the treatment has to permanently
select for cheats. However, as discussed above, the cooperator:cheater balance
has not been shown to be supportive of the elimination of the cooperative trait in
a natural experimental setting [Raymond et al., 2012]. A potentially successful
strategy was used by Ross-Gillespie et al. [2014] who found that quenching extra-
cellular siderophores in a Pseudomonas culture reduced the virulence of the strain
without evolutionary restoration of the trait. A theoretical model in support of
this strategy where a public good is targeted instead of a vital mechanism for cell
survival was developed by Pepper [2012] and showed that such a strategy can be
evolutionary stable. It has also been argued that the cost of expressing a trait
may not be the only factor affecting its potential extinction. Virulence, spatial
heterogeneity as well as host susceptibility were among the factors identified to
influence population dynamics, concluding that species coexistence, as seen in
natural systems, is an alternative scenario [Colijn et al., 2010].
When evolutionary theory is considered as an antimicrobial strategy, it is nor-
mally assumed that the pathogen-target is the resistant-cooperator but research
has showed that antibiotic resistance genes are present in the natural gut flora
[Lu et al., 2014]. In such a case, the resistant beneficial bacteria may be out-
competed by a susceptible cheat. One then has to ask whether the cooperator
or the cheater needs to be targeted in the given infection and the answer to this
question can change the strategy dramatically.
On the basis of the results discussed above, it would appear that if it is
the pathogenic cheats that need to be targeted, then the biofilms need to be
maintained undisrupted in order to maintain the structure that benefits coop-
erators more than mixing. Additionally, high antibiotic doses need to be used.
But this would only work if the cooperators were low in the first place, i.e in
later stages of infection. If on the other hand, the target was a population of
resistant cooperators that were causing the infection, then the situation would
be more complicated. Increasing the antibiotic dose in this case, would benefit
the pathogenic cooperators, unless the biofilm was disrupted. This would mainly
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work if the cooperators were present in high frequency, as this would allow for the
establishment of the susceptible cheater. This suggests that when the pathogens
are resistant cooperators, which is commonly the case, increasing the antibiotic
dose would not help to eliminate the infection, but introducing a susceptible
strain at a later stage of infection when the cooperators are high in frequency
could work as a strategy. Targeting the public good itself as suggested by others
may then be also be an option for infections caused by cooperative pathogens. If
such a strategy was chosen, then cooperators would have to be present at a low
frequency and the biofilm would have to be disrupted. In this way the cooper-
ators would be disfavoured and more extracellular enzyme would be produced,
i.e. easier target. This strategy could be combined with an antibiotic treatment
targeting virulence [Ternent et al., 2015]. According to Colijn et al. [2010] though
any of these strategies would need to be tested in a natural system in order to
identify other potential parameters affecting the dynamics.
6.2 The effect of biofilm structure on antibiotic
tolerance
In Chapter 4 antibiotic tolerance was investigated in relation to the biofilm struc-
ture, with the aid of CLSM and OCT. Three aspects of the biofilm structure were
considered for this part of the work; the structure as a barrier to the antibiotic
penetration, mechanical responses to antibiotic treatment and strain localisation
in mixed biofilms. The hypotheses that formed the core of the experimental de-
sign in this part were: a) the antibiotic is prevented from reaching its target in the
cell by the biofilm matrix. When resistant bacteria are present in the biofilms, the
hydrolysis of the antibiotic forms an additional obstacle, protecting the cells, b)
antibiotic treatment affects the bacterial populations, changing their localisation
dynamics and c) structural changes to the antibiotic contribute to the increased
tolerance seen.
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The results showed clearly that the antibiotic could penetrate the biofilm;
neither the matrix nor β-lactamases stopped it from reaching its target in the cell
wall. However, the penetration time increased with the proportion of resistant
bacteria present. The fluorescence signal coming from the cells was reduced after
the antibiotic treatment but the effect was higher in the case of fully susceptible
cells where the cell signal decreased more than in all other cases. This result
indicated that the antibiotic is not prevented from reaching its target in the
cell and it affects all populations present, even if they are β-lactamase producers.
However, when producers are present non-producers can be affected less, therefore
the antibiotic clearance appeared to be a social trait.
In terms of strain localisation, I observed that resistant cells in mixed biofilms
occupied the bottom layers of the biofilms, near the nutrient source. The two
strains were segregated with resistant cells usually surrounding the susceptible
ones, which occupied a larger area and were higher in numbers. This segregation
suggested a cooperative behaviour if the utilisation of β-lactamases as a public
good follows the same rules as other social traits such as EPS production [Kim et
al., 2016]. A potential response to the antibiotic was noticed in the case of Low
Resistant (LR) biofilms, i.e. where the proportion of resistant bacteria in the
founding population was less than 10% (this number did not increase substan-
tially during the experiment). In LR biofilms resistant cells formed more distinct
clusters, compared to LR biofilms that had not been exposed to ampicillin. This
may be the result of the antibiotic affecting susceptible cells locally, as well as re-
sistant cells that happened to be scattered and isolated, leaving behind a stronger
cluster of resistant cells.
Finally, fully susceptible biofilms, exposed to ampicillin showed a lower poros-
ity compared to unexposed susceptible biofilms. Mixed exposed and unexposed
biofilms showed higher porosity than single-strain biofilms. If low porosity is in-
deed an indication of a stressed biofilm [Picioreanu et al., 1999], this could explain
the observed change in these experiments. Other properties of the biofilm could
be investigated using image analysis, that could provide clues for further research
in how bacterial interactions may affect the biofilm structure and the other way
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round. For instance, the direction of biofilm growth and heterogeneity can be
used as evidence for competition or cooperation within the biofilms; maybe only
one of the populations grows in a certain direction and not the others and this
may be a response to certain environmental conditions.
To the best of my knowledge this is the first time that the structure of colony
biofilms has been recorded in full depth. When colony biofilms are investigated,
the top layers only can normally be recorded with CLSM due to technical difficul-
ties related to light penetration. Drying the biofilm allowed us to overcome the
difficulty and the addition of OCT provided further information about growth in
colony biofilms.
6.3 The effect of metabolic rates on antibiotic
tolerance
In Chapter 5 the physiological state of the cells was looked at. I hypothesised
that as biofilms age they become more tolerant to antibiotics and this corresponds
to lower metabolic rates. Additionally, if low metabolic rates is a mechanism of
tolerance, then cells originating from biofilms pre-exposed to antibiotics would
show higher tolerance levels. ATP appears to reduce when dormancy mecha-
nisms are triggered and has been suggested as the phenotypic switch that induces
dormancy [Lewis, 2010b]. I found that both mean ATP production and antibi-
otic tolerance to β-lactam ampicillin and fluoroquinolone ofloxacin fluctuated in
biofilms younger than 24 h old. Subsequently, mean ATP production reduced and
stabilised over time and antibiotic tolerance increased and stabilised in a corre-
sponding pattern. Furthermore, biofilm cells that survived antibiotic treatment
were indeed more tolerant to the new antibiotic challenge, consistent with the
initial hypothesis. However, ATP production in pre-exposed biofilm cells was in
fact higher than in non-exposed ones.
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Tolerance levels seen in these experiments were significantly higher than what
was found in the literature (less than 10% tolerance), i.e. more than 50% and
often 100% of cells tolerated both antibiotics, reflecting the differences to the
methodology used. In order to retain the metabolic state of the cells as similar
as possible to what it was before biofilm disruption, the methodology chosen
deviated from the work of others who used ideal growth conditions to measure
tolerance at. The antibiotic challenge was kept relatively short (2 h) and during
this time the cells were incubated at room temperature in no nutrient containing
media. In this way the metabolic state of the cells was kept unchanged throughout
the experiments as indicated but colony counting in controls were no antibiotic
was present. In most cases, the number of cells recovered was the same as at
the point of disruption. When ideal growth conditions were used for incubation
during the antibiotic challenge, the results obtained were more in line with results
typically reported elsewhere, but the controls showed that the cells exhibited
growth under these conditions. Therefore, the extent of tolerance in biofilm-
released cells related to slow metabolic rates cannot be captured when cells are
prompted to grow. The cells surviving in this way, which is a proportion of less
than 1%, may be cells in deep dormancy or there may be a different, yet unknown,
mechanism involved.
The mean ATP production per cell in young biofilm oscillated until it sta-
bilised after 24 h. This is an indication of a differing gene regulation pattern in
immature biofilms. Mempin et al. [2013] found that extracellular ATP is produced
in planktonic bacterial cultures and that this ATP was higher in the exponential
phase and minimised at the stationary phase. The ATP production followed a
curve pattern with a peak at the transition from the exponential to the stationary
phase. These researchers found that the ATP depletion in stationary cells was
related to the ATP consumption by the cells which enhanced survival. If this is
the case, we can speculate that in young biofilms, as the population grows, more
ATP is produced until there is enough to sustain the population and as the cell
abundance stabilises the production drops. Since ATP production did not affect
tolerance negatively, this suggests that metabolism, as measured by mean ATP
production per cell, may not be the only mechanism involved in tolerance. Of
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course not all cells metabolise at the same rate in a biofilm, but given the ex-
tremely high levels of tolerance seen in these experiments, one could assume that
a generalisation regarding metabolic rates for the biggest part of the population
may not be unjustified. This does not rule out the possibility that a very small
percentage of the population is indeed in a state of dormancy, unaffected by all
the changes discussed.
In conclusion, it is critical that a methodology to measure growth and metabolic
rates in situ, in biofilms is developed in order to get a better understanding of how
metabolism may be implicated in antibiotic resistance. Additionally, it would be
interesting to compare persister levels in cooperative populations against non-
cooperative ones in order to confirm whether the suggestion that persistence may
be an insurance against the elimination of self-destructive cooperators in a pop-
ulation Ackermann et al. [2008]
6.4 Conclusion
Intracellular β-lactamases can be exploited as public goods, since they detoxify
their immediate environment. Indeed, cheating was highly enabled in the ex-
perimental system used here. However, given that the biofilms tested were not
homogeneous, i.e the resistant and susceptible populations were not perfectly
mixed, and the production of the public good was mostly intracellular, the mech-
anism of sociality needs to be investigated further. It has been reported elsewhere
that nutrient availability promotes the seclusion of cooperators within their own
group but under nutrient-stress conditions cooperators are outcompeted [Mitri
et al., 2011]. Lineage segregation is also believed to promote cooperation as
well-mixed populations allow for better exploitation of public goods [Nadell et
al., 2010], which may be related to the resistant cell clustering we observed in
antibiotic-stressed biofilms when the resistant phenotype was rare.
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Another line for investigations could be directed towards the changes in the
mechanical properties of the biofilms as a response to mixed populations and to
antibiotic stress. Porosity was a parameter evidently affected in my experiments.
Stress appeared to decrease porosity when mixed population biofilms appeared
to form more porous biofilms irrespective of antibiotic stress conditions. These
results indicate that the use of space in biofilms is affected both by social inter-
actions and environmental conditions.
Finally, the study of metabolism in biofilms would benefit greatly from the
development of a methodology that could accurately measure metabolic rates in
situ. However, what could constitute a reliable indicator of growth in relation
to metabolic rates would also benefit from further work. My results indicate
that cells in mature biofilms are slow metabolisers and highly tolerant to antibi-
otics, however, it is not clear whether this correlation is true in younger biofilms
where high metabolic rates correlated with high tolerance as well. Although, this
discrepancy may just be due to the use of ATP as an indicator of growth.
The problem of increased antibiotic resistance is an evolutionary problem and
it should approached as such. However, caution is required when changing the
bacterial population balance in natural systems. For instance, Zipperer et al.
[2016] recently discovered a novel antibiotic-producing bacterial strain which is a
natural inhabitant of the human nose that, when present, prevented Staphylococci
infections. This is a good example of bacterial warfare indicating that bacterial
sociality can have a positive, as well as negative effect on human health. Inter-
ventions cannot be a blunt instrument but, if used wisely, this can be a promising
area for the development of new therapeutic strategies.
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Appendix A
PCR primers and cycle
conditions
198
	Table	1:	All	primers	used	for	cloning.	Homology	in	primer	sequences	are	shown	in	red.	
Purpose	
Primers	 Sequence	 Function	 Product	size	
Template	
Cloning	
componen
ts	
CATSacIF1	(1226)	
5’	–	
AAAAGAGCTCGGCGTAGCA
CCAGGCGTT		
CAT	gene	(sticky	ends)	
–	forward	primer	
1026bp	
pTOPOdif	
CATSacIR1(2251)	
5’	–	
AAAAGAGCTCGGCCGCCAG
TGTGATGGA	
CAT	gene	(Sticky	ends)	
–	reverse	primer	
CTXSacIF1(69329)	
5’-	
AAAAGAGCTCACGGTCTGCG
TTGTCGGG		
CTX-M	gene	(sticky	
ends)	–	forward	primer	
1463bp	
pCT	
CTXSacIR1(71242)	
5’	–	
AAAAGAGCTCCTGCAAACG
GTGCTGCGG		
CTX-M	gene	(Sticky	
ends)	–	reverse	primer	
CyanSacF4(2177)	
5’-	
AAAAGAGCTCTTCTGCGCTC
GGCCCTTC	
Cyan	–	amp	out	
Forward	primer	
2930bp	
pAmCyan/	
pE2-Crimson	
CyanSacR4(1781)	
5’	–	
AAAAGAGCTCTGCCCGGCGT
CAATACGG	
Cyan	–	amp	out	Reverse	
primer	
	
Cyanlac	F1	(72)	
5’	–	
CCCGACTGGAAAGCGGGCA
G		
Fluorescence	gene	
forward	primer	
1073bp	
pAmCyan/	
pE2-Crimson	
PCR	
Confirmati
on	of	
white	
colonies	
Cyanlac	R1	(1144)	 5’	–	ACCGTCTCCGGGAGCTGCAT	
Fluorescence	gene	
reverse	primer				
199
		Table	2:	PCR	conditions	for	CTXM	+SacI	sites	and	Cyan	(amp	out)+SacI	sites/Crimson(amp	out)+SacI	sites	withQ5	High	Fidelity	polymerase	and		CTXMSacI	F1/R2	and	CyanSacI	F4/R4	primers	respectively	Step	 Temperature	 Time	Initial	denaturation	 98	 1min	Denaturation	 98	 10sec	Annealing	 70	 30sec	Extension	 72	 40	sec	Repeat	steps	2-4	for	34	times	Final	extension	 72	 2min	Incubation	 10	 Forever		Table	3:	PCR	conditions	for	CAT+SacI	sites	with	Q5	High	Fidelity	Polymerase	and	CATSacI	F1/R1	primers	Step	 Temperature	 Time	Initial	denaturation	 98	 1min	Denaturation	 98	 10sec	Annealing	 71	 30sec	Extension	 72	 40	sec	Repeat	steps	2-4	for	34	times	Final	extension	 72	 2min	Incubation	 10	 Forever		Table	4:	Conditions	for	colony	PCR	to	confirm	Cyan+CTXM	DH10β	transformants	with	One	Taq	Hot	Start	Polymerase	and	CTXMSacI	F1/R1	primers	Step	 Temperature	 Time	Initial	denaturation	 94	 5min	Denaturation	 94	 30sec	Annealing	 70	 30sec	Extension	 72	 1.30	min	Repeat	steps	2-4	for	34	times	Final	extension	 72	 5	min	Incubation	 10	 Forever		Table	5:Colony	PCR	for	confirmation	of	Cyan+Cat	DH10β	transfromants	with	One	Taq	Hot	Start	Polymerase	and	CATSacI	F1/R1	primers	Step	 Temperature	 Time	Initial	denaturation	 94	 5min	Denaturation	 94	 30sec	Annealing	 71	 30sec	Extension	 72	 1	min	Repeat	steps	2-4	for	34	times	Final	extension	 72	 5	min	Incubation	 10	 Forever		
200
Table	6:	Colony	PCR	for	confirmation	of	Cyan+CAT	DH10β	white	colonies	from	plasmid	stability	assay	with	OneTaq	Hot	Start	Polymerase	and	CyanLac	F1/R1	primers	Step	 Temperature	 Time	Initial	denaturation	 94	 5min	Denaturation	 94	 30sec	Annealing	 60	 30sec	Extension	 68	 1.10	min	Repeat	steps	2-4	for	34	times	Final	extension	 68	 5	min	Incubation	 10	 Forever		 	 			Table	7:	Typical	PCR	reaction	for	a	final	volume	of	25μl	per	reaction	(double	quantities	were	used	for	a	final	reaction	volume	of	50μl)	
Components	 Quantities	(μl)	
DNA	 1.0	 1.0	
dNTPs	[10mM]	 0.5	 0.5	
Forward	primer	[10μΜ)	 1.25	 1.25	
Reverse	primer	[10μM)	 1.25	 1.25	
DNA	Polymerase	(Q5)	 0.25	 0.25	
Polymerase	buffer	 5.0	 5.0	
Polymerase	enhancer	 -	 5.0	
Water	 15.75	 10.75		Table	8:	Typical	colony	PCR	reaction	with	OneTaq	polymerase	for	a	final	reaction	volume	of	50μl	
Components	 Quantities	(μl)	
DNA	 0.0	
dNTPs	[10mM]	 1.0	
Forward	primer	[10μΜ)	 1.0	
Reverse	primer	[10μM)	 1.0	
DNA	Polymerase	(OneTaq)	 0.25	
Polymerase	buffer	 10.0	
Polymerase	enhancer	 5.0	
Water	 31.75											
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Table	9:Primers	used	for	the	sequencing	of	the	constructed	plasmids		Primer	 Sequence	 Plasmid	pCrimCTXM-3819R			 GAT	ACG	GGA	GGG	CTT	ACC	A		 CrimCTXM	&	CyanCTXM	pCrimCTXM-1319F			 GGC	CTC	GTG	ATA	CGC	CTA	TT		 CrimCTXM	&	CyanCTXM	pCrimAT-2870R			 CCG	GCT	CCA	GAT	TTA	TCA	GCA		 CrimCAT		pCrimCAT-1376F			 ACG	TCA	GGT	GGC	ACT	TTT	CG		 CrimCAT	pCyanCAT-2833R			 GAT	ACG	GGA	GGG	CTT	ACC	A		 CyanCAT	pCyanCAT-1333F		 	 GGC	CTC	GTG	ATA	CGC	CTA	TT		 CyanCAT		
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Appendix B
Crystal violet assays
Figure B.1: CV assay 1
203
Figure B.2: CV assay 2
Figure B.3: CV assay 3
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Figure B.4: CV assay 4
Figure B.5: CV assay 5
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Figure B.6: All assays
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Appendix C
Lectin Screening
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 FITC conjugated Lectins   
1 AAA_Anguilla anguilla - FITC F-4901 Sanbio 
2 ABA_Agaricus bisporus  - FITC F-5001 Sanbio 
3 ACA_Amaranthus caudatus FITC F-8201 Sanbio 
4 AIA_Artocarpus integrifolia - FITC F-6301 Sanbio 
5 AMA_Arum maculatum FITC F-8012 Sanbio 
6 ASA_Allium sativum - FITC F-8007 Sanbio 
7 BDA_Bryonia dioica - FITC F-8002 Sanbio 
8 BPA_Bauhinia purpurea - FITC F-2501 Sanbio 
9 CA_Colchicum autumnale - FITC F-8004 Sanbio 
10 CAA_Caragana aborescens - FITC F-6701 Sanbio 
11 Calsepa_Calystega sepiem - FITC F-8011 Sanbio 
12 ConA_Canavalia ensiformis - FITC F-1104 Sanbio 
13 CPA_Cicer arietinum - FITC F-6601 Sanbio 
14 CSA_Cytisus scoparius - FITC F-3201 Sanbio 
15 DBA_Dolichos biflorus - FITC L-9533 Sigma 
16 DGL_Dioclea grandiflora - FITC F-9002 Sanbio 
17 DSA_Datura stramonium - FITC F-5701 Sanbio 
18 ECA_Erythrina cristagalli - FITC F-5901 Sanbio 
19 EEA_Euonymus europaeus - FITC F-4201 Sanbio 
20 GHA_Glechoma lederacea - FITC F-9003 Sanbio 
21 GNA_Galanthus nivalis - FITC F-7401 Sanbio 
22 GS-I_Griffonia simplicifolia - FITC L-9381 Sigma 
23 HAA_Helix aspersa - FITC F-3801 Sanbio 
24 HHA_Hippeastrum hybrid (Amaryllis) - FITC F-8008 Sanbio 
25 HMA_Homarus americanus - FITC F-6201 Sanbio 
26 HPA_Helix pomatia - FITC L-1034 Sigma 
27 IRA_Iris hybrid - FITC F-8010 Sanbio 
28 LAA_Laburnum alpinum - FITC F-5301 Sanbio 
29 LAL_Laburnum anagyroides - FITC F-8101 Sanbio 
30 LBA_Phaseolus lunatus - FITC F-1701 Sanbio 
31 LcH_Lens culinaris - FITC F-1401 Sanbio 
32 LEA_Lycopersicon esculentum - FITC L-0401 Sigma 
33 LFA_Limax flavus - FITC F-5101 Sanbio 
34 Lotus_Tetragonolobus purpurea - FITC L-5644 Sigma 
35 LPA_Limulus polyphemus  - FITC F-1501 Sanbio 
36 MAA_Maackia amurensis - FITC F-7801 Sanbio 
37 MNA-G_Morniga G - FITC F-9005 Sanbio 
38 MOA_Marasmium oreades - FITC F-9001 Sanbio 
39 MPA_Maclura pomifera - FITC F-3901 Sanbio 
40 NPA_Narcissus pseudonarcissus  - FITC F-8006 Sanbio 
41 PHA-E_Phaseolus vulgaris -  FITC F-1802 Sanbio 
42 PHA-L_Phaseolus vulgaris -  FITC F-1801 Sanbio 
43 PMA_Polygonatum multiflorum FITC F-8009 Sanbio 
44 PNA_Arachis hypogaea  FITC F-2301 Sanbio 
45 PSA_Pisum sativum - FITC L-0770 Sigma 
46 PSL_Polyporus squamosus - FITC F-9006 Sanbio 
47 PTA_Psophocarpus tetragonolobus - FITC L-3264 Sigma 
48 PWA_Phytolacca americana - FITC F-1901 Sanbio 
49 RPA_Robinia pseudoaccacia  - FITC F-4101 Sanbio 
50 SBA_Glycine max - FITC F-1301 Sanbio 
51 SJA_Sophora japonica - FITC F-2901 Sanbio 
52 SNA_Sambucus nigra - FITC F-6802 Sanbio 
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53 STA_ Solanum tub - FITC F-4701 Sanbio 
54 TKA_Trichosanthes kirilowii  - FITC F-5601 Sanbio 
55 TL_Tulipa sp.  - FITC F-8001 Sanbio 
56 UDA_Urtica dioica  - FITC F-8005 Sanbio 
57 UEA-I_Ulex europaeus - FITC L-9006 Sigma 
58 VFA_Vicia faba - FITC F-4801 Sanbio 
59 VGA_Vicia graminea FITC F-4400 Sanbio 
60 VRA_Vigna radiata - FITC F-6501 Sanbio 
61 VVA_Vicia villosa - FITC F-4601 Sanbio 
62 WFA_Wisteria floribunda  - FITC F-3101 Sanbio 
63 WGA_Triticum vulgaris - FITC L-4895 Sigma 
 Alexa488 labeled lectins   
1 AAL_Aleuria aurantia lectin  Vector 
2 CCA_Cancer antennarius crude L-7200 Sanbio 
3 Co_Codium fragile L-2638 Sigma 
4 IAA_Iberis amara L-3300 Sanbio 
5 MIA_Mangifera indica crude L-6000 Sanbio 
6 PAA_Perseau americana crude L-6100 Sanbio 
7 PA-I_Pseudomonas aeruginosa L-9895 Sigma 
8 PPA_Ptilota plumosa L-9260 Sigma 
9 RTA_Trifolia repens crude L-5800 Sanbio 
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